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Starch is a carbohydrate that consists of two different types of glucose polymers, 
the linear α-1,4 linked amylose and the branched α-1,4, α-1,6 linked amylopectin 
[1]. Starch is produced by green plants where it functions as the major means to 
store energy gained from photosynthesis. It is usually stored in granules which, 
depending on the producing plant, differ in size and shape. Starch granules are 
commonly stored in seeds, fruits, rhizomes or tubers. Starch is a major carbon 
and caloric source in the human diet. In addition starch is also used in non-food 
applications such as adhesives, paper making, stiffing textiles and detergents. For 
most of these applications starch granules need to be solubilized and modified 
or (partly) degraded. 
 
Figure 1: Schematic representation of the organization of starch granules; A: SEM image of a wheat 
starch granule (2000x) treated with MaAmyA for 48 h (chapter 2); B: model showing the layers in 
a starch granule; C: organization of amylopectin (black) and amylose (blue) in starch granules and 
their relation to the layers; D: structures of amylose and amylopectin.
Starch granules mainly consist of highly organized amylose and amylopectin 
polymers which form semi-crystalline structures [1]. Three starch crystallinity 
types (A, B and C) have been identified which originate from different botanical 
origin. Type A crystallinity is mainly found in cereal starches such as wheat starch, 
type B is more common in potato starch and type C in seeds [2]. Starch granules 
consist of semicrystalline and amorphous layers (Fig. 1). In the semicrystalline 
layers the amylose molecules are highly organized and densely packed together, 
which makes them poorly accessible for enzymatic degradation by amylases 
[2,3]. To utilize the energy stored in starch granules, plants employ the enzyme 
glucan water dikinase (GWD) which phosphorylates the granular amylose and 
amylopectin polymers, making them accessible for degradation by β-amylase 
[4,5]. Most other organisms, including humans, do not have GWD enzymes, 





Most foods are processed and heated during preparation. This causes starch 
granules to swell and take up water. If this continues the starch granule loses 
its original highly organized structure and breaks apart, making the starch 
accessible for degradation by amylases. The process of starch granule swelling 
and losing its organized structure is called gelatinization [6]. Gelatinization plays 
an important role in the texture of various foods such as soup and sauces. Starch 
thus is not only a carbon and energy source but also adds functionality to various 
foods.
Degradation of starch in the human digestive system
Starch degradation in humans starts in the mouth where during chewing salivary 
α-amylase is mixed with the food. Degradation continues in the duodenum where 
pancreatic α-amylase is added. These endo-acting α-amylases degrade starch to 
short gluco-oligosaccharides like maltose and maltotriose. In the small intestine 
the gluco-oligosaccharides are degraded into glucose by brush border enzymes 
such as exo-acting α-glucosidase. The released glucose is then absorbed into the 
bloodstream [7]. Depending on how fast starches are degraded into glucose by 
these human gastrointestinal tract (GIT) enzymes, they are classified as either 
Rapidly Digestible Starch (RDS), Slowly Digestible Starch (SDS) or Resistant Starch 
(RS). The classification is based on an in vitro test called the Englyst test, which 
simulates in vivo digestion [8,9]. Starches which are degraded within 20 min 
are defined as RDS. Starches that are degraded between 20 and 120 min are 
defined as SDS. Starches that are not degraded within 120 min are defined as 
RS. Resistant starches are categorized in different types (RS1-5) based on the 
mechanism which makes them resistant (Table 1) [10,11]. Starch granules belong 
to RS2; due to their crystallinity these granules are resistant and therefore only 
slowly hydrolyzed by regular α-amylases [8,10].
Until humans invented fire and started to cook food, RS1 (physical inaccessible 
starch) and RS2 were the only 2 types of resistant starches which were part of 
the human diet, and gut bacteria likely evolved the ability to degrade these 
resistant starches in the large intestine. When humans started to cook and 
process food, the amount of RS2 in those cooked foods was reduced, making 
more starch available for degradation by human GIT enzymes [8]. On the other 
hand, a new type of resistant starch was introduced, retrograded starch (RS3) 
which forms when starchy foods are cooked and then left to cool down [8]. It is 
likely that gut bacteria again adapted and evolved improved abilities to degrade 
RS3 starch. Today, we eat all kinds of foods which may include raw fruits and 
vegetables, which contain RS2, as well as precooked potatoes which contain RS3. 
Even though RS is not degraded by the human GIT enzymes, no RS1, RS2 or 
RS3 starch is found in the feces of healthy adult humans [8,12]. This shows that 
present day gut bacteria present in the large intestine are able to fully ferment 




The consumption of high quantities of RDS causes a high insulin response which 
is considered unhealthy and a risk factor in development of diabetes [7,11]. 
Consumption of SDS leads to a much lower insulin response [15]. The consumption 
of SDS and RS also has been linked to an increased butyrate concentration in the 
large intestine [15–18] which is linked to various health beneficial effects such as 
colon cancer prevention [16] and prevention of insulin resistance [19]. For this 
reason the food industry is interested in methods to decrease the amount of 
RDS in foods and increase the amount of SDS and RS. Since RS is only fermented 
in the large intestine it can be used as a prebiotic to stimulate the growth of 
beneficial gut bacteria. Although it has been shown that RS1, RS2 and RS3 are 
fully fermented in the large intestine [8,11], the exact mechanisms used by 
bacteria to degrade these resistant starches are not understood. 
Table 1: Resistant Starch (RS), types and classification




Whole grain wheat 
Resistance can be reduced 
by milling, chewing
[8]
RS2 Granular starch Raw potato starch
Resistance can be reduced 






Cooked and then 
cooled starchy 
foods 
Resistance can be partly 
















plexed high amylose 
starch
Resistance depends on 
the Amylose lipid complex
[14]
For health beneficial effects the RDS content of our food may be reduced by 
replacing it by granular starch (RS2). Starch granules may be degraded in the 
large intestinal tract by bacteria that employ pore forming enzymes, especially 
those enzymes employing Carbohydrate Binding Module 74 (chapter 3). 
Bioinformatics of carbohydrate acting enzymes
Due to advances in technology, the role of bioinformatics in molecular biology 
research is increasing quickly. Previously when a bacterial strain with an 
interesting feature was found a lot of molecular work, such as the construction 
and screening of a gene library, was required to identify the genes related to 
that feature. Nowadays sequencing costs have reached levels at which it is 
affordable to sequence the full genome. Bioinformatics is then used to identify 
potentially interesting genes, in our case genes that encode starch acting 




genes, and DNA regions lacking predicted genes need to be examined in more 
detail to find potential genes encoding novel enzymes. All genes of interest can 
then be cloned, or synthesized, the encoded proteins expressed, purified and 
characterized. A variety of bioinformatics tools and databases were used for the 
analysis of the enzymes and protein domains studied in this thesis. The most 
important ones are briefly described in the following paragraphs. 
The Carbohydrate-Active enZYmes Database
The Carbohydrate-Active enZYmes (CAZy) Database [20] is one of the tools 
commonly used in carbohydrate research. It lists all carbohydrate acting enzymes 
found in finished genome sequences as well as those that have been fully 
characterized. The enzymes are grouped into different classes based on their 
activity. Currently 5 classes are defined: Glycoside Hydrolases (GHs); Glycosyl 
Transferases (GTs); Polysaccharide Lyases (PLs); Carbohydrate Esterases (CEs) 
and Auxiliary Activities (AAs). The classes are subdivided into numbered families 
based on the primary structure of the enzymes. Some larger families have been 
further subdivided into subfamilies also based on the primary structure. Most 
families have been grouped into clans based upon their fold (3D structure) and 
catalytic machinery [20]. Apart from enzyme classes, CAZy also lists conserved 
domains that are commonly associated with carbohydrate acting enzymes. 
These domains are usually part of carbohydrate acting enzymes but have an 
independent fold and 3D structure. Currently, only a single type of associated 
domain has been defined in CAZy: Carbohydrate Binding Modules (CBMs). The 
publicly available version of the CAZy database does not contain information 
about the exact domain organization of the enzymes. CAZy also does not give 
information about other conserved domains, such as FNIII (fibronectin) domains. 
The Conserved Domain Database (CDD)
After it became apparent that the primary structure of protein domains is 
commonly highly conserved, databases such as the Conserved Domain Database 
(CDD) [21] were made. CDD contains sequence alignment models for many 
different protein domains and also includes models from the SMART [22], Pfam 
[21], COG [23], TIGRFAM [24] and NCBI Clusters databases [25]. Protein domain 
models are defined based on the consensus sequences from an alignment of 
all (potential) members and 3D structure information is used to improve the 
prediction of protein domain model boundaries. For each protein domain model 
a Position-Specific Scoring Matrix (PSSM) is calculated and a PSSM ID is assigned. 
CDD can be used through its search program “CD-search” which uses the PSSMs 
and BLAST (Basic Local Alignment Search Tool) to indicate all conserved domains 
currently in CDD in one or many query amino acid sequences [21]. Since CDD 
is not coupled to the CAZy database, it does not indicate all domains in these 
enzymes. In addition domains can be listed under another name which does not 




DataBase for automated Carbohydrate-active enzyme ANnotation (dbCAN) 
Another bioinformatics tool is dbCAN [26] which works similar to “CD-search” 
but focuses on carbohydrate acting enzyme domains. It is able to identify all 
protein domains with their CAZy names and, unlike CDD, is able to find most 
carbohydrate acting enzymes domains. In contrast to CDD, dbCAN contains 
domain models based on Hidden Markov models (HMM) [27] build from the 
multiple sequence alignment for each domain [26]. No 3D structure information 
is used to make or improve these protein domain models. Since the borders of 
protein domains generally show more sequence variation, these borders cannot 
unambiguously be identified. Therefore they are commonly not (completely) 
included in the HMM models. As a result, dbCAN typically shows domains a 
bit shorter than their full length based on their 3D structure. Since the dbCAN 
database only contains information about carbohydrate acting enzyme domains, 
other domains such as FNIII domains are not included. Therefore a combination 
of both CDD and dbCAN data was used during the work described in this thesis. 
Identification of potential novel domains 
The tools mentioned above can only identify protein domains with a primary 
sequence which is similar to known domains that have been included in a 
database. After using these tools it is possible that a part of an (predicted) amino 
acid sequence that is being analyzed does not have any domain allocated to it. 
This part nevertheless may contain a novel unknown protein domain. To identify 
a potential novel domain this part of the sequence can be used in a regular 
protein BLAST search [28] to analyze whether the sequence is conserved in other 
proteins in the databases. If this is the case the sequence can be submitted to 
the Protein Homology/AnalogY Recognition Engine (Phyre2) server [29]. Phyre2 
predicts the secondary and tertiary structure of an amino acid sequence and 
compares them to known structures in the databases. For each possible hit it 
gives a confidence score based on how well the (predicted) structures match, 
as well as the sequence identity. A low sequence identity combined with a high 
confidence score indicates a potential novel domain. For confirmation, these 
potential domains need to be expressed and analyzed to determine activity or 
interaction (such as carbohydrate binding) or to resolve the 3D structure.
Degradation of starch 
Starch is degraded by various glycosidases (EC 3.2.1.-), of which α-amylases 
(EC 3.2.1.1) are the major enzymes involved (Fig. 2). The α-amylases are endo-
acting enzymes that hydrolyze the two main components of starch, amylose and 
amylopectin, into short malto-oligosaccharides. These are further degraded by 
exo-acting hydrolases into (α-D-)glucose monomers. For example in humans 
the exo-acting hydrolase, α-glucosidase (EC 3.2.1.20) is secreted in the small 
intestine to degrade short oligosaccharides into glucose (Fig. 2) which is then 




include β-amylases (EC 3.2.1.2) which release maltose as final product, and 
γ-amylases (EC 3.2.1.3) which release (β-D-)glucose. Isoamylase (EC 3.2.1.68) 
is a debranching enzyme which hydrolyzes the α-1,6 glucosidic linkages found 
at branch points in amylopectin. Other enzymes active on starch include iso-
maltase (EC 3.2.1.10) and pullulanase (EC 3.2.1.41). 
Figure 2: Schematic representation of the reaction of α-amylase (blue arrow) and α-glucosidase 
(red arrow) on amylose. Both enzymes hydrolyze the α-1,4 glucosidic linkages between glucose 
monomers The endo-acting α-amylase releases oligosaccharides of various size, depending on 
where the enzyme acted on amylose. The exo-acting α-glucosidase releases one glucose monomer 
from the non-reducing end of amylose.
α-Amylase (EC 3.2.1.1)
α-Amylases are endo-acting enzymes which hydrolyze the α-1,4 glucosidic 
linkages between glucose monomers in amylose and amylopectin (Fig. 2). Since 
they are endo-acting enzymes they are able to hydrolyze at random positions in 
the polymer and therefore rapidly reduce the average length of the amylose and 
amylopectin polymers that make up starch. Due to this, α-amylases can rapidly 
decrease the viscosity of a gelled starch solution. Maltose and maltotriose are 
the smallest products released by typical α-amylases [30,31]. 
α-Amylases occur wide spread among all types of organisms and are well-known 
and studied [31–37]. Most amylases are part of the glycoside hydrolase family 
13 (GH13) which is part of the GH-H clan, together with GH70 and GH77. This 
clan is known for its typical 3D structure of the catalytic domain which consists 





The GH13 family has currently over 30,000 members listed in the CAZy database. 
The majority of them has been assigned to one of the 42 defined subfamilies 
based on the amino acid sequence of their catalytic domains. Thus far α-amylases 
have been found in the subfamilies 1, 5, 6, 7, 10, 12, 14, 15, 19, 10, 21, 24, 27, 28, 
32, 36, 39, as well as outside any defined subfamily [20,39]. A small number of 
known α-amylases have a catalytic domain with another 3D structure (without a 
TIM barrel). These belong to the GH57 or GH119 families and are not discussed 
in this thesis. Some well-known examples of α-amylases are human salivary 
amylase [36,40], human pancreatic amylase [41], pig pancreatic amylase (PPA) 
[32], Taka-amylase A from Aspergillus oryzae (TAA) [33] and Bacillus licheniformis 
amylase (BLA) [34].
Figure 3: Schematic representation of the catalytic domain of GH13 hydrolases. The upper part of 
the figure indicates the 8 β-sheets (blue arrows) and α-helices (red cylinders) that form the TIM 
barrel which are all part of region-A. Region-B is indicated by the B-box. Region-C is indicated by 
the C-box. The lower part shows the schematic domain organization of the catalytic domain. Red 
box: AB-regions of the catalytic domain. Yellow box: C-region of the catalytic domain.
All GH13 α-amylases possess three regions, indicated as A, B and C. The A-region 
contains the conserved catalytic residues and the 8 α-helices and β-sheets that 
form the TIM barrel (Fig. 3). The B-region is located between the 3rd β-sheet and 
3rd α-helix of the TIM barrel and contains a calcium binding site. The C-region is 
located after the TIM barrel and consists of only β-sheets, including a Greek key 
motif (Fig. 3) [33,34,42]. It forms a secondary structure that is separate from 
the AB-regions, and is therefore classified as a separate domain. Despite being 
a separate domain, the C-region is required for activity but the exact role of the 
domain is currently unknown. In some cases the C-region has been linked to raw 
starch binding [43,44]. However, this does not explain the requirement of the 
domain for activity on soluble substrates.
α-Glucosidase (3.2.1.20)
α-Glucosidase enzymes are exo-acting glycoside hydrolases that release glucose as 
final product (Fig. 2). Most α-glucosidases belong to the GH13 family and have the 
same conserved regions (A, B, C) and structure with a (β/α)8 barrel as α-amylases 
(Fig. 3). So far α-glucosidases have been found in the GH13 subfamilies 17, 21, 
23, 29, 30, 31, 40 as well as outside any defined subfamily [20,39]. In addition to 
GH13, α-glucosidase enzymes have also been identified in the GH4, GH31, GH63, 




to a family. Some of these do not share all conserved regions and have a catalytic 
domain with a different 3D structure, consisting of only α-helices (α/α)
6 
[20,45]. 
Carbohydrate Binding Modules - CBMs
A Carbohydrate Binding Module (CBM) is defined as a contiguous amino acid 
sequence within a carbohydrate-active enzyme with a discrete fold which has 
carbohydrate binding activity but no enzymatic activity [46]. The domains are 
typically around 100 aa long and have an all β-sheet secondary structure (Fig. 
4) [20,47]. Each CBM type usually contains 2-3 conserved aromatic residues 
which are involved in the binding of carbohydrates. The interaction between 
CBMs and carbohydrates is mainly mediated through hydrogen bonds and 
hydrophobic interactions. The binding is relatively weak and reversible, with 
binding coefficients in the mili to micro molar range. Irriversible binding like 
cellulose cohesin-dockerin complexes have binding coefficients in the nano 
to picomolar range. Since CBM bind reversible, carbohydrate acting enzymes 
can use CBMs to bind to carbohydrates and dissociate after catalysis to bind 
to another carbohydrate chain. To increase the binding strength some CBM 
domains (such as CBM20) have more than one binding site [48]. Alternatively, 
enzymes also may contain multiple copies of a CBM. For example CBM25 which 
only has one functional binding site [49], commonly has multiple copies in a 
protein or is combined with other CBMs [20], (chapter 2). 
CBMs have currently been identified in about 10% of all GH enzymes listed 
in the CAZy database [20,50] (chapter 3). In 1978 mild proteolysis studies 
performed on a glucoamylase enzyme already described that a shorter active 
form of the enzyme was obtained after treatment which had decreased activity 
on soluble substrates [51]. Additional studies published in 1982 demonstrated 
starch binding for short catalytic inactive part of the protein which resulted in 
the proposal of starch binding domain (SBD) [52]. In 1986 similar studies on a 
cellulose enzyme resulted in the proposal of Cellulose binding domains (CBD) 
[53]. During the next decade more carbohydrate binding domains were found 
and described in various carbohydrate acting enzymes that either bound to 
cellulose [54–56] or starch [57,58] but also to other carbohydrates such as xylose 
[59] (xylan binding domains) and chitin [60] (chitin binding domains). When 
this became apparent it was decided in 1999 to rename all domains that were 
able to bind to a carbohydrate into Carbohydrate Binding Modules (CBM) and 
defied them in numbered CBM families based on the phylogeny of their primary 
structure (amino acid sequence). Currently, SBDs have been identified in CBM 
families 20, 21, 25, 26, 34, 41, 45, 48, 53, 58, and 69 [20]. Studies have shown 
that, using molecular tools, an SBD could be attached to an enzyme lacking an 
SBD which was unable to bind raw starch, were the engineered enzyme gained 
the ability to bind to raw starch [61–63]. It has also been shown that SBDs enable 




Fibronectin type 3 domains (FNIII domains)
A Fibronectin type 3 (FNIII) domain is an evolutionary conserved protein domain 
that is about 100 aa long which consists of 7 β-sheets and does not have any sulfide 
bonds (Fig. 5) [66]. It was first identified as the third conserved internal repeat in 
the human plasma protein fibronectin and thus was named fibronectin repeat 3, 
shortened to FNIII [67]. FNIII domains are wide spread among eukaryotes were 
they usually function as linkers to arrange other domains in space, as is also 
the case (concluded from electron microscopy studies) for human fibronectin 
[66,68]. Some variants of FNIII domains have been shown to have a functional 
role in the formation of protein-protein interactions [68–70]. FNIII domains are 
commonly found in extracellular eukaryotic proteins, especially in animals, but 
also occur in plant and yeast proteins. While the other fibronectin repeats (FNI 
and FNII) are only found in proteins of Eukarya, FNIII domains also are found in 
proteins of Bacteria and Archaea. The first FNIII domains in prokaryotes were 
reported in the chitinase A1 from B. circulans WL-12A in 1990 [71]. Two years later 
it was found that the FNIII domain was also present in other bacterial enzymes 
acting on different carbohydrates [58]. More recently FNIII domains have also 
been found in bacterial proteins other than carbohydrate acting proteins [70]. 
Currently about 33% of all known FNIII domains are found in bacteria were they 
are wide spread among the various species and genera [22]. 
Figure 4: 3D Structure of 
CBM25. β-sheets are indicated 
as yellow broad arrows, 
α-helices as purple arrows. 
Image made in JSmol based 
on the data from PDB record 




The role of FNIII domains in carbohydrate acting enzymes has been studied but 
due to contradicting results no clear function for these domains in carbohydrate 
acting enzymes is known. They have been studied in most detail in chitinases and 
amylopullanases but results between various studies differ. For example deletion 
studies have shown that the FNIII domains of chitinase A1 from B. circulans WL12 
has a positive effect on the hydrolysis of insoluble chitin [60], while on the other 
hand the FNIII domains in B. licheniformis chitinase did not have any effect on 
hydrolysis [73]. Amylopullulanase studies also show contradicting results. In one 
study the FNIII domains could be completely removed without having any effect 
on enzyme activity or binding [74], while in another study, one FNIII domain had 
a positive effect on enzyme activity [75]. Since the function of FNIII domains 
in carbohydrate acting enzymes was unclear, we used bioinformatics analysis 
combined with literature study to determine the function of FNIII domains in 
carbohydrate acting enzymes (Chapter 5). 
Figure 5: 3D Structure of FNIII. β-sheets are indicated as yellow broad arrows, α-helices as purple 
arrows. Image made in JSmol based on the data from PDB record 1FNA, published in [72].
Degradation of resistant and granular starches by bacterial enzymes
As mentioned before, human gastro-intestinal enzymes cannot degrade resistant 
starches. In the large intestine, RS1, RS2 and RS3 resistant starches nevertheless 
are fully fermented [8,12]. This indicates that bacteria present in the human 
gut have specialized enzymes and mechanisms to degrade these starches. 
Tables 2 and 3 show an overview of bacterial enzymes, obtained from various 
enviroments, which are described in literature as able to degrade raw granular 
starch (RS2). The enzymes are highly variable in size (53 – 148 kD) and absence 
or presence of SBDs. In larger amylases, removal of additional domains such as 
SBDs usually only had an effect on raw starch binding and or degradation. The 




Table 2: Complete overview of all fully sequenced bacterial enzymes for which raw starch 
degradation was experimentally demonstrated and published. All enzymes are active on 
both granular and soluble starch. Protein size was calculated from the sequence information. 
GH-subfamily information was obtained from CAZy, C-region domain classification was 














Bacillus sp. B1018 CGT BAA14140.1 GH13_2 Amy_C CBM20 Yes note ND 77 [83–85] Raw starch degradation inhibited by EDTA while raw starch binding is unaffected
Bacillus sp. TS-23 Alpha AAA63900.1 GH13_5 DUF 1939 CBM20 Yes note Yes 54 [76,86] CBM20 not required for raw starch degradation but essential for raw starch binding.
Bacillus sp. no. 195 Alpha BAA22082 GH13_32 Amy_C 2x CBM25 Yes note ND 72 [64] Raw starch degradation decreased with CBM25 copy, absent without CBM25
Kocuria varians Alpha BAJ52728.1 GH13_32 Amy_C 2x CBM25 Yes ND 77 [65]
Streptococcus bovis 148 Alpha BAA24177 GH13_28 Amy_C 2x CBM26 Yes LM 77 [87–89] LM: only light microscopy images
Lactobacillus plantarum A6 Alpha AAC45780.1 GH13_28 Amy_C 4x CBM26 ND Yes 100 [90,91]  
Thermobifida fusca Alpha ABF13430 GH13_32 Amy_C CBM20 ND ND 64 [92]  
Anoxybacillus contaminans Alpha CBX51726.1** GH13_5 Amy_C CBM20 Yes Yes 70 [93] Subfam based on AAA63900.1 
Bacillus cereus Beta BAA34650.1 GH14 None CBM20 ND Yes 62 [94]  
Bacillus firmus CGT AGR66230.1 GH13_2 Amy_C CBM20 Yes ND 80 [95]  
Bacillus subtilis strain AS01a Alpha AGC23389.1 GH13_28 Amy_C CBM26note ND Yes 72 [96] Additional CBMs may be present
Bacillus subtilis S8-18 Alpha AGJ03897.2 GH13_28 Amy_C CBM26note ND Yes 57 [97] Additional CBMs may be present
Unknown marine bact. (AmyP) Alpha ADK21254.1 GH13_39 None CBM69 ND Yes 70 [98,99]  
Cytophaga sp. Alpha AAF00567.1 GH13_5 DUF1939 None ND ND 58 [100]  
Geobacillus stearothermophilus Alpha ABH10675.1 GH13_5 DUF1939 None ND Yes 62 [101]  
Bacillus sp. YX-1 Alpha ABW87262 GH13_5 DUF1939 None ND ND 56 [102]  
Saccharomycopsis fibuligera KZ Alpha ADD80242.1 GH13_1 DUF1966 None No ND 54 [103]  
Bacillus amyloliquefaciens Alpha ADE44086.1 GH13_5 DUF1939 None Yes Yes 58 [94,104]  
Geobacillus thermoleovorans subsp. 
stromboliensis Alpha ADG45817.1 GH13_X cyc-maltodext_C None Yes LM 57 [105]
No subfam in CAZy, only light microscopy images
Bacillus licheniformis ATCC 9945a Alpha AEM05860.1 GH13_5 DUF1939 None Yes LM 55 [106] Only light microscopy images
Bacillus licheniformis Alpha ABW90124.1 GH13_5 Aamy_C None ND ND 56 [107,108] Commercial enzymes Termamyl 60 L
Bacillus aquimaris MKSC 6.2 CGT* AER68125.1 GH13_x cyc-maltodext_C None Yes Yes 60 [109] No subfam in CAZy, paper: GH13_37
Microbacterium aurum B8.A (MaAmyA) Alpha AKG25402.1 GH13_32 Amy_C 2x CBM25 
CBM74
Yes Yes 148 Chapters 2-3 This thesis 
Microbacterium aurum B8.A (MaAmyB) Exo AOF40721.1 GH13_42 Novel 2x CBM25 Yes ND 135 Chapter 4 This thesis





Enzyme type abbreviations:  Alpha: α-amylase  
   Beta: β-amylase  
   CGT: cyclomaltodextrin glucanotransferase 





* The enzyme is presented as an alpha-amylase, though experimental evidence for that is lacking. 
Its C-region is typical for cyclomaltodextrin glucanotransferase, hich also fits with the experimental 
results obtained for a similar enzyme which as shown to convert 100% soluble starch into 
α-cyclomaltodextrin [110]
**Although not confirmed by GenBank, this number is likely to refer to the protein described in 














Bacillus sp. B1018 CGT BAA14140.1 GH13_2 Amy_C CBM20 Yes note ND 77 [83–85] Raw starch degradation inhibited by EDTA while raw starch binding is unaffected
Bacillus sp. TS-23 Alpha AAA63900.1 GH13_5 DUF 1939 CBM20 Yes note Yes 54 [76,86] CBM20 not required for raw starch degradation but essential for raw starch binding.
Bacillus sp. no. 195 Alpha BAA22082 GH13_32 Amy_C 2x CBM25 Yes note ND 72 [64] Raw starch degradation decreased with CBM25 copy, absent without CBM25
Kocuria varians Alpha BAJ52728.1 GH13_32 Amy_C 2x CBM25 Yes ND 77 [65]
Streptococcus bovis 148 Alpha BAA24177 GH13_28 Amy_C 2x CBM26 Yes LM 77 [87–89] LM: only light microscopy images
Lactobacillus plantarum A6 Alpha AAC45780.1 GH13_28 Amy_C 4x CBM26 ND Yes 100 [90,91]  
Thermobifida fusca Alpha ABF13430 GH13_32 Amy_C CBM20 ND ND 64 [92]  
Anoxybacillus contaminans Alpha CBX51726.1** GH13_5 Amy_C CBM20 Yes Yes 70 [93] Subfam based on AAA63900.1 
Bacillus cereus Beta BAA34650.1 GH14 None CBM20 ND Yes 62 [94]  
Bacillus firmus CGT AGR66230.1 GH13_2 Amy_C CBM20 Yes ND 80 [95]  
Bacillus subtilis strain AS01a Alpha AGC23389.1 GH13_28 Amy_C CBM26note ND Yes 72 [96] Additional CBMs may be present
Bacillus subtilis S8-18 Alpha AGJ03897.2 GH13_28 Amy_C CBM26note ND Yes 57 [97] Additional CBMs may be present
Unknown marine bact. (AmyP) Alpha ADK21254.1 GH13_39 None CBM69 ND Yes 70 [98,99]  
Cytophaga sp. Alpha AAF00567.1 GH13_5 DUF1939 None ND ND 58 [100]  
Geobacillus stearothermophilus Alpha ABH10675.1 GH13_5 DUF1939 None ND Yes 62 [101]  
Bacillus sp. YX-1 Alpha ABW87262 GH13_5 DUF1939 None ND ND 56 [102]  
Saccharomycopsis fibuligera KZ Alpha ADD80242.1 GH13_1 DUF1966 None No ND 54 [103]  
Bacillus amyloliquefaciens Alpha ADE44086.1 GH13_5 DUF1939 None Yes Yes 58 [94,104]  
Geobacillus thermoleovorans subsp. 
stromboliensis Alpha ADG45817.1 GH13_X cyc-maltodext_C None Yes LM 57 [105]
No subfam in CAZy, only light microscopy images
Bacillus licheniformis ATCC 9945a Alpha AEM05860.1 GH13_5 DUF1939 None Yes LM 55 [106] Only light microscopy images
Bacillus licheniformis Alpha ABW90124.1 GH13_5 Aamy_C None ND ND 56 [107,108] Commercial enzymes Termamyl 60 L
Bacillus aquimaris MKSC 6.2 CGT* AER68125.1 GH13_x cyc-maltodext_C None Yes Yes 60 [109] No subfam in CAZy, paper: GH13_37
Microbacterium aurum B8.A (MaAmyA) Alpha AKG25402.1 GH13_32 Amy_C 2x CBM25 
CBM74
Yes Yes 148 Chapters 2-3 This thesis 




Table 3: Complete overview of bacterial enzymes without sequence information for which raw 
starch degradation was experimentally demonstrated and published. All enzymes are active 









binding Pore forming Size (kDa) References Notes
Bacillus circulans F-2 Alpha ND Yes Peeling note 93 [111–113] Peeled granules after 7 days incubating by the bacterium (full culture)
Bacillus sp. IMD 435 Alpha Yes Yes note ND 63, 44 [77] Only full length, a shorter 44 kDa was unable to bind or degrade granular 
starch
Bacillus sp. IMD 434 Alpha Yes Yes note ND 69, 44 [78] Only full length, a shorter 44 kDa was unable to bind or degrade granular 
starch
Bacillus sp. WN11 (76 kDa enzyme) Alpha Yes Yes ND 76 [79]  
Bacillus sp. WN11 (53 kDa enzyme) Alpha ND Yes ND 53 [79]  
Clostridium butyricum T-7 Alpha ND Yes ND 89 [114]  
Bacillus subtilis 65 Alpha ND No Yes 65 [115]
Bacillus subtilis IFO 3108 (67 kDa) Alpha Yes Yes note ND 67, 45 [80]
Binding was dependent on pH, at higher pH, binding was decreased on 
starch but degradation was hardly affected. Shorter 45 kDa version was 
unable to bind or degrade granular starch
Bacillus sp. UEB-S Alpha ND ND Yes 130 [116]
Bacillus sp. ALSHL3 Alpha Yes Yes note Yes 72, 55 [81] Only full length degrades raw starch and produces pores. A shorter 55 
kDa was unable to bind or degrade granular starch
Bacillus amyloliquifaciens ABBD Alpha ND ND Yes 97, 55, 45 [117]  Likely a heterodimer of 45 kDa and 55 kDa. 
Klebsiella pneumoniae AS-22 CGT ND Yes ND 75 [110] No hydrolysis on soluble starch but instead 100% conversion into al-
pha-cyclodextrin
Lactobacillus amylophilus GV6 AMP ND Yes ND 90 [118]
Bacillus stearothermophilus Alpha ND ND LM not reported [119] Only light microscopy images
Rhodopseudomonas sp T-20 Alpha ND Yes ND 58 [120]




Enzyme types abbreviations:  Alpha: α-amylase  
   AMP: amylopullulanase  
   CGT: cyclomaltodextrin glucanotransferase 
* Indications for presence of CBM are for example the observation of a shorter enzyme variant 







binding Pore forming Size (kDa) References Notes
Bacillus circulans F-2 Alpha ND Yes Peeling note 93 [111–113] Peeled granules after 7 days incubating by the bacterium (full culture)
Bacillus sp. IMD 435 Alpha Yes Yes note ND 63, 44 [77] Only full length, a shorter 44 kDa was unable to bind or degrade granular 
starch
Bacillus sp. IMD 434 Alpha Yes Yes note ND 69, 44 [78] Only full length, a shorter 44 kDa was unable to bind or degrade granular 
starch
Bacillus sp. WN11 (76 kDa enzyme) Alpha Yes Yes ND 76 [79]  
Bacillus sp. WN11 (53 kDa enzyme) Alpha ND Yes ND 53 [79]  
Clostridium butyricum T-7 Alpha ND Yes ND 89 [114]  
Bacillus subtilis 65 Alpha ND No Yes 65 [115]
Bacillus subtilis IFO 3108 (67 kDa) Alpha Yes Yes note ND 67, 45 [80]
Binding was dependent on pH, at higher pH, binding was decreased on 
starch but degradation was hardly affected. Shorter 45 kDa version was 
unable to bind or degrade granular starch
Bacillus sp. UEB-S Alpha ND ND Yes 130 [116]
Bacillus sp. ALSHL3 Alpha Yes Yes note Yes 72, 55 [81] Only full length degrades raw starch and produces pores. A shorter 55 
kDa was unable to bind or degrade granular starch
Bacillus amyloliquifaciens ABBD Alpha ND ND Yes 97, 55, 45 [117]  Likely a heterodimer of 45 kDa and 55 kDa. 
Klebsiella pneumoniae AS-22 CGT ND Yes ND 75 [110] No hydrolysis on soluble starch but instead 100% conversion into al-
pha-cyclodextrin
Lactobacillus amylophilus GV6 AMP ND Yes ND 90 [118]
Bacillus stearothermophilus Alpha ND ND LM not reported [119] Only light microscopy images




The smaller amylases usually belong to other GH13 subfamilies then the larger 
enzymes with extra domains (Table 2). This indicates that the catalytic domain 
itself can also play an important role in the ability of the enzyme to degrade 
granular starch.
Upon examination of starch granules, which have been partly degraded by 
amylases, with Scanning Electron Microscopy (SEM), two different types of 
degradation can be observed. Some enzymes form pores in the granules 
[81,93,94,96,97,101,109,115–117]. One enzyme was reported to peel off layer 
after layer of the granules, making them gradually smaller until they are degraded 
[112]. There are however few studies that investigated a direct role of SBDs in 
pore formation as most studies employing microscopy do not include enzyme 
truncation studies, and vice versa. In part this is due to the lack of sequence 
information available at the time SEM imaging was performed. Since many 
protein sequences have now become available, an overview can be made of the 
domain organizations of amylases with reported activity on granular starches 
(Table 2). In only one study SEM images were made from starch granules treated 
with enzyme constructs with and without the SBD. Removal of the CBM20 from 
the GH13_5 α-amylase of Bacillus sp. strain TS-23 greatly reduced starch binding 
capacity of the enzyme but it had no effect on the raw starch degrading activity 
or pore formation, which was observed for both constructs [76]. Table 2 also 
reveals that many of the amylases that are active on granular starches lack 
starch binding domains. Most of these are relatively short and thus are unlikely 
to contain additional domains next to the catalytic domain. In addition they 
often belong to different GH13 subfamilies and have a different C-region. 
In 1998 it was found that barley amylase, which does not have any CBM, has 
specialized surface binding sites (SBS) for binding to raw starch [121]. It was 
demonstrated that SBS can bind to starches and also assist in their degradation 
[43].These sites are located in the catalytic domain at the A and C regions. 
Table 2 shows that the shorter raw starch degrading amylases mainly belong to 
GH13_1 and GH13_5, for which SBS have been identified [122–124] while larger 
enzymes with CBMs belong mainly to GH13_28 and GH13_32, in which no SBS 
have been identified. In addition, the truncation study of the GH13_5 amylase 
from Bacillus sp. strain TS-23 showed that even though a CBM was present, it 
was not required for raw starch degradation [76], while in the GH13_32 amylase 
from M. aurum B8.A, raw starch degradation and pore formation activity is lost 
upon deletion of its 2 CBM25 domains, while soluble starch activity remained 
similar (chapter 2). We therefore hypothesize that short, CBM lacking, raw 
starch degrading enzymes utilize SBS to degrade raw starch without the need for 
CBMs. This would explain why they belong to different subfamilies and contain 





Based on its ability to grow on native granular potato starch, a bacterium was 
isolated from sludge obtained from a potato starch production plant waste 
water treatment facility [125]. The strain belongs to the Microbacteriaceae 
family (genus Microbacterium), which are Gram-positive soil dwelling bacteria. 
The Microbacteriaceae family is closely related to the Bifidobacteriaceae 
family, which is known for various probiotic bacteria such as Bifidobacterium 
adolescentis [126]. The isolate was identified as a Microbacterium aurum strain 
and designated Microbacterium aurum B8.A. It is a coccoid rod-shaped, non-
motile, gram-positive, aerobic bacterium that does not form spores [127]. It 
forms deep yellow colored colonies which gave the strain its name. Although 
there are currently 25 published Microbacterium genome sequences, no 
Microbacterium aurum genome sequence has yet been published. 
The Microbacteriaceae family is closely related to the Bifidobacteriaceae 
family, which is known for various probiotic bacteria such as Bifidobacterium 
adolescentis [126]. The isolate was identified as a Microbacterium aurum strain 
and designated Microbacterium aurum B8.A. It is a coccoid rod-shaped, non-
motile, gram-positive, aerobic bacterium that does not form spores [127]. It 
forms deep yellow colored colonies which gave the strain its name. Although 
there are currently 25 published Microbacterium genome sequences, no 
Microbacterium aurum genome sequence has yet been published. 
In previous work it was demonstrated that in contrast to the M. aurum DSMZ 
8600 type strain, the M. aurum B8.A strain secretes enzymes which degrade 
granular starches through pore formation [127]. The genome of the strain was 
sequenced and found to contain 111 carbohydrate acting enzyme homologs 
including 37 glycoside hydrolases, of which 15 belong to the GH13 family (Valk 
et al., manuscript in preparation). Interestingly two completely novel, large 
and multi-domain, GH13 enzymes were found located next to each other on 
the genome which are absent from other genome sequenced Microbacterium 
strains, while homologs for most of the other GH13 enzymes were present. In 
addition a large fragment of about 500 amino acids with most of the additional 
domains appeared to be duplicated between these two GH13 enzymes. This 
thesis describes the characterization of these two large multi-domain amylases, 




Scanning electron microscope image of a partly degraded wheat starch granule after 72 hours of 
incubation with MaAmyA, a heterologously expressed α-amylase enzyme from Microbacterium 





The aim of this study was to explore the amylolytic enzyme system employed by 
the Gram-positive bacterium Microbacterium aurum B8.A to degrade raw starch 
granules and to assess the roles of specific enzyme domains.
Chapter 2 describes the characterization of MaAmyA, a large multi-domain 
α-amylase, with 2 CBM25 domains, 4 FNIII domains and a novel C-terminal 
domain. Phylogenetic analysis showed that it differs greatly from other related 
amylases currently in databases. Mutant MaAmyA proteins with C-terminal 
deletions of different lengths revealed an essential role of the CBM25 domains 
in the granular starch utilization and pore forming ability of MaAmyA. 
Chapter 3 describes the characterization of the novel CBM74 located at the 
C-terminus of MaAmyA. Phylogenetic analysis showed that CBM74 is mainly 
found in large and complex α-amylases, many of which originate from bacteria 
isolated from human gut related environments. Therefore a role of CBM74 in 
degradation of resistant starches in the large intestine is suggested. 
Chapter 4 describes the characterization of MaAmyB, a member of a novel 
subfamily of GH13. This enzyme shows exo-acting activity with a preference 
to initially release maltohexaose, but is also able to degrade maltohexaose to 
maltose while releasing glucose. In addition the chapter discusses how MaAmyA 
and MaAmyB may have evolved from related bacterial enzymes. 
Chapter 5 studies the role of FNIII domains in MaAmyA and MaAmyB and other 
carbohydrate acting enzymes mainly using bioinformatics tools and approaches, 
and concludes that these domains are likely to function as flexible linkers 
between the various domains present. 
Chapter 6 summarizes the thesis contents. A model is proposed for the combined 
actions of MaAmyA and MaAmyB resulting in efficient degradation of granular 
starches, taking into account the specific roles of the various domains.
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Abstract
The bacterium Microbacterium aurum strain B8.A, originally isolated from a 
potato plant waste water facility, is able to degrade different types of starch 
granules. Here we report the characterization of an unusually large, multi-
domain M. aurum B8.A α-amylase enzyme (MaAmyA). MaAmyA is a 1417 amino 
acid protein with a predicted molecular mass of 148 kDa. Sequence analysis 
of MaAmyA shows that its catalytic core is a family GH13_32 α-amylase with 
the typical ABC domain structure, followed by a Fibronectin (FNIII) domain, 
two Carbohydrate Binding Modules (CBM25) and another three FNIII domains. 
Recombinant expression and purification yielded an enzyme with the ability to 
degrade wheat and potato starch granules by introducing pores. Characterization 
of various truncated mutants of MaAmyA revealed a direct relation between the 
presence of CBM25 domains and the ability of MaAmyA to form pores in starch 
granules, while the FNIII domains most likely function as stable linkers. At the 
C-terminus, MaAmyA carries a novel 300 aa domain which is uniquely associated 
with large multi-domain amylases; its function remains to be elucidated. 
We conclude that M. aurum B8.A employs a novel multi-domain enzyme system 
to initiate degradation of starch granules via pore formation. 
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Introduction
Starch is an excellent carbon- and energy source for many micro-organisms, 
which employ a dedicated set of proteins for extracellular hydrolysis of this 
polysaccharide, uptake of shorter oligosaccharides into the cell, and further 
degradation into glucose. Most studies on degradation of starch by microbial 
enzymes have focused on soluble starch. This has resulted in identification and 
characterization of a large variety of enzymes, cleaving either α(1-4) or α(1-6) 
linkages in amylose and amylopectin. Most of these enzymes belong to glycoside 
hydrolase family 13 (GH13) [20]. Sequence diversity is such that at the moment 
family GH13 counts a total of 40 subfamilies [20]. Most of the new members 
in subfamilies are identified in DNA sequencing projects and biochemical 
information about the activity and specificity of these potentially new enzymes 
is strongly lagging behind.
Many plants produce starch in a granular form for the storage of carbohydrates. 
The crystallinity of such granules varies with the plant source. Potato starch 
granules have a relatively high degree of crystallinity making them notoriously 
resistant to bacterial and fungal degradation [128–130]. Nevertheless, some 
micro-organisms have been reported to employ enzymes able to digest granular 
starch [98,131]. 
Amylases found to be involved in granular starch degradation are often multi-
domain enzymes that include one or more Carbohydrate Binding Modules 
(CBMs) which aid in the binding of the enzyme to the granular substrate 
[64,65,132,133].
In previous work we have isolated various bacteria able to grow on potato 
starch granules as carbon source and evaluated their enzymatic degradation 
mechanism. Initially this resulted in identification of an enzyme mechanism 
involving peeling off layer after layer of the starch granules in Paenibacillus 
granivorans [134]. 
In this paper we focus on the bacterium Microbacterium aurum strain B8.A that 
originally has been isolated from a potato plant waste water facility. It is able to 
degrade different types of starch granules as carbon and energy source. Recently 
we reported that it attacks and degrades granular potato starch by an alternative 
mechanism initially involving pore formation in wheat, tapioca and also potato 
starch granules[127]. 
This paper reports the characterization of an unusually large M. aurum B8.A 
α-amylase enzyme (MaAmyA) that is able to form pores in starch granules in 
vitro and that belongs to the GH13 subfamily 32 (GH13_32). MaAmyA is about 2 
times larger than other GH13_32 members with a single catalytic domain. Next 
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to the catalytic domain, MaAmyA also contains two CBM25 domains and it is the 
only known GH13_32 member with FNIII domains. Multiple deletion constructs 
of MaAmyA were expressed and characterized to study the roles of the different 
domains in degradation of both soluble and granular starches. A direct relation 
between the presence of CBM25 domains in MaAmyA and its ability to form 
pores in starch granules was observed. 
Materials and Methods
Bacterial strains, media, and plasmids
Microbacterium aurum strain B8.A was isolated from a waste water treatment 
plant of a potato starch processing factory. Isolation and growth conditions have 
been described previously [127]. Escherichia coli TOP10 and BL21(DE3) were 
cultivated at 37 oC overnight in LB with orbital shaking (220 rpm). When required, 
ampicillin or kanamycin was added to a final concentration of 100 or 50 µg·mL-1, 
respectively. Vector pZERO-1 (Invitrogen) was used to construct a genomic 
library of M. aurum B8.A in E. coli Top10. The pCR-XL-TOPO vector (Sigma) was 
used for sequencing of the MaAmyA encoding gene; pET-15b (Novagen) was 
used as expression vector for the amyA gene constructs in E. coli BL21(DE3). 
Bioinformatic tools
All BLAST searches were performed with NCBI BLASTP using standard settings. 
To find all sequences related to the catalytic domain of MaAmyA, aa57-504 were 
used as query in BLAST searches, using standard settings but with the maximum 
target sequences increased to 1000 (instead of the default 100). Conserved 
domains were detected using both the NCBI conserved domain finder [135] with 
forced live search, without low-complexity filter, using the conserved domain 
database (CDD), and dbCAN [26] with standard settings. Signal sequence was 
predicted with SignalP4.1 [136] using standard settings. Catalytic AB regions 
of the GH13 domain sequences were extracted from the full length enzymes 
based on dbCAN domain information. CBM25 domain sequences were extracted 
from the full length protein sequences based on CDD information. Alignments 
were made of the extracted domain sequences with Mega6.0 [137] using its 
build-in muscle alignment with standard settings. Alignments were checked for 
the correct positions of conserved residues and manually tuned when needed. 
Phylogenetic trees were made with Mega6.0 using the maximum likelihood 
method with gaps/missing data treatment set on “partial deletion” instead 
of “full deletion”. Trees were visualized with Interactive Tree Of Life v2 [138]. 
The protein domain annotations shown in the trees are based on combined 
data from CDD and dbCAN. Information about GH13 subfamilies was obtained 
from the CAZy database [20]. An initial tree with a diverse selection of all GH13 
subfamilies was constructed to select the closest related subfamilies for display 
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in the final tree. The selection included multiple amylases from each of the 40 
defined subfamilies, which varied in domain organization and origin. The final 
tree based on catalytic domain region AB, included MaAmyA, all GH13_32 
members present in the CAZy database as well as a selection of themost closely 
related proteins based on the initial tree. The tree based on CBM25 domain 
sequences included the CBM25 domains from MaAmyA as well as 153 CBM25 
domains listed in CAZy with a GenBank link. 
Genomic DNA library and gene identification 
Chromosomal DNA isolated of M. aurum B8.A was partially digested with 
Sau3A restriction enzyme (NEB), cloned into the pZERO-1 vector (Invitrogen) 
and transformed to E. coli Top10. Transformants were grown on LB agar plates 
containing red amylopectin to screen for α-amylase activity [139,140]. Colonies 
producing the largest halo sizes were isolated and the plasmid inserts sequenced.
Expression constructs of MaAmyA in E. coli
To easily create C-terminal truncations of MaAmyA, pBAD-VV was constructed 
by insertion of a synthesized multiple cloning site (containing removable N- 
and C-terminal His-Tags, a stop codon after the C-terminal His-Tag and various 
restriction sites (NdeI, SpeI, NotI, PstI and EcoO109I) into pBAD/Myc-His B, 
using NcoI and EcoRI. The existing NdeI site in pBAD/Myc-His B was disrupted 
with site directed mutagenesis. Full length amyA gene was obtained using 
PCR with the FW primer: gatgcatgatatcatatgtatccgaaaggaacaggcgca and RV 
primer: gctactctagaggatccttaacaccttggggtgggtgtgtggacta (restriction sites are 
underlined). The resulting PCR product was ligated into pCR-XL-TOPO vector and 
then inserted into pBAD-VV using NdeI and SpeI restriction (Fig. S1). The final 
constructs were made through single restriction and self-ligation of amyApre 
and subsequently transferred to pET15b using NdeI and EcoRI. The amyA 
construct was obtained through PstI restriction, the amyA2 construct through 
NotI restriction, and amyA4 through EcoO109I restriction (Fig. S1). For the 
amyA7 construct, an additional PstI site was inserted in the amyApre construct 
through site directed mutagenesis, which was then cut with PstI, self-ligated and 
transferred to pET15b (Fig. S1). All products were confirmed through sequencing 
(GATC-Biotech). Final constructs all had an N-terminal His-Tag from the pET15b 
vector and a C-terminal His-Tag from amyApre. The terminator present in pET15b 
was removed. All constructs were prepared with both an N- and C-terminal 
His-Tag.
Protein expression 
Recombinant E. coli strains were grown as 500 ml cultures in 3 l flasks, with 
100 µg·ml-1 ampicillin and 50 µM (final concentration) IPTG for 6 h at 30 °C (220 
rpm) and then for 40 h at 18 °C (220 rpm). Cells were collected by centrifugation 
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at 4250 x g for 20 min at 4 °C (Thermo Lynx 4000). Pellets were resuspended 
in 50 mM Tris-HCl buffer pH 6.8 containing 10 mM CaCl
2
. Protease inhibitors 
(Mini EDTA-free Protease Inhibitor, Roche) were added and cells were broken 
by sonication (15 sec at 10,000 Ω, 30 sec cooling, 7 x). Cell debris and intact 
cells were removed by centrifugation at 15,000 x g for 20 min at 4 °C. Resulting 
cell free extracts were immediately used for His-Tag purification of recombinant 
proteins. 
His-Tag purification
The pH of E. coli cell lysates was adjusted to pH 7.5 and after mixing with Ni-NTA 
(Sigma-Aldrich) they were left to bind for 1 h at 4 °C. The column was washed 
5 times with 2 column volumes of 50 mM Tris buffer pH 8.0 containing 10 mM 
CaCl
2, 
250 mM NaCl, 20 mM imidazole. Then the column was eluted 3 times 
with 2 column volumes of 50 mM Tris buffer pH 8.0 containing 10 mM CaCl
2
, 
250 mM NaCl, 500 mM imidazole. Elution fractions were desalted using a 5 ml 
desalting column (Amersham Pharmacia Biotech) and stored at 4 °C in standard 
assay buffer (50 mM Tris-HCl buffer pH 6.8 containing 10 mM CaCl
2
). 
M. aurum B8.A culture fluid production
M. aurum B8.A was grown as a pre-culture overnight at 37 °C at 220 rpm in LB 
medium. MMTV medium [127] containing 1% (w/v) granular potato starch (200 
ml in a 1 l flask) was inoculated with 200 µl preculture and grown for 48 h at 30 
°C, 220 rpm. The golden yellow cultures were harvested by centrifugation at 
4250 x g for 20 min at 4 °C (Thermo Lynx 4000). The resulting cell free culture 
fluid containing the extracellular enzymes was collected, 100 µg·ml-1 ampicillin 
and 100 µg·ml-1 kanamycin were added and the culture fluid was stored at 4 °C. 
Standard assay buffer 
A 50 mM Tris-HCl buffer pH 6.8 containing 10 mM CaCl
2
 was used as standard 
assay buffer for enzymatic incubations. Unless indicated otherwise all incubations 
were performed at 37 °C.
Activity staining on SDS-PAGE
SDS-PAGE analysis was used to determine protein masses. The locations of 
starch-acting enzymes were visualized in the gels on basis of their activity. SDS-
PAGE was performed as described by Laemmli [141] using precast THX gels (Bio 
Rad). Use of THX gels prevented appearance of the additional bands of protein 
fragments which were observed previously [127] (see discussion). After loading 
and running, gels were washed 3 times for 5 min in MilliQ to remove SDS and then 
incubated for 2 h in standard assay buffer containing 0.5% soluble potato starch 
(Sigma-Aldrich) [65]. After incubation the gel was stained with Lugol’s iodine 
(2.5% I
2
 / 5% KI) to visualize active protein bands. After imaging, gels were partly 
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destained by washing in MilliQ and then stained with Bio-Safe™ Coomassie Stain 
(Bio Rad) to visualize proteins. The Fermentas PageRuler prestained marker was 
included in each gel.
Activity assay and activity unit determination using CNPG3 as substrate
The CNPG3 compound with a 2-chloro-4-nitrophenol (CNP) group coupled to 
maltotriose (G3) is a suitable substrate to determine α-amylase activity [142]. 
The assay is based on the detection of the released CNP group from the CNPG3 
substrate by α-amylase activity. The enzyme solution (10 µl) to be tested was 
prepared in a 96-well microtiter plate. Prewarmed substrate (100 µl 2 mM 
CNPG3) was added and the reaction was followed through absorbance reading 
at 405 nm for 10 min in a microtiter plate reader (Spectramax plus, Molecular 
Devices, Sunnyvale CA, USA) set at 37 °C. A calibration curve was prepared 
using 0.03-0.15 mM CNP (Sigma) in assay buffer. The activity was calculated as 
µmole CNP released min-1·µl-1 of enzyme solution. One unit was defined as the 
amount of enzyme needed to release 1 mmole CNP·min-1 under standard assay 
conditions.
Enzymatic activity on soluble potato starch
Hydrolysis of soluble potato starch was determined with the 2,4-dinitrosalicylic 
acid (DNS) method by measuring the increase of reducing ends in time [143]. A 
0.4% soluble potato starch (Sigma-Aldrich, catalog no. S2004) solution in assay 
buffer was preheated at 37 °C in a heating block (VWR). Then, 2.6 U·ml-1 (CNPG3 
assay) of enzyme preparation (in assay buffer) was added at 0 min, in a total 
volume of 500 µl. Samples of 50 µl were taken at 0, 7, 14, 21, 28 min. The reaction 
was stopped by adding 50 µl DNS reagent [143] and immediate incubation at 
100 °C for 7 min in a heating block. Afterwards the samples were left to cool 
down and 400 µl of MilliQ water was added. Absorbance was measured at 540 
nm in a spectrophotometer (Spectramax Plus). A standard curve containing 833 
– 8333 µM glucose, as well as a blank sample to which no enzyme was added, 
were included. 
Granular starch degradation
The degradation of granular starch was followed by measuring the release of 
soluble carbohydrates from the granules, as determined with the Anthrone 
method [144]. Two different granular starches were used: milled potato starch 
(AVEBE) and wheat starch (Sigma-Aldrich, catalog no. S5127). Granules were 
sterilized through gamma irradiation (Synergy Health). The moisture content 
of the starches was determined with a dry-matter balance (Sartorius). For 
calculations of the percentage of starch degradation, the dry-matter content of 
the starches was considered to be 100% carbohydrate, since other components 
like protein form a minor part of the contents (<2%). Ampicillin and kanamycin 
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(100 µg·ml-1 final concentrations) were added to prevent bacterial growth. 
His-Tag purified E. coli cell free extract blank (empty vector) was included as a 
negative control. 
Granular starch substrate (2.3 ml 3.3%, w/v) was prepared in a 15 ml tube including 
300 U (CNPG3 assay) of the enzyme to be tested. Samples were incubated 
at 37 °C in a rotating wheel and gently mixed. At T= 0,1,2,3,4,5,6,14,24,48 h 
200 µl samples were taken from the suspension and centrifuged for 20 min 
at 14,000 x g. Supernatant (50 µl) was transferred to clean glass test tubes. 
Samples containing more than 8 mg·ml-1 carbohydrate were diluted with assay 
buffer before analysis. MilliQ (200 µl) and 2 ml Anthrone reagent [144] were 
added and mixed. Samples were incubated in a boiling water bath for 10 min, 
cooled down in a cold water bath and the absorbance measured at 620 nm in a 
spectrophotometer (Spectramax Plus). A calibration curve of 1.66-8.33 mg·ml-1 
glucose was included. Determination of activity (Table 1) was based on the 
hydrolysis during the first 6 h of incubation.
Pelleted starch granules were dried for 48 h at 48 °C and stored in a desiccator 
for at least 1 day. The dried starch granules were transferred to SEM stubs 
with double-sided adhesive tape and coated with gold. Scanning electron 
micrographs (SEM) were taken using the JSM-6301F Scanning Microscope 
(JEOL at the UMCG Microscopy and Imaging center (UMIC), Groningen, The 
Netherlands). The accelerating voltage (3.0 kV) and the magnification are shown 
on the micrographs. For each wheat starch sample three images were recorded 
of the same area at 750x, 2000x and 5000x magnification. For each potato 
starch sample 2 images were recorded of the same area at 2500x and 25000x 
magnification. 
Determination of pore surface sizes was performed using the digitally recorded 
SEM images with lowest magnification. Pictures were loaded in Adobe Photo 
shop (version 6.0) in grayscale picture modus, zoomed to true pixel. Pores were 
selected with “the magic wand” selection tool at following settings: size 1 pixel, 
tolerance 40, contiguous, no Anti-Alias. A total of 10 pores were randomly 
chosen and the number of pixels selected by ‘the magic wand’ was recorded for 
each pore. The average and standard deviations were calculated. The scale bar 
was used to determine the conversion of pixel numbers to µm2. 
Nucleotide sequence accession number
The sequence for the novel amylase gene amyA, isolated from M. aurum B8.A 
has been deposited into GenBank database under accession no. KP901246. 
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In previous work [127] we reported that culture fluid of M. aurum B8.A degraded 
granular starches by introducing pores initially. To identify the starch acting 
enzyme(s) involved, a M. aurum B8.A DNA library of 70,000 clones was screened 
for α-amylase activity. The clone with the highest activity carried a vector with 
an insert of 11.6 kb. DNA sequencing revealed a complete open reading frame 
of 4227 nt encoding a large, multi-domain (putative) α-amylase enzyme of 1409 
amino acids (with a predicted mass of 148 kDa), including a signal sequence of 
34 aa. The sequence of this unusually large α-amylase, designated MaAmyA, 
was confirmed when the full genome of M. aurum B8.A was sequenced recently 
(Valk et al., manuscript in preparation). 
The catalytic domain of MaAmyA shows similarity to glycoside hydrolase family 
13, subfamily 32 (GH13_32), which currently includes 109 members and is 
mainly found in bacteria [20]. The catalytic domain contains the A, B and C 
regions typical for the α-amylase superfamily [38] as well as all catalytic residues 
and regions generally conserved in α-amylases [31]. The characterization of 
MaAmyA revealed that it was enzymatically active with soluble starch but also 
degraded starch granules by introducing pores (see below). 
Figure 1: Schematic representation of the domain organization of MaAmyA and the different 
truncated derivatives, MaAmyA2, MaAmyA4, MaAmyA7, and the two related GH13_32 
amylases of Bacillus sp. No. 195 and K. varians ATCC 21971. The first and last amino acid 
number for each domain as well as the total number of aminoacids are shown in MaAmyA. 
Predicted molar masses are indicated. Colors indicate conserved regions or domains: □: 
signal sequence; ■: GH13 catalytic domain AB region; ■: GH13 catalytic domain C region; 
■: FNIII domain; ■: CBM25 domain; ■: unknown domain.
Domain organization 
A CDD [135] search revealed a total of 7 domains in MaAmyA: the N-terminal 
GH13 catalytic domain is followed by 1 FNIII domain, 2 CBM25 domains, and 
3 highly similar FNIII domains (>95% identity) (Fig. 1). The C-terminal tail of 
MaAmyA of 331 aa does not match with any known domain. A BLAST search 
nevertheless returned 26 hits for similar 300 aa long fragments (34-60% identity, 
48-72% similarity). Of the 26 hits, 21 are part of predicted multi-domain 
α-amylases. 
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Figure 2: Phylogenetic tree of all 109 GH13_32 members in CAZy, Jonesia denitrificans amylase 
(GenBank ACV09568.1) and MaAmyA. The tree is based on the alignment of α-amylase catalytic 
domains (regions AB) obtained from DbCAN (aa 74-362 for MaAmyA). Domain organization was 
based on combined CDD and DbCAN data. For comparison, mixed selections of the related subfamilies 
GH13_5, GH13_6, GH13_7, GH13_27 and GH13_28 are also included. At numbers 32 and 5, clades 
with these numbers of sequences similar to the nearby shown sequences have been collapsed to 
improve the readability of the tree. The GH13 subfamilies are indicated through the background color 
of the protein names. Domain colors and shapes are explained in the legend.
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An additional four hits are genomically linked to a nearby ORF encoding an 
α-amylase, further indicating a relation between this domain and α-amylases. 
None of these putative amylases belong to subfamily GH13_32; instead 21 
belong to GH13_28. The 300 aa fragment is usually located C-terminally of the 
catalytic domain, either at the C-terminus or in between other domains. None of 
these multi-domain α-amylases have been characterized biochemically.
Phylogenetic tree of subfamily GH13_32
In an MaAmyA full length BLAST search [28], the GH13_32 α-amylases of Bacillus 
sp. no. 195 (GenBank BAA22082) and Kocuria varians ATCC 21971 (GenBank 
BAJ52728) came up as highest similarity hits. The latter enzymes consist of a 
catalytic domain and two CBM25 domains (Fig. 1). With a predicted mass of 77 
kDa they are much smaller than the 148 kDa MaAmyA. Both enzymes have been 
described as granular starch degrading GH13_32 amylases but their mechanism 
of action on starch granules has not been investigated [39,64,65,145–147]. A 
phylogenetic tree based on the catalytic AB regions of MaAmyA and all other 
GH13_32 members [20] shows the diversity within this subfamily (Fig. 2). 
MaAmyA closely clusters with 5 other members, in a subgroup of in total 52 
GH13_32 members. Surprisingly, MaAmyA is the only protein in this subfamily 
with FNIII domains and the C-terminal tail of 300 aa. Interestingly one blade of 
the tree contains GH13_32 enzymes with a second GH13_14 catalytic domain 
(pullulanase), and several binding domains. Only one of these large enzymes has 
been described in literature [148]. 
Members of GH13_32 are richly decorated with diverse starch binding domains 
(Fig. 2). Approximately 66% of all GH13_32 subfamily members contain one 
or two CBM20 domains. CBM25 domains are relatively rare among the single 
catalytic domain enzymes (present in 7 members of GH13_32 including 
MaAmyA). However, none of the other currently known GH13_32 enzymes 
in CAZy or in the NCBI database containing non-redundant protein sequences 
possesses FNIII domains or the 300 aa C-terminal tail (data not shown). This 
makes MaAmyA an exceptional member of GH13_32.
To obtain more insight into the evolutionary origin of the CBM25 domains in 
MaAmyA, phylogenetic analysis was performed (Fig. 3). The phylogenetic tree 
shows clustering of the CBM25 domains present as tandems in MaAmyA, the 
two closely related GH13_32 enzymes of Bacillus and K. varians, and a third 
enzyme from Jonesia denitrificans DSM 20603 (GenBank ACV09568.1) with a 
similar global domain organization. The latter enzyme has not been allocated 
to a specific GH13 subfamily in CAZy but it clearly clusters with other GH13_32 
amylases (Fig. 2). 
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Figure 3: Phylogenetic tree of all 153 CBM25 domains in CAZy with sequences in GenBank and 
MaAmyA. The tree is based on the CBM25 domains obtained from CDD (aa 604-681 and 707-783 
for MaAmyA); therefore, proteins with multiple CBM25 domains also have multiple entries in the 
tree. Domain organization was based on CDD data. At number 34 a clade containing 34 sequences of 
single CBM25 domains was collapsed to improve the readability of the tree. The GH (sub)families are 
indicated through the background color of the protein names, proteins without catalytic domain are 
not colored. Domain colors and shapes are explained in the legend.
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Expression and His-Tag purification of MaAmyA
MaAmyA was successfully expressed in E. coli as full length protein and in 
truncated forms MaAmyA2, MaAmyA4 and MaAmyA7 (Fig. 1), with His-Tags 
at both the N- and C-termini of all constructs. Studies with proteins carrying 
a single His-Tag showed that only the C-terminal His-Tags were functional in 
metal-affinity chromatography purification; the presence of the N-terminal 
His-Tag resulted in higher expression levels (data not shown). Removal of the 
predicted N-terminal signal sequence did not improve protein yields (data not 
shown). Expression levels were low for all forms. Different expressions strains, 
vectors and conditions, including pBAD vector based constructs, different 
E. coli strains and a Rhodococcus expression system, were tested to improve 
expression without noticeable improvement (data not shown). The amount of 
protein obtained after purification of MaAmyA and the truncated derivatives 
was relatively low; no protein bands were visible after SDS-PAGE analysis with 
silver staining. In gel activity-staining (after SDS-PAGE and washing steps) of the 
MaAmyA protein and truncated versions, using soluble potato starch, confirmed 
the presence of all MaAmyA protein derivatives with the expected masses (Fig. 
4). The full length MaAmyA protein of 148 kDa, and the MaAmyA7 truncation 
of 114 kDa, lacking the C-terminal tail, both showed a minor additional activity 
band between 200 and 300 kDa, which may be the result of protein dimerization. 
MaAmyA also showed a band at the same height as the MaAmyA7 truncation 
which may indicate early expression termination in E. coli and (partial) loss of 
the C-terminal tail. A similar effect is seen with the MaAmyA4 truncation of 83 
kDa, which shows a lower band of approximately 73 kDa, corresponding to the 
expected mass of MaAmyA4 without the second CBM25 domain. Storage of 
the enzymes for 5 months at 4 °C did not affect these results, indicating that 
the observed fragments were not formed due to enzyme instability (data not 
show). M. aurum culture fluid showed a single activity band at the same height 
as MaAmyA. No background E. coli amylase activity was detected (empty vector 
construct). 
Enzyme activity 
The activities of the purified MaAmyA and truncated enzyme derivatives were 
determined on both soluble potato starch and granular wheat and potato starch 
(Table 1). The MaAmyA activity was set at 100 % for each substrate. The activity 
on granular potato starch was too low to be determined. MaAmyA4, MaAmyA7 
and MaAmyA have similar activity ratios for both soluble and granular starch 
(Table 1). The truncated enzyme MaAmyA2 clearly holds activity with soluble 
starch (79%) but its activity on granular starch is strongly reduced compared to 
the full enzyme. Especially the two CBM25 domains thus play a crucial role in the 
activity of MaAmyA on granular starch (see Figure 1). 
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Figure 4: Activity staining on SDS-PAGE with soluble starch of heterologously expressed, His-
Tag purified M. aurum B8.A proteins. M = marker, A = empty vector; B = MaAmyA2 (62 kDa); 
C = MaAmyA4 (83 kDa); D = MaAmyA7 (114 kDa); E = MaAmyA (148 kDa); F = M. aurum B8.A 
culture fluid. Marker masses are indicated. The main activity bands correspond with the expected 
masses of the expressed proteins.
Granular starch degradation
To study the roles of the different MaAmyA domains on pore formation in 
granular starch, wheat starch granules were incubated with MaAmyA and 
truncated MaAmyA2, MaAmyA4 and MaAmyA7 enzymes. 
Table 1: Relative activities of MaAmyA and truncated derivatives on 0.4% soluble potato starch 
and 3.3% granular wheat starch. Incubations with soluble starch were performed in triplicate, 
with granular starch in duplicate. An empty vector construct was used as negative control 
Relative activity on 
soluble starch (%)
Relative activity on wheat starch 
granules (%)
MaAmyA2 79 ± 3 9 ± 1
MaAmyA4 99 ± 2 94 ± 2
MaAmyA7 97 ± 4 83 ± 10
MaAmyA 100 ± 3 100 ± 10
M. aurum B8.A culture fluid 123 ± 5 122 ± 16
Negative control <2 <5
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During the first 6 h of incubation, MaAmyA, MaAmyA7, MaAmyA4 as well as 
the M. aurum B8.A culture fluid showed similar rates of degradation of granular 
starch, whereas MaAmyA2 and the negative control were much slower (Fig. 
5). To exclude a possible effect of the FNIII domain present in MaAmyA2, the 
experiment was also performed with this domain removed which gave similar 
results (data not shown). After longer incubation times, MaAmyA, MaAmyA7 
and MaAmyA4 continued to show similar curves but their degradation rates 
had decreased over time and activity reached a threshold at about 20%. The 
M. aurum culture fluid was most active in degrading granular starches, reaching 
about 80% degradation of wheat starch after 72 h.
Figure 5: Degradation of granular wheat starch in time by M. aurum B8.A culture fluid, MaAmyA 
and truncated MaAmyA enzymes. In each reaction, 300 U of enzyme activity (CNPG3 assay) was 
added. His-tag purified empty vector E. coli extract was added as a negative control. The total 
carbohydrate concentration in the supernatant was determined (Anthrone) and the percentage of 
granular starch degraded was calculated.
When fresh MaAmyA4 enzyme sample (300 U, CNPG3 assay) was added at 
t=24 h and t=48 h to MaAmyA4 incubations with wheat starch granules, the 
degradation rate increased again, reaching 40% degradation after 72 h (data not 
shown). This indicated that the rate of degradation decreased at least partly due 
to loss of enzyme activity within the first 48 h. The granular substrate itself thus 
was further degradable by MaAmyA4.
A selection of samples with similar degradation percentage was used for SEM 
imaging analysis (Fig. 5, 6). After 48 h of incubation the wheat starch granules 
treated with M. aurum B8.A culture fluid had lost their granular structure and 
only debris remained (data not shown).
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Figure 6: SEM images of wheat starch granules following incubation with the different M. aurum 
B8.A enzyme samples (300 U, CNPG3 assay). Magnification, x5,000. All images show granules 
that were incubated for 48 h except the culture fluid samples, which were incubated for 6h. 
A: M. aurum B8.A culture fluid; B: MaAmyA; C: the negative control; D: MaAmyA2; E: MaAmyA4; 
F: MaAmyA7.
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The SEM images were used for analysis of the pore sizes using imaging software 
(Fig. 7). Incubations with MaAmyA clearly resulted in homogeneous pore 
formation (Fig. 6B). Wheat starch granules degraded with M. aurum B8.A 
culture fluid (Fig. 6A) additionally showed a set of large pores (LP) that were 
approximately 20 times larger and absent in the MaAmyA treated granules (Fig. 
7, see LP). The truncated proteins MaAmyA7 and MaAmyA4 also introduced 
homogeneous pore sizes, although these pores were approximately 3 times 
smaller than those formed by MaAmyA (Fig. 7). This indicated a possible role 
for the C-terminal protein tail in formation of larger pores. MaAmyA2 (Fig. 6D) 
does not show pore formation and these granules look similar to the negative 
control samples (Fig. 6C). Apparently, the presence of the CBM25 domains in 
MaAmyA4 is sufficient for pore formation in granular starches. The incubations 
and subsequent image analysis were also performed with granular potato 
starch, which gave similar results: pore formation in granules was observed for 
the truncated MaAmyA constructs that included the CBM25 domains but was 




Figure 7: Pore sizes in wheat starch granules after incubation with different MaAmyA enzymes, 
or M. aurum culture fluid. The images used to determine the pore sizes were lower magnification 
images (750x) taken in the same region as the images shown in Fig. 6. All samples had been 
incubated for 48 h except the culture fluid samples which were incubated for 6 h. Culture fluid 
treated samples showed also a set of large pores (LP) which were included as a separate group.
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Discussion
This paper reports the characterization of MaAmyA, a multi-domain α-amylase 
enzyme of Microbacterium aurum B8.A, carrying four FNIII and two CBM25 domains, 
plus a novel C-terminal domain of 300 aa. The MaAmyA enzyme degrades granular 
starches by initially introducing pores. Deletion of the additional domains did not 
affect activity on soluble starch. The data clearly show that the CBM25 domains 
are essential for activity with granular starch and for pore formation. CBM25 
domains previously have been shown to be involved in granular starch degradation 
[64,65], but a role in pore formation specifically has not been reported before. 
The MaAmyA enzyme thus allows M. aurum B8.A to degrade granular starches 
directly, without the need for starch gelatinization. This may be a more general 
situation in the natural environment. Extracellular bacterial α-amylases 
degrading starch granules by peeling off layer after layer [134], or by introducing 
pores in starch granules [90,96,127] (this paper), may occur more widespread 
than currently described in literature.
On basis of its catalytic domain MaAmyA belongs to the CAZy GH13_32 
subfamily, but its length and the presence of FNIII domains and a C-terminal tail 
make it an exceptional member of this subfamily (Fig. 2). To study the roles of 
the different domains, MaAmyA as well as four C-terminally truncated proteins 
were successfully expressed in E. coli, purified and characterized. Low levels of 
expression were achieved; therefore the activity with the CNPG3 substrate was 
used to standardize the amount of protein used in further experiments. We 
assumed that the presence or absence of additional domains had no effect on the 
activity with CNPG3, in view of the small size of this substrate, and that a direct 
relation exists between CNPG3 activity and enzyme concentration. However, 
this assumption can only be made for MaAmyA and its truncated versions, but 
may not hold for M. aurum culture fluid which may contain additional enzymes. 
The M. aurum culture fluid shows a very high ratio of granular starch activity 
over CNPG3 activity (Fig. 5), compared to MaAmyA. It is therefore likely that 
the culture fluid contains one or more additional enzymes with low activity on 
CNPG3 but high activity on starch granules. 
FNIII domains 
MaAmyA has four FNIII domains, which is an unusually high number compared 
to other GH13 enzymes. α-Amylases generally lack FNIII domains (none found 
in the other 109 GH13_32 members) and when present there are rarely more 
than two. The three adjacent FNIII domains in MaAmyA are almost identical and 
may be the result of recent duplications, suggesting that they provide a strong 
evolutionary advantage. In eukaryotes, FNIII domains are widely spread and well 
known for their protein-protein interactions [71]. In prokaryotes FNIII domains 
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were initially only found in carbohydrate acting enzymes [149] but more recently 
they have been identified in a wide variety of bacterial proteins [70,150]. Little 
is known about the function(s) of FNIII domains in amylases. Published reports 
about FNIII domains in carbohydrate acting enzymes do not show a clear 
common function, with results pointing at possible roles in substrate binding 
or in enzymatic activity [60,73,74,151–153]. So far there are no reports of FNIII 
domains in prokaryotes with a function in protein-protein interactions. 
In the present study, no direct effect of the FNIII domains on substrate binding or 
enzyme activity was observed (Fig. 5-7, Table 1). Previously, FNIII domains were 
suggested to function as stable linkers between separate domains in bacterial 
cellobiohydrolase [152] and chitinase enzymes [73]. Also the FNIII domains in 
MaAmyA may function as stable linkers, between the catalytic domain and the 
CBM25 domains, and the C-terminal tail. 
CBM25 domains 
Enzymes acting on insoluble carbohydrates like granular starches often possess 
carbohydrate binding modules (CBM) [131]. When functioning in starch binding, 
they are known as starch binding domains (SBD). Currently SBDs have been 
identified in CBM families 20, 21, 25, 26, 34, 41, 45, 48, 53, 58 and 69 [20]. 
The functions of CBM25 domains have been described previously and their 
3D-structures have been resolved [44,49,147,154]. It also has been demonstrated 
that the CBM25-26 tandem in the maltohexaose forming amylase from Bacillus 
halodurans C-125 has a 50 fold stronger binding affinity to granular corn starch 
than each of these single domains [49]. A similar effect, though much lower, 
has been observed for the CBM25 tandem found in the two homologs closely 
related to MaAmyA: in the halophilic K. varians α-amylase the binding affinity 
of the CBM25 tandem was only 20% higher than that of a single CBM25 [145]. 
Despite this low increase in binding affinity, the homologous enzyme in Bacillus 
sp. no. 195 showed a 2 to 4 fold increase in degradation rate of different granular 
starches, compared to a single CBM25 domain attached to the C-terminus [64]. 
This work shows that CBM25 domains greatly enhance the ability of MaAmyA 
to degrade granular starch through the formation of pores in the granules (Figs. 
5-7), while they have little effect on activity on soluble substrates (Table 1). 
Phylogenetic analysis revealed that the CBM25 domains of MaAmyA are most 
closely related to each other, which suggests that a duplication of this CBM25 
domain occurred. The same is true for the other GH13_32 amylases with two 
CBM25 domains (Figs. 2, 3). The CBM25 domain tree (Fig. 3) suggests that an 
ancestral GH13_32 amylase acquired a single CBM25 domain, which duplicated 
only recently in the different enzymes independently, resulting in a tandem 
of CBM25 domains. These duplication events may have improved the binding 
capability and the granular starch degradation rates of the enzymes [64,145].
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Another remarkable feature of MaAmyA is the presence of a single FNIII domain 
between the catalytic core and the 2 CBM25 domains, even though both the 
CBM25 (Fig. 3) and catalytic domain (Fig. 2) cluster with two related GH13_32 
amylases lacking FNIII domains. In view of the recent duplications of the CBM25 
and FNIII domains we conclude that the M. aurum MaAmyA is able to easily 
acquire and include other domains and duplicate them. 
C-terminal tail
The presence of three FNIII domains between the preceding CBM25 domains 
and the C-terminal tail, potentially functioning as stable linkers, suggests that 
the C-terminal tail of MaAmyA has a specific functional role. Homologs were 
found in 21 other large multi-domain α-amylases. The 300 aa C-terminal tail thus 
appears to represent a novel domain that is often part of a large multi-domain 
α-amylase. The pores formed by full length MaAmyA on granular wheat starch 
are approximately 3 times larger than pores formed by AmyA4 and AmaA7 
lacking the tail (Figs. 6, 7). At present, the mechanism by which the C-terminal 
protein tail has an effect on granule pore size is unknown; deletion had no 
apparent effect on enzyme activity (Table 1, Fig. 5). Further research is needed 
to elucidate the precise role of this novel domain.
Comparison of MaAmyA with M. aurum B8.A culture fluid
The M. aurum B8.A culture fluid degraded wheat starch up to 60% further than 
incubations with only MaAmyA. Part of this difference can be explained by 
instability of MaAmyA. Still, the sharp increase in degradation rate (between 
6-12 h, Fig. 6A) could not be achieved with MaAmyA alone. Furthermore, the 
granules degraded by culture fluid show a different pore pattern than those 
degraded by MaAmyA indicating the presence of additional enzymes in the 
culture fluid. The recently obtained genome sequence of M. aurum B8.A (V. 
Valk, R. M. van der Kaaij, and L. Dijkhuizen, unpublished data) revealed 14 other 
family GH13 enzymes, one of them in close proximity to MaAmyA. In previous 
work with M. aurum B8.A culture fluids, multiple activity bands were visible in 
gels with soluble starch [127]. The current study shows that most of the sizes 
of these activity bands correspond to the sizes of the four truncated enzymes. 
Therefore it is likely that the SDS-PAGE gel analysis procedure resulted in the 
loss of one or more domains from MaAmyA. When pre-cast THX-gels were used, 
these artifacts were strongly reduced (Fig. 4). However, the culture fluid sample 
showed a second weak activity band of approximately. 130 kDa in the smear 
below the main band. This band does not correspond to any of the truncated 
MaAmyA masses. Also in view of the difference between CNPG3 activity and 
granular starch activity of the culture fluid, it appears likely that M. aurum B8.A 
harbors one or more additional enzymes involved in granular starch degradation.
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Figure S1: Schematic overview of amyApre and the different constructs prepared from it. 
AmyApre was created by cloning the amyA gene from M. aurum B8.A into pBAD-VV, a modified 
pBAD/Myc-His B vector. Final constructs were produced through restriction with the underlined 
restriction enzyme and self-ligation. 
* = Inserted PstI site to create amyA7 
# = NotI, PstI and EcoO109I sites
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Abstract
Microbacterium aurum B8.A is a bacterium that originates from a potato starch-
processing plant and employs a GH13 α-amylase (MaAmyA) enzyme that forms 
pores in potato starch granules. MaAmyA is a large and multi-modular protein 
that contains a novel domain at its C-terminus (Domain 2). Deletion of Domain 
2 from MaAmyA did not affect its ability to degrade starch granules but resulted 
in a strong reduction in granular pore size. Here, we separately expressed and 
purified this Domain 2 in Escherichia coli and determined its likely function in 
starch pore formation. Domain 2 independently binds amylose, amylopectin 
and granular starch but does not have any detectable catalytic (hydrolytic or 
oxidizing) activity on α-glucan substrates. Therefore we propose that this novel 
starch binding domain is a new carbohydrate binding module (CBM), the first 
representative of family CBM74, that assists MaAmyA in efficient pore formation 
in starch granules. Protein-sequence based BLAST searches revealed that CBM74 
occurs widespread, but in bacteria only, and is often associated with large and 
multi-domain α-amylases containing family CBM25 or CBM26 domains. CBM74 
may specifically function in binding to granular starches to enhance the capability 
of α-amylase enzymes to degrade resistant starches. Interestingly, the majority of 
family CBM74 representatives are found in α-amylases originating from human 
gut associated Bifidobacteria where they may assist in raw starch degradation. 
The CBM74 domain thus may have a strong impact on the efficiency of resistant 
starch digestion in the mammalian gastrointestinal tract.
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Introduction
Starch is an abundantly available carbohydrate, present as storage material in 
plants [155]. It forms an important part of food and feed for humans and animals. 
Depending on the preparation of our food, native plant starch granules may still 
be present in the form of resistant starch; after heating mostly solubilized starch 
remains [12]. Also due to their high crystallinity, starch granules are relatively 
resistant against enzymatic degradation. Nevertheless, a diversity of bacteria is 
able to degrade granular starch, employing highly efficient α-amylase enzymes 
(www.cazy.org) [20]. α-Amylases acting on starch granules generally contain 
one or more Carbohydrate Binding Modules (CBMs). Such auxiliary domains 
may serve to position the enzyme active site into close and prolonged vicinity 
of starch granules, allowing hydrolysis of the insoluble substrate [47,156,157]. 
More recently, lytic polysaccharide monooxygenases (LPMOs) have been shown 
to oxidatively degrade insoluble polysaccharides, including cellulose, chitin and 
resistant starches. Starch LPMOs belong to family AA13 and thus far are only 
found in fungal species [158,159]. 
In previous work we have isolated the Gram-positive bacterium Microbacterium 
aurum strain B8.A from the sludge of a potato starch-processing factory on the 
basis of its ability to use granular starch as carbon- and energy source for growth. 
Extracellular enzymes hydrolyzing granular starch were detected in the growth 
medium of M. aurum B8.A [127]. Recently we reported the characterization of 
the raw starch degrading α-amylase MaAmyA enzyme of M. aurum B8.A (chapter 
2, published as [160]). This very large α-amylase enzyme (1417 aa) carries 
multiple Carbohydrate Binding Modules (2 CBM25) and Fibronectin domains 
(4 FNIII) and initiates granular starch degradation by introducing pores (Fig. 1). 
At its C-terminus, MaAmyA carries a novel protein domain of 300 aa (Domain 
2). A truncated MaAmyA variant in which Domain 2 was removed (MaAmyA7) 
remained fully active in starch granule degradation but introduced pores 
approximately 3 times smaller in size than full length MaAmyA (Fig. 1). Further 
deletions from the C-terminal end including the 2 CBM25 domains resulted in 
the loss of granular starch degradation ability (chapter 2, published as [160]). 
Carbohydrate binding modules (CBMs) are non-catalytic protein modules 
associated with carbohydrate-active enzymes that bind to carbohydrate 
substrates and stimulate the catalytic efficiency of the enzyme [161]. CBMs 
are found in approximately 10% of all known glycoside hydrolase (GH) proteins 
recorded in the CAZy database [20,162], currently with a total of 71 CBM families. 
Starch binding domains (SBDs), constituting a CBM subgroup, are able to bind to 
starch. Currently SBDs have been found in CBM families 20, 21, 25, 26, 34, 41, 
45, 48, 53, 58, 68 and 69 [163]. SBDs are usually 100-130 aa long [48,57,163] and 
mainly present in GH13 α-amylases, GH15 glucoamylases, GH77 amylomaltases 
and GH14 β-amylases [20,162]. The best studied SBDs are found in the CBM20 
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family. Next to binding, some SBD also play a role in the disruption of the starch 
structure [157] thereby making the polymer better accessible for hydrolysis 
by the catalytic domain [164,165]. Some α-amylases contain multiple binding 
domains, from the same or different CBM families, which generally results in an 
increase in starch binding capability of the enzyme [49,64]. 
In this study we expressed and purified Domain 2 from the MaAmyA enzyme 
in Escherichia coli and show that this novel C-terminal domain does not exhibit 
any detectable hydrolytic or oxidase activity but independently interacts with 
soluble and resistant starches. This novel SBD constitutes a new CBM family 
that assists large and multi-modular α-amylases in forming pores in resistant 
starch granules. Based on amino acid sequence similarity searches, we identified 
that this novel domain is most often associated with large (>1000 aa) and 
multi-modular GH13 α-amylases that contain additional starch binding CBMs 
(CBM25 and CBM26) and several FNIII domains. Interestingly, Domain 2 most 
often occurs in Bifidobacteria species that are associated with the human 
gastrointestinal tract; therefore it is most likely important in facilitating resistant 
starch degradation by bacteria in the mammalian gut. 
Figure 1: SEM images of wheat starch granules. A: incubated for 48 h with negative control sample 
(empty vector sample), B: incubated for 72 h with MaAmyA7, C: Incubated for 72 h with MaAmyA. 
The domain organization of the enzyme used for incubation of the granules is show below the 
images, using the following colors to indicate the different domains; ■: signal sequence; ■:GH13 
catalytic domain; ■: FNIII domain; ■:CBM25 domain; ■:Domain 2. For more details see chapter 2, 
(published as [160]).
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All BLAST searches were performed with NCBI BLASTP using standard settings. 
Conserved domains were detected using both the NCBI conserved domain finder 
[135] with forced live search, without low-complexity filter, using the conserved 
domain database (CDD) and dbCAN [26] with standard settings. Alignments were 
made with Mega6.0 [137] using its build-in muscle alignment with standard 
settings and manually tuned. Alignments were visualized with Jalview 2.8.1 [166]. 
Phylogenetic trees were made with Mega6.0 using maximum likelihood method 
with gaps/missing data treatment set on partial deletion instead of full deletion. 
Trees were visualized with Interactive Tree Of Life v2 [138]. Information about 
the GH13 subfamilies was obtained from the CAZy database [20]. The domain 
organization shown in the tree is based on the combined dbCAN and CDD data. 
Signal sequences were predicted with SignalP 4.1 using “Gram-positive bacteria” 
organism group and “Sensitive” D-cutoff values [136]. Domain prediction 
servers SBASE, DOBO and DOMpro [167-169] were used with standard settings. 
Secondary and tertiary structure prediction was done using the Phyre2 server 
with standard settings [29].
Cloning and expression
CBM74 (aa1116-1415) was cloned from the M. aurum B8.A amyA gene construct 
(chapter 2, published as [160]) into pET15b using the LIC system [170,171] and the 
Fwd and Rev primers CAGGGACCCGGTGCGCTCTACTCGACCAACCCGTCGTCGCAG 
and CGAGGAGAAGCCCGGTTACAAGAAGCCTACGCTCGCGAAGCGAGC. A 
recombinant E. coli strain with an empty pET15b vector was used to produce a 
negative control sample. 
Production and purification of CBM74 protein
CBM74 -pET15b was transformed into E. coli BL21* DE3 cells (Novagen). One 
liter of LB broth supplemented with ampicillin (50 ug/ml) was inoculated with a 
5 ml overnight starter culture and incubated with shaking at 37 oC until an OD
600
 
of 1.0 was reached. Protein production was induced by the addition of 1 mM 
IPTG and the culture was incubated for a further 16 h at 20 oC. E. coli cells were 
harvested by centrifugation (4,250 g for 20 min) and the pellet was resuspended 
in 25 ml of 20 mM Tris-HCl pH 8.0, 500 mM NaCl (Buffer A) containing 0.2 mg/
ml lysozyme and 0.2 mg/ml DNaseI and lysed by sonication. The lysed cells 
were subjected to centrifugation (15,000 g for 45 min). The supernatant did not 
contain any soluble protein, CBM74 protein was only present in inclusion bodies 
in the cell pellet. The cell pellet was washed twice with Buffer A containing 0.1% 
Triton X-100 to remove membrane debris, then washed twice with Buffer A. 
The inclusion bodies were then denatured by resuspension in 200 ml Buffer A 
containing 8 M urea, and stirred overnight at room temperature. The following 
day the solution containing denatured CBM74 protein was spun down (4,250 g 
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for 20 min) and the denatured protein was dialyzed in a stepwise manner into 
2 L of Buffer A supplemented with 5 mM CaCl
2
 and 5 mM MgCl
2
 and decreasing 
concentrations of urea (4 M, 2 M, 0 M). Each dialysis step was performed over 
24 h, and the final 0 M urea dialysis step was performed twice over 48 h using 
snakeskin dialysis membrane with a 10 kDa MWCO pore size (Thermo Scientific). 
The resulting dialyzed supernatant contained soluble, refolded CBM74 protein 
which was >95% pure as assessed by SDS-PAGE (not shown), and yielded >300 
mg soluble CBM74 protein per liter of E. coli culture. CBM74 protein was further 
purified by immobilized metal affinity chromatography (IMAC), taking advantage 
of the N-terminal His
6
 tag present. The IMAC purification was carried out using 
established protocols (chapter 2, published as [160]). Purified proteins were 




All binding studies were performed in standard binding buffer (50 mM Tris-HCl 
buffer pH 6.8 containing 10 mM CaCl
2
). Granular wheat (Sigma-Aldrich, catalog 
no. S5127), waxy corn (Sigma-Aldrich, catalog number S9679) and potato starch 
(AVEBE), and cellulose (Sigma-Aldrich catalog number C6413) were washed with 
standard binding buffer and 0; 0.05; 0.1; 0.25; 0.5; 0.75; 1.0; 1.5; 2.0; 2.5; 5.0; 
7.5% (m/v) suspensions of granules were prepared in the same buffer. Of each 
suspension, 100 µl was transferred to a clean 2 ml reaction tube and the buffer 
removed through centrifugation (5,000 g for 20 sec). Subsequently, 100 µl His-
Tag purified CBM74 (0.3 mg/ml),100 µl of empty vector negative control sample 
or 100 µl of BSA (0.3 mg/ml) was added to each pellet (in triplicate). For cellulose 
and BSA, only suspensions of 2.5% (m/v) were included. The mixtures were 
incubated for 2 h at 4 °C on a roller bench. Unbound protein was removed by 
centrifugation (10,000 g for 15 sec). Pellets of the 5% (m/v) samples were kept 
for additional experiments. The supernatant was transferred to a microtiter plate 
suitable for UV measurements (Falcon), and assayed at 280 nm in a microtiter 
plate reader (Spectramax Plus; Molecular Devices, Sunnyvale, CA) with a path 
length of 0.25 cm. 
Pellets of the 5% (m/v) wheat and potato starch granule suspensions were 
washed three times with 100 µl standard binding buffer for 30 min at 4°C, 
followed by centrifugation; the supernatant of the 3rd wash was collected. Each 
100 µl suspension was then split into two 50 µl suspensions, resulting in six 50 
µl suspensions for each granule type. Two elution steps for bound CBM74 were 
performed. In the first step 50 µl standard binding buffer containing 5% (m/v) of 
the carbohydrate (buffer, maltose, glucose, dextrose, iso-maltose or mannose) 
to be tested for elution was added, mixed for 30 min on a roller bench at room 
temperature, and collected by centrifugation. In the 2nd elution step, 50 µl 
5x concentrated SDS sample buffer was added, mixed for 5 min and granules 
collected through centrifugation. Of the third washing and first elution steps, 
supernatant fractions of 20 µl were mixed with 5 µl 5x SDS sample buffer and 
57
CBM74 is a novel starch binding domain 
3
loaded onto SDS-PAGE. Of the 2nd elution 20 µl supernatant was mixed with 5 
µl buffer and loaded onto SDS-PAGE; on each gel a protein marker (Fermentas) 
and a negative control (empty vector) sample were also included. Afterwards 
the gels were stained with Coomassie Brilliant Blue R (Bio-Rad) to visualize the 
protein bands, or used for semi-dry Western blot (Bio-Rad). Additional controls 
were performed to exclude any effects of proteins naturally attached to starch 
granules (washed granules eluted with SDS-sample buffer).
The amount of CBM74 bound to the starch granules was determined with the 
calculated molar extinction coefficient (using the ExPASy ProtParam tool [172]) 
of CBM74 (49850 M−1·cm−1) and the following formula:









Bound CBM  = Concentration of CBM74 that bound to the granules (M) 
A
280 total
   = Absorbance of total CBM74 protein available for binding at zero time 
A
280 unbound
  = Absorbance of unbound CBM74 protein after 2 h incubation with granules  
ε   = Calculated molar extinction coefficient of CBM74 (= 49850 M−1·cm−1) 
l  = Spectrophotometer path length (= 0.25 cm) 
Using a Scatchard plot [173,174] the concentration of bound CBM74 divided by 
the concentration of unbound CBM74 was plotted against the concentration of 
bound CBM74. All concentrations were normalized to an equal amount of starch 
granules. 
The dissociation constants (K
d
) were determined though non-linear regression 
analysis with Microsoft Excel 2010 as described by Kemmer et al. [175], using a 
one site binding model [176]: 













Bound CBM   = Concentration of CBM74 that bound to the granules (M) 
B
max
   = The maximum binding capacity 
[S]   = Starch granule concentration (mg/ml) 
K
d
   = Dissociation constant (mg/ml)
The Ka values are equal to Kd
-1 
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Western blot
Samples were transferred onto a nitrocellulose membrane (Pharmacia) through 
semi-dry blotting (Trans-Blot Semi-Dry SD cell, Biorad) for 15 min at 20 V, using 
transfer buffer (50 mM Tris-HCl, 40 mM Glycine, 1.75 mM SDS, pH 9). After blotting, 
membranes were blocked for 1 h at room temperature with blocking buffer (140 
mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4) (Calbiochem, PBS 
tablets) containing 1% m/v BSA (Sigma) and 0.05% Tween 20 (Sigma). Then the 
membranes were incubated for 1 h with blocking buffer containing 0.02% v/v 
1-step Anti-His antibody (Qiagen), and washed (with block buffer) 3 times for 
5 min. After washing, membranes were activated with fresh mixed ECL reagent 
(Pharmacia) and exposed in a Chemidoc (Bio-Rad) for up to 30 min. 
Polysaccharide macroarray binding analysis 
The macroarray method used is based on the procedure described in [177]. All 
carbohydrates were obtained from Sigma unless indicated otherwise. Soluble 
potato starch, granular potato starch (AVEBE), granular wheat starch, granular 
waxy corn starch, amylopectin, maltodextrin and pullulan were dissolved in 
Milli-Q at a concentration of 10 mg/ml (m/v). Granular starches were (partially) 
dissolved by heating the suspension in a heating block set at 100 °C for 10 min. 
Amylose was dissolved by adding 0.1 M NaOH and subsequent addition of an 
equal volume of 0.1 M HCl. Macroarrays were prepared by spotting 1 µl of each 
dissolved carbohydrate onto a nitrocellulose (Pharmacia) membrane. The His-
Tagged protein MaAmyA7 lacking domain CBM74 and containing both an N- 
and C-terminal His-Tag (chapter 2, published as [160]) was used as a positive 
method control for proper His-Tag detection on each membrane. After spotting, 
membranes were dried to the air for at least 2 h. After blocking (see Western 
blot) the membranes were probed with 300 µg His-Tag purified CBM74, 100 
µg of His-Tag purified CBM41 (a well-characterized starch binding domain) as a 
positive control [177] or an equal volume of the negative control (empty vector) 
sample in 10 ml blocking buffer and incubated at 4 °C for 1 h. Subsequently 
membranes were treated as regular Western blots after blocking.
CBM74 enzyme catalytic activity testing
The potential catalytic activity of CBM74 on starch was tested by incubation of 
30 µg CBM74 in 1 ml standard binding buffer (50 mM Tris-HCl buffer pH 6.8 
containing 10 mM CaCl
2
) containing 10 mg/ml soluble potato starch. To test 
for LPMO activity [6] the following was added: 10 mM CuCl
2
; 5 mM L-cysteine 
(adjusted to pH 6.8); 5 µl (30 unit) barley β-amylase (Megazyme, Ireland, 1,000 
fold diluted in standard binding buffer) as well as all possible combinations of 
these additions. Reactions were incubated for 24 h at 37 °C in a heating block. 
Products formed were analyzed on TLC as described previously [178] and MALDI-
TOF MS (Shimadzu AXIMA Performance) using 2,5-dihydroxybenzoic acid (DHB) 
as matrix. All incubations and analyses were performed in duplicate.
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Results
Identification of a novel protein domain in MaAmyA
Recently we reported the characterization of MaAmyA, a large and multi-
domain α-amylase from M. aurum B8.A (1417 aa) which is able to form pores 
in starch granules. MaAmyA carries 2 CBM25 domains and 4 FNIII domains, plus 
a novel protein domain at its C-terminus that is approximately 300 aa (Domain 
2) (chapter 2, published as [160]). Deletion of this Domain 2 did not affect the 
ability of MaAmyA7 to hydrolyze granular starch, but the average pore sizes in 
starch granules were reduced 3-fold (Fig.1). This strongly suggests that Domain 
2 has a specific functional role, which is investigated here both experimentally 
and with various bioinformatics tools. 
The 300 aa C-terminal tail encoding the predicted Domain 2 of MaAmyA (Genbank 
AKG25402.1, aa1116-1415) was successfully cloned and expressed in E. coli. 
Most Domain 2 protein accumulated in inclusion bodies. After denaturing and 
refolding, soluble Domain 2 protein was obtained. SDS-PAGE analysis revealed a 
protein of 37.5 kDa, matching the predicted size of Domain 2, with > 85% purity 
(based on SDS-PAGE analysis) (data not shown).
Domain 2 of MaAmyA binds to soluble and insoluble starches
The Domain 2 protein (7 µM) was able to bind to wheat, potato and waxy 
corn starch granules present in a 5% m/v suspension. The effects of various 
carbohydrates on this binding of Domain 2 (7 µM) to the granules was studied. 
After Domain 2 binding, starch granules were washed and elution was attempted 
with 5% (m/v) solutions of maltose, glucose, dextrose, iso-maltose or mannan. 
None of these carbohydrates elicited the release of a detectable amount of 
Domain 2 from the granules (using SDS-PAGE or Western blot analysis with anti-
His-Tag). In a second elution step SDS-sample buffer efficiently released bound 
Domain 2 from the starch granules. SDS-PAGE analysis of the samples obtained 
showed protein bands corresponding to the expected mass of Domain 2 protein 
at 37.5 kDa. Also Western blot analysis with anti-His-Tag antibodies showed a 
single band at 37.5 kDa. An empty vector negative control sample did not show 
any bands (data not shown). 
To examine the possible interactions of Domain 2 with non-granular 
carbohydrates, a macroarray containing starches from several sources, as well 
as various other polysaccharides, was prepared. Purified His-Tagged Domain 2 
protein was allowed to bind to the nitrocellulose-bound starches, and its binding 
was visualized using anti-His-Tag antibodies (Fig. 2). Domain 2 was shown to bind 
to all tested starches, plus amylose and amylopectin. No relevant signals were 
detected in the empty vector negative control sample. No binding of Domain 
2 to any of the non-starch polysaccharides was observed. Positive controls 
included on each macroarray yielded expected results. Domain 2 of MaAmyA 
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thus represents a novel CBM, an SBD that is able to bind to amylose, amylopectin 
and starch granules. 
To determine the affinity of Domain 2 for starch binding, 7 µM Domain 2 protein 
was incubated with increasing percentages of different types of starch granules 
(Fig. 3). Microgranular cellulose (2.5% m/v) was included as a negative control 
and did not show any interaction with Domain 2 (data not shown). At low 
concentrations of starch granules a clear relation was observed between the 
amount of Domain 2 bound and the concentration of starch granules. At higher 
granule concentrations the amount of bound Domain 2 leveled off, indicating 
that all Domain 2 that was able to bind (45-75% of total) after the denaturation/
renaturation isolation procedure from inclusion bodies had bound to the starch 
granules. Potato starch showed a different pattern compared to wheat and corn 
starch. Potato starch saturation was reached at a lower concentration of starch 
granules and the total amount of Domain 2 that bound was significantly lower 
than with wheat and waxy corn starch (Fig. 3). The Scatchard plots [173] in which 
the concentration of bound Domain 2 divided by unbound Domain 2 was plotted 
against the concentration of bound Domain 2 were linear for all three starch 
types which suggests a single mode of binding for Domain 2 (no cooperativity). 
When it is assumed that Domain 2 has a single mode of binding, the estimated 
Ka values are: 0.15 ± 0.02 mg/ml for wheat starch granules; 0.14 ± 0.02 mg/ml for 
waxy corn starch granules and 1.4 ± 0.5 mg/ml for potato starch granules. These 
affinities are in the same range as reported for other SBD such as CBM20and 
CBM41 [132,177]. An empty vector negative control series did not show any 
protein binding with any of the granules. In addition, no aspecific protein binding 
to the granules was observed with bovine serum albumin (BSA).  
Figure 2: Polysaccharide binding macroarray with detection of bound His-
Tagged CBM74 and CBM41 proteins.  
 
Polysacharide substrates (rows):  
A: soluble potato starch 
B: boiled granular potato starch 
C: boiled granular wheat starch 







K: N- and C-terminally  
His-Tagged MaAmyA7  




Protein samples (columns):  
X : CBM74 
N: negative control  
 (empty vector sample)  
P: positive control  
(His-Tagged CBM41 sample) [177]
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Domain 2 does not show hydrolytic or LPMO enzymatic activity 
Domain 2 was tested for enzyme catalytic activity on soluble potato starch. Since 
a eukaryotic starch-degrading lytic polysaccharide monooxygenase (LPMO) was 
recently discovered that needed a cofactor (cysteine) and β-amylase to visualize 
its activity [158,159], we performed similar co- incubations with Domain 2 
protein. Even after incubation of 30 µg of Domain 2 for 24 h, no products were 
detected using TLC and MALDI-TOF MS analysis. Under the conditions tested 
we thus were unable to detect any starch acting hydrolytic or LPMO activity for 
Domain 2. 
Occurrence of Domain 2 in bacterial genomes 
A BLAST search with the Domain 2 amino acid sequence returned 77 hits 
(November 2015) for a 286-328 aa long fragment (E>4·10-25), all from bacterial 
origin. Three additional significant hits were ignored as these sequences were 
incomplete; in all cases the partial domain was located adjacent to a gap in the 
genome sequence. Domain 2 thus is not unique for MaAmyA and occurs more 
widespread in bacterial proteins. In view of its starch binding activity, absence 
of enzymatic activity, stimulatory effect on pore formation by the MaAmyA 
enzyme, and more abundant distribution in bacteria, we conclude that Domain 
2 proteins constitute a novel CBM family, designated family CBM74.
For secondary and tertiary structure prediction the amino acid sequence of 
the CBM74 domain of MaAmyA was submitted to the Phyre2 server [29]. The 




Figure 3: Binding of CBM74 protein 
(7 µM) to increasing amounts 
of different starch granules 
(0-2.5%, m/v). The unbound 
CBM74 concentration after 
incubation with starch granules 
was determined in triplicate 
through UV measurements at 280 
nm, using the calculated molar 
extinction coefficient of CBM74. 
The concentration of bound 
CBM74 was then calculated by 
subtracting the value after binding 
from an included total protein 
value (without starch granules). 
CBM74 did not bind to 2.5% m/v 
microgranular cellulose while 
BSA did not show binding to any 
of the granules tested (data not 
shown). Values are means±SD. 
: wheat starch granules 
: waxy corn starch granules 
: potato starch granules
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fragment (aa 14-110) showed resemblance to the structure of CBM9 in Xylanase 
A of Thermotoga maritima MSB8 (PDB:1I8A[A) (78% confidence) although the 
amino acid identity is low (24%) [179]. CBM9 has only been found in association 
with xylanases [180]. The predicted structure for this part of CBM74 showed 5 
β-sheets with high confidence scores, similar to CBM9. The remaining aa 111-
300 fragment did not show significant structural similarity with other known 
proteins. The predicted structure for this part of CBM74 showed 7 additional 
β-sheets with high confidence scores (Fig. 4).
Alignment of CBM74 of MaAmyA and its 76 homologs
A sequence alignment was made with all CBM74 homologs (Fig. 4). MaAmyA 
CBM74 has 34-60% identity and 48-73% similarity with its 76 homologs. Several 
conserved aromatic residues were identified, which may be of special interest 
since these are often involved in carbohydrate interaction and binding [46,181,182]. 
The overall similarity is lower in the middle part of the CBM74 domain (aa113-
201) although some aromatic residues are conserved here as well. Based on 
the alignment, two clusters were defined: cluster A with 50 sequences (45-67% 
identity, 61-78% similarity) and cluster B (35-60% identity, 48-73% similarity) 
with 27 sequences, including CBM74 from MaAmyA (see also the phylogenetic 
tree in Fig. 5). The homologs in cluster A contain an additional 86 conserved 
residues, including 8 aromatic residues, compared to the homologs in cluster B. 
CBM74 is a single domain protein
The results of the Phyre2 prediction showed structural similarity between aa14-
110 of CBM74 and CBM9. When CBM9 of Xylanase A from T. maritima MSB8 
(GenBank AAD35155.1) was included in the alignment, the first tryptophan (aa 
72) of CBM9, which is known to be involved in ligand binding [179], aligned with 
the conserved tryptophan at aa 70 in cluster B (Fig. 4). Within cluster A, this 
tryptophan is mostly substituted by a tyrosine. The second tryptophan (aa176) 
involved in ligand binding in CBM9 is not conserved in CBM74. CBM74 is much 
larger than CBM9 and has multiple other conserved aromatic residues that may 
be involved in further interactions with starch.
Figure 4 (next page): Sequence alignment of all 77 known CBM74 homologs (November 2015), 
including MaAmyA CBM74. CBM9 (aa 729-843) of Xylanase A of Thermotoga maritima MSB8 was 
included as reference [179]. For visibility, only a limited number of the CBM74 sequences (8 out 
of 50 of cluster A and 17 out of 27 of cluster B) are shown representing the maximal amount of 
variation visible between the sequences. The aa numbers are based on MaAmyA CBM74. The solid 
black line indicates the separation between clusters A and B. The dashed black line indicates the 
2 subgroups in cluster A. The gray line shows the secondary structure of CBM74 from MaAmyA 
(aa 1116-1416 of AKG25402.1) as predicted by Phyre2, with blue boxes representing β-sheets 
and green boxes representing α-helices. Color code used for amino acids: ■: aromatic residues 
conserved in all sequences; ■: aromatic residues only conserved in cluster A; ■: other conserved 
residues in all sequences; ■: only conserved in cluster A; ■: only conserved in cluster B. GenBank 
accession numbers are used as names followed by the aa number were the similarity with 
MaAmyA CBM74 protein starts. 
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The similarity between CBM9 and only the first part of CBM74 may indicate that 
CBM74 is in fact a combination of 2 domains. To investigate whether CBM74 
represents one or two domains, the aa sequence of the CBM74 domain of 
MaAmyA was submitted to three domain prediction servers (SBASE, DOBO 
and DOMpro) [167-169,183], which all predicted that it represents a single 
domain. Also in view of the observation that all 77 CBM74 homologous domains 
in the databases have a similar length (286-328 aa), we conclude that CBM74 
represents a single domain protein. 
Phylogenetic analysis of all family CBM74 members
A phylogenetic tree based on the alignment of all family CBM74 homologs and 
a selection of known CBM sequences from CAZy is shown in Figure 5, along with 
the domain organization of the proteins they belong to. The phylogenetic tree 
shows that all CBM74 homologs cluster together as a new group, separate from 
previously described CBMs. The CBM74 homologs are most closely related to 
CBM9, also reflecting the structural homology described above. Family CBM74 
shows clustering that in general matches with the host species that harbors the 
CBM74 containing protein (Fig. 5). Clusters A and B, as identified in the sequence 
alignment (Fig. 4) are clearly visible in the tree as well. Cluster A is the largest 
CBM74 cluster, containing all the CBM74 members that are part of proteins from 
mainly Bifidobacterium species, while cluster B consists of all the others (Fig. 4, 
5). CQR56564 is most likely linked to the α-amylase that is preceding it in the 
genome (CQR56565.1). Therefore CQR56564.1 was linked to this α-amylase to 
reveal the full organization of the protein. For comparison both are shown in the 
phylogenetic tree (Fig. 5). 
Of the 77 unique (and restored) CBM74 proteins, 69 CBM74 domains are part 
of Glycoside Hydrolase family 13 (GH13) α-amylases. They all have the ABC-
domains typical for α-amylases [184], even though this is not always shown in 
the domain organization (Fig. 5). This is due to the fact that a number of these 
proteins possess C-domains with a primary sequence that has a low identity with 
C-domains currently in databases. However, structural analysis using Phyre2 
[29] revealed that despite this low sequence identity all proteins shown have a 
predicted fold that is similar to that of GH13 C-domains, including the all β-sheet 
fold and typical greek key motive [184]. Of all 77 CBM74 containing proteins, 
only MaAmyA of M. aurum B8.A has been characterized experimentally, namely 
as a granular starch degrading α-amylase (chapter 2, published as [160]). Most 
of the 69 CBM74 containing α-amylases have catalytic domains that belong 
to the GH13_28 subfamily (59 sequences) or GH13_19 (9 sequences). Only 
MaAmyA from M. aurum belongs to the GH13_32 family (chapter 2, published 
as [160]). The CBM74 domain is generally present in the middle (64 sequences) 
of the protein, but never directly adjacent to the catalytic domain (Fig. 5). It 
is also found at the C-terminus of these proteins (13 sequences), but never at 
the N-terminus. MaAmyA has a C-terminal CBM74 which is preceded by 3 FNIII 
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domains (chapter 2, published as [160]). FNIII domains are only found in 8 other 
CBM74 containing proteins; these proteins mostly contain a GH13_19 catalytic 
domain, one or more CBM25 domains and a C-terminal CBM74 (Fig. 5). Of the 
CBM74 proteins, 8 are not linked to a catalytic domain. In most cases, however, 
α-amylase catalytic domains are encoded by immediately adjacent genes in 
their respective genomes.
CBM25 and the structurally related CBM26 domain [133] are commonly present in 
the CBM74 containing α-amylases (Fig. 5). At least one CBM25 (in 25 sequences) 
or CBM26 (in 43 sequences) domain is present about 150 aa after or about 200 aa 
(300 aa only in case of MaAmyA) before CBM74 in these α-amylases. In 5 out of the 
8 CBM74 containing proteins without a catalytic domain, CBM26 is present about 
200 aa before the CBM74 domain. The general domain organization of CBM74 
containing proteins, and the location of this domain in these proteins, appears to 
be related to the identity of the bacterial host species (Fig. 5) (see next paragraph).
Bacterial species harboring proteins with CBM74 homologs 
Our data show that 69 of the 77 CBM74 homologs are present in large and multi-
domain putative α-amylases that are mainly encoded by bacteria isolated from 
the mammalian gut or gut related environments. The 50 proteins with CBM74 
homologs in cluster A mainly originate from Bifidobacterium species (48 proteins) 
while 2 originate from Prevotella species. Most of these species were isolated from 
mammalian gastrointestinal tract (GIT) related environments (45 species), 2 were 
isolated from hamster dental plaque and 1 from chicken GIT, while for 2 the source 
of isolation is unknown (Fig. 5). All CBM74 containing proteins in this cluster are 
large and multi-domain α-amylases that belong to the GH13_28 subfamily. 
The CBM74 containing proteins from Bifidobacterium can be split into 2 groups; 
with and without CBM26. The general domain organization for the group with 
CBM26 is: GH13_28 catalytic domain, ~150 aa gap, CBM74, Big_2, CBM26, Big_2, 
additional binding domains (CBM13, 20 or 25). Big_2 is a bacterial domain with 
an Ig-like fold, commonly found in bacterial and phage surface proteins [135]. The 
Big_2 domain is widely distributed in carbohydrate acting enzymes. Its function 
is not clear, but removal of the Big_2 domain from a termite gut bacterium GH10 
xylanase greatly reduced the activity of this enzyme [185]. In a few cases CBM26 
is replaced by CBM25. The general domain organization for the group without 
CBM26 is: GH13_28 catalytic domain, ~150 aa gap, CBM74, Big_2, CBM25, 1-3 
Big_2, 1-3 SLH (Surface Layer Homology) domains. Some shorter members lack 
the SLH domains. The C-terminal SLH domains are associated with non-covalent 
anchoring to the cell surface S-layer via a conserved mechanism involving wall 
polysaccharide pyruvylation [186,187]. Interestingly this group without CBM26 
forms a separate subgroup within CBM74 cluster A (Fig. 5). The two proteins 
from Prevotella species are shorter and consist of a GH13_28 catalytic domain, a 
CBM26 domain, and a C-terminal CBM74 domain. 
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Figure 5 (previous page): Phylogenetic tree of all 77 known CBM74 homologs (November 2015), 
including MaAmyA CBM74, together with a selection of sequences from CBM9, CBM20, CBM25 
and CBM26 for which the 3D structures are known (based on http://www.CAZy.org). The part 
of the full protein sequence that was used to construct the tree (the CBM74 domain) is shown 
as a diamond. The domain organization of the full proteins shown is based on combined CDD, 
DBcan and Blast (for CBM74) data. The CBM74 domain is indicated in pink. CDD does not 
recognize C-domains in all α-amylases. However, manual assessment of the amino acid sequence 
downstream of the indicated GH13 AB-domain using Phyre 2 revealed that a C-domain is present 
in all proteins (see text). The outer ring between the accession numbers and the protein domain 
organization indicates the bacterial host species, while the inner ring between the tree and the 
accession numbers shows the source of isolation of the host organism. Tree line colors correspond 
to the different CBM families. The background color of the accession numbers indicates the GH 
(sub)family of the catalytic α-amylase domain. The solid line shows the separation between 
CBM74 cluster A and B. The dashed line shows the separation between the 2 subgroups of cluster 
A. The scale bar indicates 0.1 amino acid replacement per site.
The 27 proteins with CBM74 homologs in cluster B have more diverse origins (Fig. 5): 
5 Paenibacillus strains, all isolated from soil (5 strains); 5 Streptococcus strains, 
mainly isolated from mammalian gut related environments (3 strains); 4 
Clostridium strains, mainly isolated from mammalian gut related environments 
(3 strains); 2 Eubacterium strains from mammalian gut related environments; 2 
Aliagarivorans strains isolated from seawater; 1 M. aurum strain (studied in this 
paper) from a potato waste water treatment plant [127]; 3 Ruminococcus strains 
of which 1 from mammalian gut related environments; 1 Ruminobacter strain 
from a mammalian gut related environment; 1 Succinivibrionaceae strain from 
mammalian gut related enviroments;1 Succinimonas strain from mammalian 
gut related environment and 1 Orenia marismortui strain isolated from soil. The 
five CBM74 containing proteins from Paenibacillus strains stand out as these 
are the only ones next to MaAmyA that contain FNIII domains, CBM25 domains 
and a C-terminal CBM74 (Fig. 5). Despite this similar domain organization, the 
individual CBM25 and FNIII domains of MaAmyA do not show high similarity 
with those from the Paenibacillus enzymes or with the CBM25 domains from 
other CBM74 containing enzymes in phylogenetic trees based on either domain 
(data not shown).
Within the group of CBM74 containing proteins, specific GH13α-amylase 
subfamilies can be linked to different bacterial species (Fig. 5). For example, 
CBM74 containing α-amylases that belong to GH13_28 are found in Clostridium 
(4), Bifidobacterium (48), Streptococcus (5) strains and Prevotella (2), while 
those belonging to GH13_19 are found in Paenibacillus (5), Eubacterium (1), 
Ruminobacter (1), Succinivibrionaceae (1) and Succinimonas (1) strains. MaAmyA 
of M. aurum is the only GH13_32 protein (chapter 2, published as [160]).
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Discussion
The large and multi-domain MaAmyA α-amylase from M. aurum B8.A (1417 aa) 
is able to degrade granular starch (Fig. 1) and contains a novel domain at its 
C-terminus. This 300 aa Domain 2 is able to bind to raw starch granules (Fig. 
3) as well as to amylose and amylopectin (Fig. 2). The length of Domain 2 is 
comparable to the length of the recently described starch degrading LPMO 
[158,159]. Since one LPMO family, now defined as Auxiliary Activity 10 (AA10), 
was initially characterized as a CBM (CBM33) [188] we screened Domain 2 for 
mono-oxygenase activity but were unable to find any. Interestingly, currently 
(Feb 2016) identified LPMOs, defined as AA families 9, 10, 11 and 13 in the CAZy.
org database, do not contain any additional catalytic domains and are part of 
relatively small proteins (average 350 aa) that usually contain no more than two 
additional domains [20]. This is unlike Domain 2 which is usually part of large 
multi-domain proteins containing a GH13 catalytic domain. This sets Domain 2 
apart from currently known LPMO’s. Since Domain 2 is usually found combined 
with a GH13 catalytic domain, a non-catalytic function seems more likely for 
Domain 2. A majority of the Domain 2 containing proteins have a predicted 
signal sequence and are therefore likely secreted by the host, Domain 2 could 
also act as a cell wall anchoring domain. However, such domains are usually 
located at the protein termini [186,187,189,190], while Domain 2 is often found 
in the middle. It therefore seems unlikely that Domain 2 functions as a cell wall 
anchoring domain. 
In previous work (chapter 2, published as [160]) the full length MaAmyA 
enzyme and a mutant with deleted Domain 2 (MaAmyA7) showed similar starch 
degrading activity with both soluble and granular starch. As a major difference, 
the pores formed in starch granules by MaAmyA were about three times larger 
than those formed by MaAmyA7 (chapter 2, published as [160]). These results 
suggest that Domain 2 plays a specific role in binding to starch granules (Fig. 2, 
3), thereby assisting in their degradation (Fig. 1). 
No specific enzyme activity was found associated with Domain 2 itself. This 
MaAmyA Domain 2 thus appears to constitute a novel SBD/CBM, and was 
designated CBM74. It displays highest affinity for binding to potato starch granules 
(Fig. 3). Although potato starch granules are larger than wheat and maize starch 
granules [176], this does not automatically result in a higher affinity. In a binding 
study of Pig Pancreatic Amylase (PPA) binding to different starches granule types 
it was shown that PPA had a lower affinity for potato starch then maize and 
wheat starch. In addition when one type of starch granules was separated into 
two pools based on the granule sizes, PPA showed higher affinity for the smaller 
granules [176]. In a study with CBM20 it was found that the affinities for potato 
and maize starch granules were similar [191]. The differences in affinity could 
also be related to the crystallinity type of the starch granules, which is mainly 
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dependent on the plant species that produced the granules [192]. Since potato 
starch granules have a B-type crystallinity while wheat and maize starch granules 
have an A-type crystallinity [192], this corresponds with the differences in 
affinities we found. This could indicate that CBM74 has a higher affinity for B-type 
crystallinity granules. However more research is needed to fully understand the 
mechanism of binding of CBM74. 
CBM74 is 300 aa long and therefore exceptionally large compared to other 
known CBMs which are generally between 50 and 200 aa long [20,193]. It is 
noteworthy that 90% of all identified protein domains are shorter than 200 aa 
[194,195]. Several domain prediction servers indicated CBM74 to be a single 
domain. All 77 CBM74 homologs identified in the present study have a similar 
length and showed similarity over the full ~300 aa, thus also indicating that 
CBM74 is a single and complete domain without internal duplications. Therefore 
we conclude that CBM74 is indeed a single domain and an extraordinarily large 
CBM.
CBM74 clearly occurs more widespread and is commonly part of extremely large 
(>1300 aa) multi-domain GH13 amylases that also contain CBM25 or CBM26 
domains next to a single catalytic domain. Less than 2% of all GH13 members 
currently listed in the CAZy database are 1300 aa or longer [20]. On average GH13 
α-amylases are about 650 aa long with usually only up to two additional domains 
[20]. The α-amylase proteins with a CBM74 domain appear to be specialized in 
the degradation of starches that are difficult to hydrolyze enzymatically.
Most of the currently known CBM74 containing α-amylases (at least 80%) 
originate from bacteria isolated from the GIT (Fig. 5). This number could be 
slightly biased due to the relatively high number of GIT bacterial genomes that 
have been sequenced; about 28% of all fully sequenced bacterial genomes are 
part of the Human Microbiome Project [196]. Nevertheless, the high percentage 
of CBM74 domains found in enzymes from GIT related bacteria may indicate 
that CBM74 fulfills a specific role in starch digestion in the intestinal tract. In the 
human GIT, most of the (soluble) starch from food is degraded by α-amylases 
and glucoamylases of the host organism. However, Resistant Starch (RS) is 
harder to degrade due to its crystallinity or due to complex formation, either 
occurring naturally or after food processing [8,12]. Under normal conditions RS 
is fermented completely by microorganisms in the colon of the host [8,12]. 
Resistant Starch can be divided into five different types (RS1-5). The higher the 
RS number, the lower the degradation rate by human α-amylases in the GIT. 
RS3, also known as retrograded starch, is of special interest since it is formed 
without any additions and resists regular food processing, or is even formed 
during processing [12,197]. It is well known that SBDs greatly enhance the ability 
of α-amylases to degrade granular starches [154]. Since most CBM74 homologs 
are found in large α-amylases with additional SBDs it appears likely that CBM74 
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plays a role in resistant (granular) starch binding. 
The ability of Bifidobacteria to degrade RS has been demonstrated in literature. 
Animal studies in which rats colonized with human microflora were fed a high RS 
diet showed that the number of Bifidobacteria and Lactobacilli in the microflora 
increased 10 to 100 fold when compared to a high sucrose diet, demonstrating 
a link between RS fermentation and representation of these two genera 
[198]. As shown in Figure 5, CBM74 is present in α-amylases from 22 different 
Bifidobacterium strains, constituting over 45% of all sequenced Bifidobacterium 
strains listed in GenBank (November 2015). Another study showed that 
Ruminococcus bromii L2-63 and Bifidobacterium adolescentis L2-32 individually 
are able to degrade especially RS3 up to about 50%, and even up to > 90% when 
co-cultured. In an obese test subject with a low percentage of RS fermentation, 
both R. bromii and B adolescentis were absent from the microflora [126]. Addition 
of B. adolescentis L2-32 or R. bromii L2-63 improved RS3 fermentation with ~20% 
and ~45%, respectively, the latter restoring fermentation to levels similar to 
those of healthy volunteers. Proteins containing CBM74 homologs are present 
in the genomes of both these strains (WP_015523730.1 and EDN82501.1 in Fig. 
5), but absent in the genomes of two other strains used in the same study which 
were unable to improve RS3 degradation significantly (Eubacterium rectale A1-
86 and Bacteroides thetaiotaomicron 5482) [126]. 
The relative abundance of CBM74 in mammalian gut Bifidobacterium α-amylases 
is taken to suggest that CBM74 has a major role in degradation of RS in the 
mammalian GIT. The presence and proper functioning of this CBM74 domain 
thus may have strong effects on the efficiency of mammalian food digestion.
CBM74 thus may assist MaAmyA in the degradation of RS through binding to it. 
The binding of CBM74 to starch granules has been demonstrated experimentally 
(Fig. 3). In addition to binding, CBM74 may also be involved in preparation of 
the substrate (granule) surface for degradation, in a similar way as it is seen for 
CBMs in cellulase enzymes, where CBMs assist in unwinding the carbohydrate 
chains, making them more accessible for the action of the catalytic domain [47]. 
As shown, the presence of CBM74 results in formation of larger pores in starch 
granules (Fig. 1).
Our bioinformatics analysis revealed 77 CBM74 homologs in databases and 
confirmed that CBM74 constitutes a single domain. The CBM74 homologs 
clustered together in a phylogenetic analysis (Fig. 5) and showed low identity 
to other known CBMs. We therefore conclude that CBM74 represents a novel 
starch binding CBM family.
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Abstract
The bacterium Microbacterium aurum strain B8.A degrades granular starches, 
using the multi-domain MaAmyA α-amylase to initiate granule degradation 
through pore formation. This paper reports the characterization of the M. 
aurum B8.A MaAmyB enzyme, a second starch-acting enzyme with multiple 
FNIII and CBM25 domains. MaAmyB was characterized as an α-glucan 
1,4-α-maltohexaosidase with the ability to subsequently hydrolyze maltohexaose 
to maltose through the release of glucose. MaAmyB also displays exo-activity 
with a double blocked PNPG7 substrate, releasing PNP. In M. aurum B8.A, 
MaAmyB may contribute to degradation of starch granules by rapidly hydrolyzing 
the helical and linear starch chains that become exposed after pore formation 
by MaAmyA.
Bioinformatic analysis showed that MaAmyB represents a novel GH13 subfamily, 
designated GH13_42, currently with 165 members, all in Gram-positive soil 
dwelling bacteria, mostly Streptomyces. All members have an unusually large 
catalytic domain (AB-regions), due to three insertions compared to established 
α-amylases, and an aberrant C-region, which has only 30% identity to established 
GH13 C-regions. Most GH13_42 members have three N-terminal domains (2 
CBM25 and 1 FNIII). This is unusual as starch binding domains are commonly 
found at the C-termini of α-amylases. The evolution of the multi-domain M. 
aurum B8.A MaAmyA and MaAmyB enzymes is discussed.
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Introduction
Many micro-organisms are able to use starch as a carbon and energy source. They 
generally employ α-amylase enzymes for extracellular hydrolysis of amylose and 
amylopectin [31]. α-Amylases represent endo-acting glycoside hydrolases that 
hydrolyze the (1-4)α-D-glucosidic linkages between glucose residues and rapidly 
degrade long polymers into shorter oligosaccharides. Degradation into glucose 
requires the subsequent action of exo-acting enzymes such as α-glucosidase 
or glucoamylase. Most α-amylases belong to the Glycoside Hydrolase family 
13 (GH13) (www.CAZy.org) [20]. Based on sequence similarity, family GH13 
enzymes are currently classified into 40 subfamilies [20,39]. So far α-amylases 
have been found in 15 of these subfamilies (GH13_1, 5, 6, 7, 10, 14, 15, 19, 
24, 27, 28, 32, 36, 37, 39) [42,99]. Not all GH13 α-amylases listed in the CAZy 
database have been classified into one of the currently established subfamilies 
[20,39,42]. α-Amylases have a catalytic domain that usually consists of 3 regions. 
Region-A contains the common (β/α)8 barrel and all the catalytic residues [34]. 
Region-B is a loop lacking a clearly defined topology, located between β3 and α3 
of region-A, containing calcium binding sites [34]. Due to the close interactions 
between regions-A and -B they are usually identified as one (catalytic) domain 
in domain databases such as the Conserved Domain Database (CDD) [135]. 
Region-C is located at the C-terminal end of regions-AB. It consists of β-sheets 
only, including a Greek key motif [33,34,42]. Although it is required for amylase 
activity, the function of region-C is not yet fully understood [199,200]. In some 
cases region-C has been linked to raw starch binding [43,44].
α-Amylase enzymes acting on raw starch commonly have additional carbohydrate 
binding modules (CBM) at their C-terminal ends [20,49,154]. Starch binding 
domains (SBD) are a subgroup of CBMs which bind to starches [154]. Only about 
10% of all GH13 enzymes contain additional domains such as SBDs. Most do 
not have more than two of them, although some α-amylases contain several 
additional domains (6 or more) resulting in large complex enzymes [20] (chapter 
3, published as [201]). We recently described MaAmyA, a large α-amylase (148 
kDa) with two CBM25 and four FNIII domains, plus a novel CBM74 domain, that 
is able to form large pores in granular starch (Fig. 1) [160,201]. MaAmyA has 
been isolated from Microbacterium aurum B8.A, a granular starch degrading 
bacterium that was obtained from a potato waste water treatment plant [127]. 
Interestingly, the pores created by MaAmyA were all of similar size while the M. 
aurum culture fluid produced a range of pore sizes (chapter 2, published as [160]). 
In addition, when staining for starch degradation activity on polyacrylamide gels, 
a 130 kD protein band was detected in the M. aurum culture fluid that could not be 
related to MaAmyA (chapter 2, published as [160]). A total of 14 GH13 members 
were annotated in the recently obtained genome sequence of M. aurum B8.A 
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(V. Valk, R. M. van der Kaaij, and L. Dijkhuizen, manuscript in preparation ), one 
of which is located directly downstream of MaAmyA (designated MaAmyB). 
These findings, together with the reported synergy between α-amylases and 
glucoamylases which significantly increased the degradation rate of raw starches 
[202–205], resulted in the suggestion that M. aurum B8.A may employ one or 
more additional enzymes to assist MaAmyA in raw starch degradation. 
Here we report the characterization of MaAmyB, a large and multi-domain 
enzyme with exo-acting starch hydrolyzing activity (Fig. 1). MaAmyB is located 
directly downstream of MaAmyA in the genome of M. aurum B8.A (V. Valk, 
R.M. van der Kaaij and L. Dijkhuizen, unpublished data). Unlike the exo-acting 
glucoamylases, which belong to the GH15 family, MaAmyB belongs to the GH13 
family and is the first characterized member of a newly defined GH13 subfamily 
(GH13_42). The 165 enzyme members of this subfamily share a conserved but 
aberrant multi-domain organization with additional domains N-terminal of their 
unusually large catalytic domain.
Figure 1: Detailed domain organization of MaAmyA and MaAmyB, compared to the general 
domain organization of GH13_42 members; numbers indicate the first and last aa of the domain 
or conserved insert. Colors indicate conserved regions or domains: □: signal sequence; ■: GH13 
catalytic domain AB region; ■: GH13 catalytic domain C region; ■: FNIII domain; ■: CBM25 domain; 
■: CBM74, a novel CBM domain (chapter 3, published as [201]); ■: aberrant C-region. Conserved 
insertions in the AB-regions of GH13_42 (including MaAmyB) are indicated as follows: ■: region-B; 
■: region-A insert 1; ■: region-A insert 2.
Materials and methods
Bacterial strains, media, and plasmids
M. aurum strain B8.A was isolated from a waste water treatment plant of a potato 
starch processing factory. Isolation and growth conditions have been described 
previously [127]. The M. aurum strain B8.A strain was deposited (deposit 
number LMG S-26033) in the BCCM/LMG culture collection of the University 
of Gent, Belgium [127]. Escherichia coli TOP10 and C43 were cultivated at 37 
oC overnight in LB with orbital shaking (220 rpm). When required, ampicillin or 
kanamycin was added to a final concentration of 100 or 50 µg·ml-1, respectively. 
pBAD-VV (chapter 2, published as [160]), a modified pBAD/Myc-His B (Novagen, 
Madison, WI, USA), was used as expression vector for the amyB gene constructs 
in E. coli C43(DE3). 
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Gene identification
The full amyB gene was amplified from the M. aurum B8.A genome (V. Valk, R.M. 
van der Kaaij and L. Dijkhuizen, manuscript in preparation) Fwd and Rev primers: 
CGTCTTCGACCTCCATATGCGAAGGAGCAGGGTCTTGCGAGAAAGCACAC and 
GCCGGCACAGAGTGCTTGAGGTAGGCGCTGCCGCTACCGATCTTG. Chromosomal 
DNA was isolated from a Microbacterium aurum B8.A culture grown at 37 oC 
overnight in LB with orbital shaking (220 rpm) using the GenElute Bacterial 
Genomic DNA Kit (Sigma-Aldrich, Zwijndrecht, the Netherlands). The product 
was cloned into the pBAD-VV vector (chapter 2, published as [160]) using NdeI 
and DraIII restriction sites. All products were confirmed through sequencing 
(GATC-Biotech, Konstanz, Germany). The amyB constructs were prepared with 
both N- and C-terminal His-Tags from the pBAD-VV vector.
Protein expression
Recombinant E. coli strains were grown as 500 ml cultures in 3 l flasks, with 
100 µg·ml-1 ampicillin and 0.05% (final concentration) arabinose (Sigma-Aldrich, 
Zwijndrecht, the Netherlands) for 6 h at 30 °C (220 rpm) and then for 40 h at 18 
°C (220 rpm). Cells were collected by centrifugation at 4,250 g for 20 min at 4 
°C (Thermo Lynx 4000). Pellets were resuspended in 50 mM Tris-HCl buffer pH 
6.8 containing 10 mM CaCl
2
. Protease inhibitors (Roche Mini EDTA-free Protease 
Inhibitor, Sigma-Aldrich, Zwijndrecht, the Netherlands) were added and cells 
were broken by sonication (15 sec at 10,000 Ω, 30 sec cooling, 7 x). Cell debris 
and intact cells were removed by centrifugation at 15,000 g for 20 min at 4 °C. 
Resulting cell free extracts were immediately used for purification of MaAmyB.
Standard Assay buffer
A 50 mM Tris-HCl buffer pH 6.8 containing 10 mM CaCl
2
 was used as standard 
assay buffer for enzyme incubations. Unless indicated otherwise all incubations 
were performed at 37 °C.
Purification of MaAmyB protein through binding to starch granules 
Granular wheat starch (Sigma-Aldrich, Zwijndrecht, the Netherlands catalog 
no. S5127) was sterilized through gamma irradiation (Synergy Health, Ede, the 
Netherlands). The sterile granules were washed two times with standard assay 
buffer. After the second wash, granules were collected through centrifugation 
and the liquid removed. Then, 5 gram freshly washed (wet) granules was added 
to 20 ml of freshly prepared cell free extracts of the E. coli cultures expressing 
MaAmyB, or the E. coli empty vector culture as control. The tubes were mixed 
until a homogeneous suspension was obtained followed by incubating overnight 
at 4 °C on a roller bench (VWR, Amsterdam, the Netherlands). The suspension 
was centrifuged at 4,000 g for 5 min and the supernatant removed. The starch 
granules were washed 2 times with 40 ml standard assay buffer for 30 min, and 
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the supernatant removed through centrifugation at 4,000 g for 5 min. To elute 
MaAmyB protein, 5 ml of 10% maltose in assay buffer was added, mixed for 
30 min and the supernatant collected through centrifugation at 4,000 g for 5 
min. The maltose was removed and the sample concentrated over 50 kD cut 
off Millipore spin filters and washed with standard assay buffer. Samples were 
concentrated to 1 ml and stored at 4 °C in standard assay buffer. 
Activity staining on SDS-PAGE
SDS-PAGE analysis was used to determine protein masses. After refolding the 
location of the MaAmyB protein could be visualized in the gels by staining for 
its starch-acting activity. SDS-PAGE [141] was performed using precast THX gels 
(Bio Rad, Veenendaal, the Netherlands). After loading and running, gels were 
washed 3 times for 5 min in Milli Q water to remove SDS and allow protein 
refolding, then incubated for 2 h at 37 °C in standard assay buffer containing 0.5% 
soluble potato starch (Sigma-Aldrich, Zwijndrecht, the Netherlands) [65]. After 
incubation the gels were stained with Lugol’s iodine (2.5% I
2
 / 5% KI) to visualize 
protein bands with α-amylase activity. After imaging, gels were partly destained 
by washing in Milli Q water and then stained with Bio-Safe™ Coomassie Stain 
(Bio Rad, Veenendaal, the Netherlands) to visualize proteins. The Fermentas 
PageRuler prestained marker was included in each gel.
Activity assay with CNPG3
The activity of MaAmyB and other enzymes was determined and standardized 
through incubation of the enzyme with 2-Chloro-4-nitrophenyl-α-D-
maltotrioside (CNPG3). This compound has a 2-Chloro-4-nitrophenyl (CNP) 
group coupled to maltotriose (G3) at its reducing end. The assay is based on 
the detection of the released CNP group from CNPG3 by absorbance reading at 
405 nm. The enzyme solution or mixture (15 µl) containing approximately 6.25 
µg·ml-1 MaAmyB protein to be tested was prepared in 96-well microtiter plates. 
Pre-warmed substrate (100 µl 2 mM CNPG3) was added and the reaction was 
followed through absorbance reading at 405 nm for 20 min in a microtiter plate 
reader (Spectramax plus, Molecular Devices, Sunnyvale CA, USA) set at 37 °C. 
One unit is defined as the amount of enzyme required to release 1 µmol CNP 
min-1 under standard assay conditions. This Unit definition is used throughout 
this paper.
Activity assay with Blocked PNPG7 substrate
MaAmyB activity was tested by incubation of the enzyme with blocked 
4-nitrophenyl-α-maltoheptaoside (blocked PNPG7) (Megazyme, Wicklow, Ierland 
). This compound has a 4-nitrophenyl (PNP) group coupled to maltoheptaose 
(G7) at its reducing end while the non-reducing end is blocked by an 4,6-linked-
O-benzylidine group. Due to this block, release of PNP generally requires 
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both endo-acting activity (α-amylase) and subsequently exo-acting activity 
(α-glucosidase). In the present work, blocked PNPG7 was tested as substrate 
by only adding the MaAmyB enzyme. The assay, based on the detection of the 
released PNP group from the blocked PNPG7 substrate by absorbance reading at 
405 nm, was performed as described for the CNP assay using 6 U (based on the 
CNP assay) MaAmyB. Negative controls included an empty vector (EV) control 
without additional enzymes, EV with added α-glucosidase (Megazyme, Wicklow, 
Ierland), EV with added α-amylase (MaAmyA2, a truncation of MaAmyA from M. 
aurum B8.A with all starch binding domains removed (chapter 2, published as 
[160]). A positive control consisted of EV with both α-glucosidase and α-amylase 
added. MaAmyA2 and the α-glucosidase were diluted in assay buffer until the 
activity on CNPG3 was 1.5-2 times the activity of MaAmyB on this substrate. 
Activity assays with other substrates
The activity of MaAmyB was tested on maltose (G2), maltoheptaose (G7), 
soluble potato starch (Sigma Aldrich, Zwijndrecht, the Netherlands, catalog no. 
S2004) and granular wheat starch (Sigma Aldrich, Zwijndrecht, the Netherlands, 
catalog no. S5127). The 900 µl substrate solution (or suspension in case of the 
granular wheat starch), containing 10 mg·ml-1 of the substrate to be tested in 
standard assay buffer, was prepared and pre-heated at 37 °C in a heating block. 
Then 100 µl enzyme preparation containing 25 µg MaAmyB (155 U), or a control, 
was added. The solution was immediately mixed and the first 100 µl sample was 
taken and frozen (-20 °C) (t = 0 h). Additional samples were taken after 1, 2, 3, 
4, 5, and 6 h for soluble substrates, and 0, 24, 48, 72, 96, and 120 h for granular 
substrates. Samples of 1 µl were analyzed on TLC (Merck, Darmstadt, Germany) 
and run overnight using a butanol, ethanol, water (5:5:3 v/v/v) running buffer, 
and stained using 40% sulfuric acid and 5% Orcinol (9,10-dihydrophenanthrene) 
in methanol [178,206]. 
Bioinformatics tools
All BLAST [28] searches were performed with NCBI BLASTP using standard 
settings. The MaAmyB catalytic domain (aa 650-1,183) (regions-AB, Fig. 1) was 
used as query in BLAST searches for related sequences, using standard settings 
but with the maximum target sequences increased to 1,000 (instead of the 
default 100). Conserved domains were detected using both the NCBI conserved 
domain finder [135] with forced live search, without low-complexity filter, using 
the conserved domain database (CDD), and dbCAN [26] with standard settings. 
Signal sequences were predicted with SignalP4.1 [136] using standard settings. 
Catalytic AB-regions in the related GH13 proteins were identified using the full 
length sequences based on dbCAN domain information. The C-region in the 
related GH13 proteins was defined based on the BLAST search results obtained 
using the aberrant C-region of MaAmyB (aa 1,194-1,259) (Fig. 1). CBM25 domain 
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sequences and FNIII domain sequences were extracted from all proteins listed 
in the 02-02-2016 release of CAZy [20] (after their sequences were obtained 
from GenBank), based on CDD information. The extracted domain sequences 
were used for construction of alignments with Mega6.0 [137] using its build-
in muscle alignment with standard settings. Alignments were checked for the 
positions of conserved residues and manually tuned when needed. Phylogenetic 
trees were made with Mega6.0 using the Maximum likelihood method with 
gaps/missing data treatment set on “partial deletion” instead of “full deletion”. 
Trees were visualized with Interactive Tree Of Life v2 [138]. The protein domain 
annotations shown in the trees are based on combined data from CDD and 
dbCAN. Information about GH13 subfamilies was obtained from the CAZy 
database [20]. An initial tree with a diverse selection of all GH13 subfamilies was 
constructed to select the closest related subfamilies for display in the final tree. 
The selection included multiple GH13 members from each of the 40 defined 
subfamilies, which varied in domain organization and origin. The final tree based 
on the catalytic domain regions-AB included MaAmyB and all homologs found 
in the NCBI non redundant protein sequences database, as well as a selection 
of members that were most closely related based on the initial tree. Protein 
structure predictions were done with the Phyre2 protein fold recognition server 
using standard settings [207].
Nucleotide sequence accession number
The sequence of amyB, isolated from M. aurum B8.A has been deposited into 
GenBank database under accession no. KX447523.1. 
Results
Gene identification
In previous work we characterized MaAmyA, a 148 kDa raw starch degrading and 
pore-forming α-amylase (glycoside hydrolase 13, subfamily 32: GH13_32) that 
was isolated from M. aurum B8.A (Fig. 1) (chapter 2, published as [160]). The 
gene encoding MaAmyA was first isolated from a DNA library clone with an 11.6 
kb insert. This insert contained a second large but C-terminally incomplete open 
reading frame (ORF) of 3,810 nt. The full 3,834 nt ORF was originally obtained 
through genome walking. The sequence was confirmed when the full genome 
of M. aurum B8.A was obtained (V. Valk, R.M. van der Kaaij and L. Dijkhuizen, 
manuscript in preparation). For this study the gene was obtained from genomic 
DNA of M. aurum B8.A using specific primers and designated amyB. It encoded a 
large multi-domain (putative) α-amylase of 1,287 amino acids, including a signal 
sequence of 53 aa, with a predicted mass of 135 kDa, designated MaAmyB..The 
genome sequence also confirmed that the gene encoding MaAmyB is located 
directly downstream of the gene encoding MaAmyA. 
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MaAmyB contains the A-, B-, and C-regions (but see specific details below) 
typical for the α-amylase superfamily [38], as well as all catalytic residues and 
conserved regions generally present in family GH13 α-amylases [208]. MaAmyB 
does not belong to any established GH13 subfamily although a large number of 
sequences similar to MaAmyB was identified in databases (Table 1). We decided 
to heterologously express amyB and to study the activity and possible function 
of the produced M. aurum B8.A MaAmyB protein. 
Expression and purification of MaAmyB
MaAmyB was successfully expressed in E. coli as a full length protein with both 
N- and C-terminal His-Tags. During purification it became apparent that neither 
of the two His-Tags present was functional. Most likely they are not accessible 
in the folded protein structure. The MaAmyB enzyme was purified on basis of 
its efficient binding to wheat starch granules, followed by washing with standard 
assay buffer and elution with maltose. Purification was followed by SDS-PAGE 
analysis (Fig. 2). The MaAmyB starch hydrolyzing activity was confirmed through 
in gel iodine activity staining of the refolded MaAmyB protein incubated with 
soluble starch (Fig. 2B). A clear zone of activity with a visible band was apparent 
for MaAmyB while no activity was observed in the empty vector control sample, 
confirming the absence of E. coli starch degrading enzymes. The activity of 
MaAmyB was 62 ± 2 U·µg-1 (CNP assay). MaAmyB activity was only observed in 
the presence of 10 mM of CaCl
2
.
Table 1: Overview of the conserved regions found in the catalytic domain of MaAmyB and their 
identity and similarity with either all identified homologs, or the GH13_42 homologs only. The 
ranges are given for the percentage identity and similarity, as well as the average values, which are 
shown between brackets.





Region-B 768-896 128 aa 164 48-79% (59%) 57-83% (68%) <1·10-41
Region-A, insert 1 961-979 19 aa 164 78-100% (86%) 83-100% (89%) <1·10-5
Region-A, insert 2 1,005-1,041 37 aa 205 44-81% (68%) 53-86% (73%) <1·10-4
C-region-like dom. 1,194-1,259 66 aa 234 32-75% (62%) 40-91% (81%) < 1·10-13
Region-A, insert 2 1,005-1,041 37 aa 164* 61-81% (71%)* 67-86% (75%)* <1·10-6
C-region-like dom. 1,194-1,259 66 aa 164* 52-75% (63%)* 75-91% (82%)* <1·10-15
* = values based on GH13_42 homologs only. 
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Figure 2: SDS-PAGE analysis and activity staining of MaAmyB. A: Regular SDS-PAGE analysis. B: In 
gel staining for starch hydrolyzing activity. Arrows indicate the position of MaAmyB. After SDS-
PAGE the gels were washed with standard assay buffer, then incubated for 2 h at 37°C in standard 
assay buffer containing 0.5% soluble starch and activity was visualized by staining with Lugol’s 
Iodine solution. The band seen in A corresponds to the main activity band in B. Both bands run at 
the predicted molar mass of 135 kDa for MaAmyB. The empty vector control did not show a band 
at 135 kDa (A) and lacked any other activity band (B). For each sample 10 µg protein was loaded. 
B = MaAmyB eluted from starch granules; EV = Empty vector control eluted from starch granules; 
Blank = Blank control eluted from starch granules; M = marker proteins. 
MaAmyB activity on different substrates
MaAmyB was incubated with maltose (G2), maltoheptaose (G7) soluble and 
granular starch as substrates. The results showed that MaAmyB is inactive on 
G2, but active on G7 as well as on soluble and granular starches. Incubation of 
MaAmyB with soluble starch resulted in initial accumulation of maltohexaose 
(G6), which in time was further hydrolyzed to smaller maltooligosaccharides, 
resulting in accumulation of mostly maltotriose, maltose and glucose after 
6 h (Fig. 3). Incubation with G7 yielded similar products, while incubation of 
granular starch with MaAmyB did not result in accumulation of maltohexaose 
but in direct release of glucose, maltose and maltotriose (Fig. S1).
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Figure 3: TLC analysis of MaAmyB products obtained in time by incubation of the enzyme (155 U, 
CNP assay) with soluble potato starch up to 6 h. EV = empty vector control incubated for 6 h. M = 
markers, size consisting of G1-G7 (glucose; maltose; maltotriose; maltotetraose; maltopentaose; 
maltohexaose; maltoheptaose). 
MaAmyB activity was also determined using blocked PNPG7 as a substrate (Fig. 
4). This substrate is generally used in a commercial kit for assaying α-amylase 
activity (Megazyme), based on the release of PNP. Normally the PNP is released 
in a two-step reaction, first involving endo-acting α-amylase activity to split 
the blocked substrate. In the second step, an exo-acting α-glucosidase activity 
(provided in large excess in the commercial kit) removes the remaining glucose 
units attached to the PNP group. When using limiting amounts of the exo-
acting α-glucosidase the overall reaction shows an acceleration in time, due to 
the sequential action of the endo-acting α-amylase (PNPG7 cleavage) and the 
α-glucosidase (PNP release) (Fig. 4, blue triangles). To our surprise, MaAmyB 
alone was able to degrade blocked PNPG7 and showed immediate PNP 
release, resulting in straight lines of absorbance versus time (Fig. 4). Negative 
controls containing E. coli extracts prepared from cells with an empty vector 
(EV), or combined with either endo-acting α-amylase (MaAmyA2) or exo-acting 
α-glucosidase, showed no PNP release (Fig. 4). The combined data shows that 
MaAmyB acts as an α-glucan 1,4-α-maltohexaosidase, an α-amylase releasing a 
maltohexaose from soluble starch, also cleaving the blocked PNPG7 substrate, 
and thus is not affected by the 4,6-linked-O-benzylidine group at the non-
reducing end of this substrate. 
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Figure 4: PNP release (absorbance at 405 nm) from the blocked PNPG7 substrate upon incubation 
with 6 U MaAmyB enzyme preparations and various control samples, (done in triplicate ± SD). 
Results obtained for MaAmyB and the positive control (EV + MaAmyA2 α-amylase + α-glucosidase) 
are significantly different (T-test for 0-500 sec, p-value : 0.028). ♦ = MaAmyB; ○ = empty vector (EV) 
control; □ = Empty vector (EV) + MaAmyA2 α-amylase; ∆ = EV + α-glucosidase; ▲ = EV + MaAmyA2 
α-amylase + α-glucosidase. 
Identification of MaAmyB as a member of a novel GH13 subfamily
A search of the NCBI non redundant protein sequences database with the 
catalytic domain (regions-AB) of MaAmyB yielded a total of 164 sequences with 
at least 54 % identity (February 2016). None of these putative starch hydrolases 
has been purified and characterized biochemically. Only AmlC of Streptomyces 
lividans TK24 has been identified as an α-amylase based on analysis in crude 
cell extracts (Yin et al. 1998). In the CAZy database, none of these MaAmyB 
homologs has been assigned to a specific GH13 subfamily. A phylogenetic tree 
containing all MaAmyB homologs, as well as selected enzymes from defined 
GH13 subfamilies, was prepared based on the partial AB-regions of the catalytic 
domain as identified by dbCAN (GH13.hmm in dbCAN), aa 690-1,121 for 
MaAmyB (Fig. 5). All MaAmyB homologs cluster together as a new group, which 
we propose to designate as the new GH13 subfamily 42 (GH13_42). 
MaAmyB homologs were found predominantly in strains of the genera 
Streptomyces (115x), Paenibacillus (7x), Kitasatospora (7x), Micromonospora 
(6x), Cystobacter (4x). Up to three homologs were found in strains of 17 other 
genera. All GH13_42 homologs thus are found in soil-dwelling Gram-positive 
bacteria. 
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GH13_42 domain organization: enlarged AB-regions and an aberrant C-region
Most of the identified GH13_42 members share a similar domain organization 
starting with 2 CBM25 domains, 1 FNIII domain and the catalytic domain (AB-
regions) (Fig. 5), which contains all catalytic residues and the 7 conserved 
regions generally found in the α-amylase superfamily (Fig. 6) [31,38,208]. The 
only exceptions are formed by two sequences separated by a single stop codon 
which are actually forming one single enzyme (CCK25026.1 and CCK25027.1), as 
well as one incomplete sequence (GenBank WP 03109885.1). Some homologs 
have an additional FNIII domain between the CBM25 domains. MaAmyB differs 
from its homologs in that it has 4 FNIII domains (Fig. 5), of which the N-terminal 
3 are highly similar to each other (>97% identity), while the 4th FNIII domain has 
lower similarity (~55% identity) (Fig. 7).
In domain databases, α-amylases are listed as proteins with 2 domains: one 
domain represents the AB-regions, while the C-region is considered as a second 
and separate domain. The AB-regions of most GH13 α-amylases are represented 
by clan CL0058 in the Pfam conserved domain database [21]. In comparison 
to CL0058, the AB-regions of GH13_42 (534 aa for MaAmyB) are about 100 
aa longer. The AB-regions of MaAmyB and 3 additional GH13_42 α-amylases 
were aligned with CL0058 from Pfam and 3 well-characterized α-amylases (Pig 
pancreatic α-amylase, Taka amylase A from Aspergillus oryzae and Bacillus 
licheniformis α-amylase) (Fig. 6). After manual tuning of the alignment using 
secondary structure information, 3 insertions could be identified in all GH13_42 
members compared to CL0058 (Table 1). Two insertions were identified in the 
A-region. The first one is a 19 aa insertion between the 5th β-sheet and 5th α-helix 
(Fig. 6), which is uniquely found in all GH13_42 homologs (E value <1·10-5). The 
2nd, a 37 aa insertion between the 6th α-helix and the 7th β-sheet, is predicted to 
form an α-helix located in close proximity to the C-region (Fig. 6). This insert is 
not only found in all 165 GH13_42 homologs but also in 41 additional putative 
α-amylases that share the aberrant C-region (see below and discussion) (E value 
<1·10-4). In addition, the B-region is 54 aa longer, compared to the 74 aa B-region 
from the CL0058 clan. This enlarged B-region is strongly conserved and uniquely 
found in GH13_42 homologs (Table 1). 
The region C-terminal of the AB-regions in GH13_42 is not recognized by CDD 
as a classical C-region. Using Phyre2, which is based on protein (3D) structure 
prediction comparison, we observed a strong structural similarity (Phyre2 
confidence of 97% or higher) between this C-terminal region in MaAmyB 
and several C-regions of α-amylases (such as the C-region of Bacillus subtilis 
α-amylase PDB1ua7, aa 348-425), although sequence identity was less than 30 
%. This low identity explains why the aberrant C-region of MaAmyB was not 
recognized by CDD. When used as a query sequence in a BLAST search, the
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Figure 5 (Left): Phylogenetic tree of MaAmyB plus its 164 homologs, and a selection of members 
from the defined GH13 subfamilies that are either associated with EC3.2.1.1 or EC3.2.1.98 [20] 
(Table S1). The tree is based on the alignment of the catalytic AB-regions (GH13.hmm) as obtained 
from dbCAN. Domain organization shown is based on a combination of CDD and dbCAN data. The 
inserts in the A-region, the B-region and aberrant C-region as indicated are based on BLAST results 
of the identified regions from MaAmyB. Subfamily information was obtained from CAZy. Aberrant 
C-region information was obtained from Supplementary Figure S2. The number 70 shows the 
location of a cluster of 70 putative α-amylases that share the aberrant C-region with the MaAmyB 
homologs but do not belong to subfamily GH13_42 (designated as GH13_VV) (Fig. S2 and S3). 
At numbers 24 and 63, clades with these numbers of sequences similar to the nearby shown 
sequences have been collapsed to improve the readability of the tree. CBM74 is a novel CBM 
domain in MaAmyA (chapter 3, published as [201]).
aberrant C-region of MaAmyB (aa 1,194-1,259) returned 234 hits including all 
164 GH13_42 members (query cover >95% and E-value < 1·10-13), thus showing 
full conservation in the GH13_42 subfamily. The other 70 hits make up an 
additional cluster of putative α-amylases (designated as GH13_VV) which are 
not part of GH13_42 (see discussion). The aberrant C-region is 66 aa long, similar 
in length to known α-amylase C-regions. Phyre2 structure prediction for the 
aberrant C-region of MaAmyB showed an all β-sheet fold including a Greek key 
motif, as is typical for α-amylase C-regions.
Evolutionary origin of MaAmyB 
Figure 7 shows the domain organization of the M. aurum B8.A MaAmyA and 
MaAmyB proteins, and three closely related relatives. As representatives of the 
novel GH13_42 subfamily, MaAmyB of M. aurum B8.A and AmlC of S. lividans 
share the three inserts in the AB-regions (Figs. 1 and 6) and the aberrant 
C-region (Fig. S2). The CBM25 and FNIII domains of MaAmyB however differ 
from those found in other members of GH13_42. The two CBM25 domains and 
3 of the 4 FNIII domains of MaAmyB are almost identical (99% identity at the 
nucleotide level) to the domains found in the M. aurum B8.A MaAmyA (Fig. 7A). 
To study the origin of these duplicated domains, additional phylogenetic trees 
were constructed based on alignment of the CBM25 and FNIII domains (Fig. S4 
and S5). This revealed that the CBM25 domains of MaAmyB do not cluster with 
the same domains in the GH13_42 subfamily (26-45% identity) (represented by 
AmlC in Fig. 7A), but with CBM25 domains attached to 4 GH13_32 amylases, 
including MaAmyA (42-49% identity) (Fig. S4) (represented by BAA22082.1 in 
Fig. 7). Phylogenetic analysis also showed that the FNIII domains of MaAmyB and 
the 3 C-terminal FNIII domains of MaAmyA, do not cluster with the GH13_42 
subfamily FNIII domains (18-38 identity, 32-59% similarity) but instead with FNIII 
domains found in chitinases (44-62% identity, 59-71% similarity) (represented 
by BAB86376.1 in Fig. 7A). The N-terminal FNIII domain of MaAmyA, however, 
clusters with FNIII domains of the GH13_42 subfamily (40-60% identity, 59-80% 
similarity) (Fig. S5). These results, combined with the fact that enzymes with a
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domain organization similar to those of MaAmyA and MaAmyB currently are not 
found in databases, suggest that the MaAmyA and MaAmyB enzymes originated 
after horizontal gene transfer and (intensive) gene (re)shuffling in M. aurum 
B8.A. 
Figure 6: Alignment of the AB-regions of MaAmyB and 3 additional GH13_42 members (CAB06816, 
BAJ27020.1, BAL91723.1), Pfam CL0058 and CDD CD11339 from the databases and 4 characterized 
α-amylases: Pig pancreatic α-amylase (PPA) (P00690.3), Taka amylase A from Aspergillus oryzae 
(TAKA) (P0C1B4.1), Bacillus licheniformis α-amylase (BLA) (P06278.1) and MaAmyA (AKG25402.1). 
The B-region is indicated in purple, the two insertions in the A-region of GH13_42 are indicated 
in grey. The α-helices of the (β/α)8 barrel are indicated in green, β-sheets in red. Conserved Ca
2+ 
binding aspartate residues are indicated in dark grey [208]. Other conserved residues are indicated 
in blue [208]. The 7 conserved regions of α-amylases are indicated with dashed orange lines and 
roman numbers [208]. Amino acid numbering as in MaAmyB. 
Interestingly, 15 of the 115 Streptomyces strains with a GH13_42 have a MaAmyA 
homolog located directly upstream of the GH13_42 homolog in their genomes. 
In these Streptomyces strains the GH13_42 is located on the complementary 
DNA strand, while the GH13_32 homolog is on the regular strand (Fig. 7B); the 
M. aurum amyA and amyB genes are both on the complementary strand. The 
Streptomyces MaAmyA homologs only possess a single CBM20 domain, lacking 
all of the CBM25, CBM74 and FNIII domains found in MaAmyA (Fig. 7A). 
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Figure 7 A: Protein domain organization of MaAmyA and MaAmyB and 4 related proteins. All 
proteins are shown with the N-terminus on the left hand side. The dotted line box indicates a 
stretch of domains that is highly similar between MaAmyA and MaAmyB (>99% identity), 
suggesting a relatively recent duplication event. Equal fill patterns indicate domains with 
high similarity. Solid filled domains do not have similarity to any other domain shown. 
AmlB (CAB06622.1) and BAA22082.1 are included as representatives of GH13_32 with high 
similarity to MaAmyA. AmlC (CAB06816.1) is included as a representative of GH13_42 with 
high similarity to MaAmyB. BAB86376.1 is included as a representative of a group of chitinases 
containing FNIII domains with high similarity to the 3 C-terminal FNIII domains of MaAmyA and 
all FNIII domains of MaAmyB. CBM74 is a novel CBM domain (chapter 3, published as [201]). 
B: Schematic representation showing the orientations of the genes encoding the M. aurum B8.A 
(MaAmyA, MaAmyB) and S. lividans TK24 (AmlB, AmlC) α-amylases. 
Discussion
This paper reports the characterization of MaAmyB, a large and multi-domain 
amylase enzyme of M. aurum B8.A with hydrolytic activity on both granular 
and soluble starches, and on a blocked PNP-maltoheptaose. The highly unusual 
primary structure of this enzyme, with enlarged AB-regions as well as an aberrant 
C-region, was also identified in 164 other uncharacterized GH13 enzymes. Given 
the high similarity between these enzymes, we defined the new GH13_42 
subfamily. MaAmyB is the only GH13_42 member with 4 FNIII domains, and 
with 2 CBM25 domains that do not cluster with the CBM25 domains in other 
GH13_42 members. Previously we reported that also the M. aurum B8.A 
MaAmyA α-amylase enzyme is unusual, the only known GH13_32 member with 
FNIII domains, and with a CBM74 domain that represents a novel SBD (chapter 
2, 3 published as [160], [201]). This raises questions about the evolutionary 
origins of these M. aurum B8.A MaAmyA and MaAmyB enzymes.
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All currently know GH13_42 members share a general domain organization with 
2 CBM25 domains and 1 FNIII domain N-terminal of the catalytic domain (Fig. 
1). This strong conservation is remarkable as usually domain organizations vary 
within subfamily members [20]. Recently we have shown that CBM25 domains 
in MaAmyA are required for granular starch activity, but have no effect on 
soluble starch activity (chapter 2, published as [160]). The role of FNIII domains 
in amylases has not been studied in detail. In MaAmyA truncation studies we 
did not see any effect for FNIII domains (chapter 2, published as [160]). The 
role of FNIII domains in carbohydrate acting enzymes in general has not been 
studied in detail. Studies that addressed the roles of FNIII domains in such 
enzymes are inconclusive [60,71,73–75,151,153,209–214]. FNIII domains 
have been suggested to act as flexible linkers [73] which corresponds to our 
findings for MaAmyA. CBM25 domains are usually located C-terminally of 
the catalytic domain, but N-terminally in GH13_42 proteins. We hypothesize 
that the FNIII domain functions as a flexible linker which enables the CBM25 
domains in GH13_42 proteins to function efficiently at the N-terminus. With 
FNIII domains representing a linker to attach the CBM25 domains, and CBM25 
domains enabeling enzymes to degrade granular substrates, we hypothesize 
that GH13_42 enzymes are involved in the degradation of granular starches. 
The M. aurum B8.A MaAmyA and MaAmyB enzymes appear to have originated 
from at least three different enzymes: a GH13_32 α-amylase, a GH13_42 
α-amylase and a chitinase (Fig. 7). Based on the sequence identities at the DNA 
level, we speculate that a single FNIII domain was duplicated twice resulting 
in three FNIII domains with high identities (95-98% at the nucleotide level). 
Together with 2 CBM25 domains, the 3 FNIII domains were duplicated between 
MaAmyA and MaAmyB. The high identity of the duplicated region (99% at the 
nucleotide level) suggests that this happened relatively recently. It is likely that in 
the environment from which M. aurum B8.A was isolated (a potato wastewater 
treatment facility), an efficient system for potato starch granule degradation is 
beneficial. We hypothesize that this evolutionary pressure caused horizontal 
gene transfer and gene (re)shuffling resulting in formation of MaAmyA and 
MaAmyB. This hypothesis is supported by the absence of enzymes with similar 
extensive domain organizations as MaAmyA and MaAmyB in the current 
databases, including 27 Microbacterium genome sequences [82], (Figs. S2, S4 
and S5), (chapter 2, 3 published as [160], [201]). 
Members of the novel subfamily GH13_42 are characterized by enlarged AB-
regions and an aberrant C-region (Figs. 1, 6). Compared to known α-amylases, 
the subfamily GH13_42 proteins have three strongly conserved insertions in the 
AB-regions (Table 1). The largest insert (54 aa) is found in the B-region which is 
known to be involved in calcium binding [34]. The aberrant C-region of GH13_42 
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proteins is strongly conserved among the subfamily members (Table 1). While 
it shares less than 30% sequence identity with the common C-region in GH13 
α-amylases, it shows a strong structural similarity. Therefore it is likely that this 
domain functions as an α-amylase C-region. Additional bioinformatics analysis 
of 70 aberrant C-regions that were identified in family GH13 members that did 
not belong to the GH13_42 subfamily revealed that they are also part of putative 
starch hydrolases with enlarged AB-regions, though different from GH13_42. 
None of these 70 putative α-amylases have been characterized biochemically. A 
phylogenetic tree based on all 234 identified aberrant C-regions and some well 
know α-amylases shows that the aberrant C-regions cluster as a separate group 
away from other C-regions (Fig. S2). In addition, the 234 aberrant C-regions 
do not show clear clusters other than those expected based on the different 
species/genus harboring the genes encoding these proteins (Fig. S2). Despite 
the close sequence relationship between the aberrant C-regions, the additional 
70 putative α-amylases do not belong to GH13_42 in view of the low sequence 
similarities in the AB-regions (< 19 % similarity); in a phylogenetic tree based 
on the AB-regions, they cluster together as an additional group, designated as 
GH13_VV (Fig. 5 and S3). In these trees the various GH13_42 homologs cluster 
across multiple species, which is an indication for horizontal gene transfer of 
the AB-regions. Interestingly most of the GH13_VV members also have highly 
conserved, enlarged AB-regions with 3 inserts at similar places as in GH13_42. 
Region-A insert 2 is partly conserved between GH13_VV and GH13_42 (Table 
S3). Region-B and region-A insert 1 are uniquely conserved within the GH13_
VV cluster (Table S3). Unlike GH13_42 not all regions are fully conserved in all 
GH13_VV members. 
So far the aberrant C-region has only been identified in starch hydrolases 
with enlarged AB-regions that also have additional domains, like CBMs. In all 
GH13_42 enzymes and most GH13_VV members, additional domains are located 
N-terminal of the catalytic domain, while generally in GH13 such domains are 
located at the C-terminus of the enzyme [20]. The absence of domains attached 
to the aberrant C-region may be relevant (for its fold and function). 
Structure prediction using the Phyre2 protein fold recognition server shows 
that region-A insert 2 in GH13_42 members forms an α-helix which lies in close 
proximity to the Greek key motif formed by the C-region (Fig. S6). Both the 
A-region inserts as well as the B- and C-regions in MaAmyB are predicted to 
be on the same side of the (β/α)8-barrel, although with low reliability (Fig. S6). 
This may indicate a functional relationship between the different enzyme parts 
as well as between the enlarged AB-regions and the C-region. We speculate 
that the C-region has a specific function in GH13_42, as may also be deduced 
from its concurrence with the enlarged AB-regions. Additional data preferably 
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including the 3D structure of a GH13_42 homolog is needed to reveal the exact 
mechanism of interaction between the different domains, and the function of 
the C-region in GH13_42 enzymes.
Only one MaAmyB homolog, AmlC from S. lividans TK24, has been described 
previously [215]. AmlC is listed in CAZy as an α-amylase (EC 3.2.1.1), based on 
an activity analysis of crude extracts, which does not discriminate between 
α-amylases and exo-acting amylases. MaAmyB is able to release PNP from 
blocked PNPG7 without requiring any additional enzymes (Fig. 4). According to 
literature, the PNP from blocked PNPG7 can only be released through successive 
activity of an α-amylase and an exo-acting glycoside hydrolase enzyme, such as 
an α-glucosidase [216]. This is also demonstrated in one of the included controls, 
with MaAmyA2 α-amylase + α-glucosidase: due to the low exo-amylase activity 
used, an acceleration in the PNP release during the first 750 sec was observed (Fig. 
4). Furthermore, α-amylases are not active on maltotriose or smaller substrates 
and release maltose as smallest product [30]. In this study, we show that 
MaAmyB can release glucose from small substrates (Fig. 3). It produces a series 
of oligosaccharides ranging from glucose to maltohexaose when soluble starch 
is used as a substrate. After 4 h the initially produced maltohexaose (G6) starts 
to decrease followed by degradation of maltopentaose (G5) and maltotetraose 
(G4). This pattern corresponds to that of an exo-acting enzyme with a preference 
for releasing G6 from starch, but which is also capable of producing glucose, 
like α-glucan 1,4-α-maltohexaosidases (EC 3.2.1.98) [217–222]. The activity of 
an α-glucan 1,4-α-maltohexaosidase on a blocked PNPG7 substrate has not been 
described in literature. Only the maltotetraose-forming amylase (EC 3.2.1.60) 
from Pseudomonas saccharophila [223,224] is described in a GRAS notice [225], 
as able to degrade blocked PNPG7 despite the blocking group, and to release 
maltotetraose (G4). It is likely that the maltohexaose releasing MaAmyB acts in 
a similar way (Figs. 3, 4). Contamination of MaAmyB by a low concentration of 
an E. coli α-amylase is unlikely as control experiments showed a clear increase 
in activity over time when an α-amylase and α-glucosidase were used (Fig. 4). In 
addition the empty vector control experiments did not show any activity even 
after prolonged incubation and addition of either an α-amylase or α-glucosidase. 
We therefore conclude that MaAmyB is an α-glucan 1,4-α-maltohexaosidase (EC 
3.2.1.98).
The finding that MaAmyB acts as an exo-amylase allows for speculation about 
its function. Synergistic action between an α-amylase and glucoamylase in 
granular starch degradation has already been described [202–205]. MaAmyB 
is located in the proximity of an α-amylase (MaAmyA) on the M. aurum B8.A 
genome, and MaAmyA introduced a different pore pattern in starch granules 
than the M. aurum B8.A culture fluid (chapter 2, published as [160]). MaAmyB 
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also is active on granular starch (Fig. S1). Therefore we hypothesize that the exo-
acting MaAmyB enzyme contributes to degradation of starch granules by rapidly 
hydrolyzing the helical and linear starch chains that become exposed after pore 
formation by MaAmyA. In addition, bioinformatics analysis revealed that in at 
least 15 Streptomyces species a (putative) GH13_32 α-amylase is located near 
a GH13_42 homolog. This suggests that the synergy between GH13_32 and 
GH13_42 members is more widely spread. 
We conclude that MaAmyB is an α-glucan 1,4-α-maltohexaosidase, the first 
characterized member of the novel GH13_42 subfamily, which functions in 
the degradation of granular starch. It is likely that the enlarged AB-regions and 
aberrant C-region contribute to this specific activity. Further research into the 
structure/function relationship of these or similar enzymes with their N-terminal 
CBM domains, enlarged AB-regions and aberrant C-region, is required to 
elucidate the roles of their different protein domains. 
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Supplemental material
Figure S1: TLC analysis of MaAmyB products obtained in time by incubation of the enzyme (155 
U, CNP assay) with maltoheptaose up to 6 h (A) or granular wheat starch up to 120 h (B). EV = 
empty vector control incubated for 6 h. M = markers, size consisting of G1-G7 (glucose; maltose; 
maltotriose; maltotetraose; maltopentaose; maltohexaose; maltoheptaose). 
Figure S2 (next page): Phylogenetic tree of the 234 aberrant C-regions identified through a BLAST 
search with the C-region from MaAmyB (aa 1194-1259), three well characterized α-amylases: Pig 
pancreatic α-amylase (PPA) (P00690.3), Taka amylase A from Aspergillus oryzae (TAKA) (P0C1B4.1) 
and Bacillus licheniformis α-amylase (BLA) (P06278.1) as well as MaAmyA (AKG25402.1) which is 
directly upstream of MaAmyB in the genome of M. aurum B8.A. The tree is based on the alignment 
of the C-regions, indicated by a diamond shape in the domain organization as identified through 
BLAST searches. Domain organization within the protein is based on a combination of CDD, dbCAN 
data. The inserts in the AB-regions are indicated based on BLAST results of the identified regions from 
MaAmyB, as well as the identified B-region from CQR582041 for GH13_VV. Subfamily information 
was obtained from the CAZy database. Numbers indicate additional members which are similar to 
the nearby shown sequences, which have been collapsed to improve the readability of the figure. 
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Supplemental material
Figure S1: TLC analysis of MaAmyB products obtained in time by incubation of the enzyme (155 
U, CNP assay) with maltoheptaose up to 6 h (A) or granular wheat starch up to 120 h (B). EV = 
empty vector control incubated for 6 h. M = markers, size consisting of G1-G7 (glucose; maltose; 
maltotriose; maltotetraose; maltopentaose; maltohexaose; maltoheptaose). 
Figure S2 (Left): Phylogenetic tree of the 234 aberrant C-regions identified through a BLAST 
search with the C-region from MaAmyB (aa 1194-1259), three well characterized α-amylases: Pig 
pancreatic α-amylase (PPA) (P00690.3), Taka amylase A from Aspergillus oryzae (TAKA) (P0C1B4.1) 
and Bacillus licheniformis α-amylase (BLA) (P06278.1) as well as MaAmyA (AKG25402.1) which is 
directly upstream of MaAmyB in the genome of M. aurum B8.A. The tree is based on the alignment 
of the C-regions, indicated by a diamond shape in the domain organization as identified through 
BLAST searches. Domain organization within the protein is based on a combination of CDD, dbCAN 
data. The inserts in the AB-regions are indicated based on BLAST results of the identified regions from 
MaAmyB, as well as the identified B-region from CQR582041 for GH13_VV. Subfamily information 
was obtained from the CAZy database. Numbers indicate additional members which are similar to 
the nearby shown sequences, which have been collapsed to improve the readability of the figure. 
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Table S1: Overview of well-known α-amylases used in the phylogenetic trees shown in Figure 5 
and Figure S3. GH13 subfamily, EC number and Organism names were obtained from CAZy. The 
members shown here were selected after an initial tree with a diverse selection of all (40) GH13 
subfamilies was constructed to select the closest related subfamilies for display in the final tree. 
From these closest subfamilies, characterized members (if available with solved crystal structures) 
with α-amylase (EC 3.2.1.1) or α-glucan 1,4-α-maltohexaosidase activity were selected to display 
in the final tree.





aa no. of 
GH13.hmm
EC# Organism name
AAA86836.1-34 AAA86836.1 27 34-352 3.2.1.1
Pseudomonas sp. 
KFCC10818





AAD54338.1-54 AAD54338.1 7 54-341 3.2.1.1 Pyrococcus woesei
AAN52525.1-51 AAN52525.1 36 51-373 3.2.1.1
Halothermothrix orenii H 
168 H 168; DSM 9562
AAR46454.1-113 AAR46454.1 10 113-424 3.2.1.1 Sulfolobus solfataricus KM1
AAS36537.1-377 AAS36537.1 none 1299-1639 3.2.1.1 Bacillus sp. KSM-1378AAS36537.1-1299 12 377-691 3.2.1.41
AAS99099.1-78 AAS99099.1 19 78-469 3.2.1.98 Bacillus halodurans LBK 34
AAY89038.1-77
AAY89038.1
32 1118-374 3.2.1.1 Bifidobacterium breve 
UCC2003AAY89038.1-1118 14 77-374 3.2.1.41
AEM89278.1-36 AEM89278.1 37 36-345 3.2.1.1 uncultured bacterium
AII00648.1-56 AII00648.1 6 56-340 3.2.1.98 Corallococcus sp. EGB
BAA02471.1-207 BAA02471.1 21 207-548 3.2.1.1
Thermoactinomyces  
vulgaris R-47
BAA88434.1-226 BAA88434.1 19 226-594 3.2.1.98 Klebsiella pneumoniae
BAB04132.1-78 BAB04132.1 19 78-469 3.2.1.98 Bacillus halodurans C-125
BAB85635.1-46 BAB85635.1 24 46-348 3.2.1.1 Anguilla japonica
BLA-56 P06278.1 5 56-403 3.2.1.1 Bacillus licheniformis MD1
CAA39096.1-76 CAA39096.1 19 76-467 3.2.1.98 Bacillus sp. H-167
CAB06816.1-401 CAB06816.1 XX 401-835 3.2.1.1/ 
3.2.1.98*
Streptomyces lividans TK24
MaAmyA-82 AKG25402.1 32 82-370 3.2.1.1 Microbacterium aurum B8A
MaAmyB-690 AOF40721.1 42 690-1121 3.2.1.98 Microbacterium aurum B8A
P56634-32 P56634 15 32-317 3.2.1.1 Tenebrio molitor
PPA-49 P00690.3 24 49-347 3.2.1.1 Sus scrofa
TAKA-60 P0C1B4.1 1 60-364 3.2.1.1 Aspergillus oryzae RIB40
*AmlC, is currently listed as an α-amylase (EC 3.2.1.1), but has not been characterized biochemically 
(see Discussion). Given the results found for MaAmyB as a member of this cluster, it is likely that 
also AmlC is actually an α-glucan 1,4-α-maltohexaosidase (EC 3.2.1.98).
Figure S3 (next page): Phylogenetic tree based on the alignment of the catalytic AB-regions (GH13.
hmm as obtained from dbCAN) of all 234 α-amylases with the aberrant C-region, 2 additional 
α-amylases with a GH13_VV B-region (CDE42123.1, CDC26735.1) and a selection of members 
from the defined GH13 subfamilies that are either associated with EC3.2.1.1 or EC3.2.1.98 [20] 
(Table S1). Domain organization within the protein is based on a combination of CDD and dbCAN 
data. The inserts in the A-, B- and C-regions are indicated based on BLAST results of the identified 
regions from MaAmyB (Table 1) and CQR58204.1 (Table S2). Species and (sub)family info was 
obtained from CAZy. Information about clustering of the aberrant C-regions was obtained from 
Figure S2. Numbers indicate clusters of additional sequences similar to the ones already shown, 
which have been collapsed to improve the readability of the tree. CBM74 is a novel CBM domain 
(see chapter 3).
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Table S2: Overview of the conserved regions found in GH13_VV, α-amylases that have a similar 
aberrant C-region as found in GH13_42. The identity and similarity of these conserved regions 
are indicated for all homologs found, except those that belong to the GH13_42 family. The ranges 
are given for the identity and similarity, as well as the average values, which are shown between 
brackets. The positions are based on CQR58204.1, a predicted α-amylase from Paenibacillus 
riograndensis SBR5, which was used as model sequence for GH13_VV.







GH13_VV Region-B 705-798 94 aa 64 27-100% (70%) 34-100% (75%)
Region-A, insert 1 858-876 19 aa 65 28-100% (71%) 33-100% (74%)
Region-A, insert 2 910-942 33 aa 41* 67-100% (92%) 70-100% (93%)
Aberrant C-region 1073-1138 66 aa 70* 32-100% (76%) 38-100% (84%)
* = region also found in GH13_42 members.
Table S3: Overview of strains, vectors and primers used during this study.
Host strain Microbacterium aurum B8.A
Routine DNA manipulation strain E.coli TOP 10
Expression strain E.coli C43
Expression vector pBAD-VV (see chapter 2 for details)
MaAmyB primers:
FW primer including DraIII restriction site (underlined)
GCCGGCACAGAGTGCTTGAGGTAGGCGC 
TGCCGCTACCGATCTTG
RV primer including NdeI restriction site (underlined)
CGTCTTCGACCTCCATATGCGAAGGAGC 
AGGGTCTTGCGAGAAAGCACAC 
Sequence primer used for primer walking to find the  
last 24 nt of the initial (incomplete) MaAmyB gene
TCGGGCAACATGGCGTTCAAG
 
Figure S4 (next page): Phylogenetic tree of the 271 CBM25 domains identified by CDD, in proteins 
that contain CBM25 domains according to CAZy (which listed 275 CBM25 domains) as well as the 
2 CBM25 domains from MaAmyB. MaAmyA (AKG25402.1) which is directly upstream of MaAmyB 
in the genome of M. aurum B8.A. is also indicated. The tree is based on an alignment of all CBM25 
domains, indicated by a diamond shape in the domain organization. Sequences with multiple 
CBM25 domains are shown multiple times, once for each CBM25 domain. Domain organization 
within proteins is based on a combination of CDD and dbCAN data. Genes/species and subfamily 
information was obtained from the CAZy database. The number 48 indicates the 48 proteins that 
consist of only a CBM25 domain, not associated with any other protein domains. Other numbers 
indicate clusters of additional members which are similar to the nearby shown sequences, which 
are not shown to improve the readability of the tree. The branch containing MaAmyB is shown 
in blue on the broad ring, GH13_42 members are indicated by the broad green ring, and other 
proteins with a GH13_32 catalytic domain are shown in yellow. 
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Figure S6: 3D model as predicted by the Phyre2 protein fold recognition server of MaAmyB 
without C-region. Although the model is less reliable for the exact structure of the inserts, it shows 
that all inserts are located next to each other, on the same side of the (β/α)8 barrel which may 
suggest a structural function. The C-region is not shown in the model but it is located on the right 









 containing A-region insert 2; Red 
= α-helix part of (β/α)8 barrel; Pink = β-sheet part of (β/α)8 barrel; Pale red = α-helix not part of 
(β/α)8 barrel; Pale yellow = β-sheet not part of (β/α)8 barrel. 
Figure S5 (next page): Phylogenetic tree of the FNIII domains identified by CD search (specific hits) 
in proteins that are listed in CAZy. The selection was based on an initial tree with all FNIII domains 
identified by CD search in proteins listed in CAZy. MaAmyB and MaAmyA (AKG25402.1), which 
is directly upstream of MaAmyB in the genome of M. aurum B8.A, are indicated. The position 
in the tree is based on the alignment of the FNIII domain indicated by a diamond shape in the 
domain organization. Sequences with multiple FNIII domains are shown multiple times, once for 
each FNIII domain. Domain organization within the proteins is based on a combination of CDD 
and dbCAN data. Enzyme class, family, subfamily and genus information was obtained from the 
CAZy database. The branch containing the first FNIII domain of MaAmyA is indicated as cluster 
A, the branch containing the remaining three FNIII domains of MaAmyA and all FNIII domains of 
MaAmyB is indicated as cluster B. 
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Abstract
Fibronectin type III (FNIII) domains were first identified in the eukaryotic plasma 
protein fibronectin, where they act as structural spacers or enable protein-
protein interactions. 
Recently we characterized two large and multi-domain amylases in 
Microbacterium aurum B8.A that both carry multiple FNIII and Carbohydrate 
Binding Modules (CBM). The role of (multiple) FNIII domains in such carbohydrate 
acting enzymes is currently unclear. Four hypothetical functions are considered 
here: a substrate surface disruption domain, a carbohydrate-binding module, as 
a stable linker, or enabling protein-protein interactions. 
We performed a phylogenetic analysis of all FNIII domains identified in proteins 
listed in the CAZy database. These data clearly show that the FNIII domains in 
Eukaryotic and Archaeal CAZy proteins are of bacterial origin and also provides 
examples of interkingdom gene transfer from Bacteria to Archaea and Eukarya. 
FNIII domains occur in a wide variety of CAZy enzymes acting on many different 
substrates, suggesting that they have a non-specific role in these proteins. While 
CBM domains are mostly found at protein termini, FNIII domains are commonly 
located between other protein domains. FNIII domains in carbohydrate acting 
enzymes thus may function mainly as stable linkers to allow optimal positioning 
and/or flexibility of the catalytic domain and other domains such as CBM.
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Introduction
The Gram-positive bacterium Microbacterium aurum B8.A was isolated from the 
sludge of a potato starch-processing factory on the basis of its ability to use 
granular starch as carbon- and energy source for growth [127]. Its extracellular 
amylolytic enzymes were able to degrade starch granules, initially by introducing 
pores. In biochemical studies we have characterized MaAmyA and MaAmyB, 
two large and multi-domain amylase enzymes. MaAmyA (148 kDa) carries two 
Carbohydrate Binding Modules (CBM25), four fibronectin type 3 (FNIII) domains 
and one CBM74 (Fig. 1), (chapter 2, 3, published as [160], [201]). Characterization 
of MaAmyA mutant proteins with C-terminal deletions of various lengths 
showed that the CBM25 domains are essential for the ability of this enzyme 
to degrade raw starch. Deletion of the C-terminal CBM74 in MaAmyA resulted 
in a threefold reduction in granular starch pore size [160,201]. Deletion of 
CBM25 and CBM74 negatively affected degradation of raw starch, but not that 
of soluble starch (chapter 2, published as [160]). In MaAmyA a total of three 
FNIII domains are present between the two CBM25 domains and the CBM74 
domain (Fig. 1). It has remained unclear what the precise function is of these 
three FNIII domains. MaAmyB (135 kDa) is the first characterized member of 
a new glycoside hydrolase family 13 subfamily (GH13_42) which has a strongly 
conserved general domain organization featuring one to four FNIII domains 
between the two CBM25 domains and the catalytic domain (with an aberrant 
C-region) (Fig. 1) (chapter 4, published as [226]). In both enzymes the precise 
function of these four FNIII domains has remained unclear therefore we decided 
to study this in more detail, focusing on carbohydrate acting enzymes in general.
Figure 1: Domain organization of MaAmyA (chapter 2, published as [160]), MaAmyB and the 
general domain organization of GH13_42 members. Numbers refer to the number of amino acids 
in the protein. The length of GH13_42 varies for each member, as a reference the length of AmlC 
from S.lividans (GenBank: CAB06816.1) is shown.Colors indicate conserved regions or domains: □: 
signal sequence; ■: GH13 catalytic domain AB region; ■: GH13 catalytic domain C region; ■: FNIII 
domain; ■: CBM25 domain; ■: CBM74, a novel CBM domain (chapter 3, published as [201]); ■: 
aberrant C-region. 
The FNIII domain is an evolutionary conserved protein domain of approximately 
100 amino acids, with a beta sandwich structure. It is one of the three types 
of internal repeats (FNI-FNII-FNIII) originally identified in the eukaryotic plasma 
protein fibronectin. FNIII domains in eukaryotic proteins usually act as structural 
spacers, to arrange other domains in space, as in fibronectin itself. FNIII domains 
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also may have functional roles in the formation of protein-protein interactions 
[68]. FNIII domains are widely found in extracellular eukaryotic proteins, 
especially in animals, but also occur in plant and yeast proteins. Whereas other 
fibronectin repeats (FNI and FNII domains) only occur in proteins of Eukarya, FNIII 
domains also are found in Bacteria, Viruses and Archaea. The first FNIII domains 
in prokaryotes were reported in 1990 [71]. Due to the low number of recognized 
bacterial FNIII domains at that time, and phylogenetic analysis placing them 
separate from the eukaryotic domains, it was suggested that prokaryotes had 
acquired FNIII domains from eukaryotes [3]. All initially identified prokaryotic 
FNIII domains were associated with carbohydrate acting enzymes, but more 
recently these domains have also been identified in fibronectin binding proteins 
(FnBP) and multiple other prokaryotic protein types [22,70,150]. Our database 
searches showed that about 33% of all FNIII containing proteins included in 
SMART (15125) are from bacteria. Approximately 19% of all bacterial FNIII 
domains occur in proteins that are directly related to carbohydrates, such as 
carbohydrate acting enzymes or proteins that contain CBMs [22]. In this work we 
focus on FNIII domains that are part of carbohydrate acting enzymes classified in 
the Carbohydrate-Active enZYmes (CAZy) database [20].
Microbial carbohydrate acting enzymes are able to degrade complex 
carbohydrates, making them available as a carbon and/or energy source for 
growth. Many are listed in the CAZy database which shows five different enzyme 
classes based on their activities and mode of action: Glycoside Hydrolases 
(GH), Glycosyl Transferases (GT), Polysaccharide Lyases (PL), Carbohydrate 
Esterases (CE) and AA (Auxiliary Activities) [20]. These classes have been 
separated into families and some (larger) families have been further separated 
into subfamilies, based on the primary structure of their protein members 
[20,39]. Approximately 10% of these enzymes include one or more Carbohydrate 
Binding Modules (CBM) [162], (chapter 3, published as [201]), (this work).
The function of FNIII domains in carbohydrate acting enzymes is currently 
unclear. So far no reciprocal protein-protein interactions have been reported 
to exist between bacterial FNIII domains, although an interaction has been 
suggested to exist between FnBP FNIII domains and eukaryotic fibronectin [70]. 
Characterization of different carbohydrate acting enzymes resulted in three 
suggestions for the role of their FNIII domains: as stable linker [60], carbohydrate 
surface disruption domain [152], carbohydrate binding module [151]. 
In this work we traced all FNIII domains present in all carbohydrate active 
enzymes listed in the CAZy database of February 2016, most of which (98%) were 
from bacterial origin. We used both bioinformatics approaches as well as the 
available literature to analyze the possible roles of FNIII domains in carbohydrate 
acting enzymes. 
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Materials and methods
Extracting FNIII domain sequences from all CAZy entries 
We extracted the (linked) GenBank accession number for each CAZy entry in the 
01-28-2016 release [20]. When no linked GenBank accession number was found, 
the linked Protein Data Bank (PDB) entry was used instead. If neither was present, 
the best matching sequence of the non-linked entries was used. In case no 
database links were listed, we attempted to trace the sequence in the databases 
using the name and strain information. Obsolete sequences were updated to 
their newer version as suggested by GenBank if available [82]. The accession 
numbers were used to extract the corresponding protein FASTA sequences from 
GenBank. All FASTA sequences were separated in files of 25,000 sequences and 
then submitted to batch CD-search, using the live search option and conserved 
domain database (CDD) database [135]. The concise output was used and all 
lines containing “specific” in the “Hit type field” and “FN3” (FNIII domains are 
designated as FN3 in CDD) in the “short name field” were extracted. The lines 
contained the start and end amino acids for each FNIII domain. Microsoft Excel 
2010 was used to extract the sequence of each FNIII domain from the full FASTA 
file. Since some sequences contained more than one FNIII domain, sequences 
of FNIII domains were named as follows: “accession number of full sequence”-
“start aa number of the FNIII domain” The output was formatted as a FASTA file.
Extracting FASTA sequences for all CBMs listed in CAZy
All enzymes containing one or more CBMs according to the CAZy annotation 
in the 01-28-2016 release were extracted as FASTA sequences, as described 
above. All FASTA sequences were separated in files of 2,500 sequences and 
submitted to dbCAN [26]. The output contained the domain organization of the 
full-length proteins with the positions of the CBMs up to CBM67 as annotated by 
dbCAN. CBM families 68 and higher are currently not included in dbCAN and are 
therefore not included in the analysis, except for CBM74 which we annotated 
manually based on our previous work (chapter 3, published as [201]). 
Bioinformatic tools
All BLAST searches were performed with NCBI BLASTP using standard settings. 
Conserved domains were detected using both the NCBI conserved domain 
finder [135] with forced live search, without low-complexity filter, using the 
conserved domain database (CDD), and dbCAN [26] with standard settings. 
Alignments were made with Mega6.0 [137] using its build-in muscle alignment 
with standard settings. Alignments were visualized with Jalview 2.8.1 [166]. 
Phylogenetic trees were made with Mega6.0 using maximum likelihood method 
with gaps/missing data treatment set on partial deletion instead of full deletion. 
Trees were visualized with Interactive Tree Of Life v2 [138]. Information about 
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enzyme activity (EC number) was obtained from the CAZy database [20]. Domain 
organization shown in the tree is based on combined data of dbCAN and 
CDD. Enzyme class information was obtained from CAZy. Secondary structure 
prediction was done using the Phyre2 server with standard settings [29]. 
Alignment and phylogenetic tree
An initial alignment and tree using all 3,219 FNIII domain sequences extracted 
from proteins in the CAZy database was constructed. Due to the high number of 
sequences the alignment was not manually tuned but directly used to produce 
a phylogenetic tree. This large tree was used to select a smaller number of 
sequences including all eukaryotic and all archaeal FNIII domains and a diverse 
selection (based on the initial tree) of bacterial FNIII domains as present in CAZy 
proteins was used for an alignment which were manually tuned and used to 
produce the phylogenetic tree shown (Fig. 2). For each selected protein, all FNIII 
domains present were included in the tree. A total of 107 proteins with 158 
FNIII domains were selected and used for the alignment and phylogenetic tree 
construction. 
Two additional phylogenetic trees were constructed based on a random 
selection of FNIII domains found in an equal number of proteins from each of 
the 4 kingdoms (Archaea, Bacteria, Eukarya, Virus), obtained from the SMART 
database: One tree based on 100 FNIII domains (Fig. S1), and one based on 
1,000 domains (data not shown). 
Determination of carbohydrate related FNIII domains
The FASTA files of all bacterial FNIII containing protein sequences listed in 
the SMART database were extracted. All 15,125 bacterial protein sequences 
were analyzed (in batches of maximal 3,000 sequences) with dbCAN. Results 
were screened for carbohydrate related catalytic domain hits. Proteins were 
considered carbohydrate related when such a catalytic domain was identified in 
the sequence.
Results & Discussion
FNIII domains are conserved protein domains of about 60-120 aa that have an all 
β-sheet secondary structure. In this work, FNIII domains are defined as domains 
indicated by CD-search as a “Specific” hit with the short name “FN3”. All domains 
matching these criteria had one of the following defined domain ID’s: cd00063, 
pfam00041 or smart00060. 
FNIII domains in carbohydrate acting enzymes listed in CAZy
In total we retrieved 575,089 unique FASTA protein sequences from the CAZy 
database. These were submitted to a CD-search which identified 3,219 FNIII 
109
FNIII domains in carbohydrate acting enzymes
5
domains, present in 2,486 CAZy proteins. Less than 0.5% of all CAZy proteins thus 
contain one or more FNIII domains, as defined by the criteria used in this study. 
Of these 2,486 proteins, 76% contained one FNIII domain, 21% contained two 
FNIII domains and 3% contained three or more FNIII domains, up to a maximum 
of seven FNIII domains in proteins CBL14028.1, CBL07763.1 and CBL13779.1. 
The 3,219 FNIII domains identified in CAZy proteins in this study is in sharp 
contrast with the 24 FNIII domains that thus far explicitly have been reported in 
characterized carbohydrate acting enzymes in the literature (see below). Clearly, 
little is known about the abundance and functionality of FNIII domains in CAZy 
proteins.
Table 1: Distribution of FNIII domains over proteins in the different CAZy enzyme classes. The last 
column indicates the distribution of FNIII domains over CAZy entries with one or more CBM (based 




AA CE GH GT PL CBM
Percentages of total CAZy entries per  
class #
2.0% 5.5% 48.5% 39.4% 1.3% 8.7%
Percentage of proteins per class containing 
(one or more) FNIII domain(s) # 2.3% 2.3% 0.6% 0.1% 0.7% 3.5%
Number of proteins per class containing 
(one or more) FNIII domain(s) #
264 720 1596 280 54 1783
Percentage of all FNIII containing proteins 
belonging to the class ##
10.6% 29.0% 64.2% 11.3% 2.2% 71.7%
GH, Glycoside Hydrolases; GT, Glycosyl Transferases; PL, Polysaccharide Lyases; CE, Carbohydrate 
Esterases; AA, Auxiliary Activities. 
* As defined by CAZy (www.cazy.org) [20] 
# Total number of proteins in each class: AA:11731, CE:31583, GH:279001, GT:226733, PL: 7245, 
CBM:50301 
## Total number of FNIII domain containing proteins: 2486 
Some proteins in this table belong to multiple CAZy enzyme classes, therefore the percentages 
shown do not add up to 100%.
FNIII domains were identified in proteins belonging to all five CAZy enzyme 
classes (Table 1). This is in contrast to the specific CBM families which are usually 
linked to one or two different enzyme classes, but so far never to all five [20]. A 
relatively large number of the FNIII domains identified were found in proteins 
that belong to the GH class (64.2%). This also reflects the fact that nearly half 
(48.5%) of all CAZy proteins belong to the GH class. When we look at the number 
of FNIII domain containing proteins in each enzyme class separately, the AA class 
has the most FNIII containing proteins (2.3%). Interestingly, the number of FNIII 
domains in CBM containing proteins is even larger: 3.5% of all CBM containing 
proteins also have one or more FNIII domains, and 71.7% of all FNIII containing 
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Figure 2 (previous page): Phylogenetic tree with all eukaryotic, archaeal and (a random selection 
of) bacterial FNIII containing proteins in CAZy. MaAmyA, MaAmyB and Clostridium thermocellum 
CbhA (GenBank CAA56918.1) were also included. Phylogeny was based on the FNIII sequences as 
defined by CDD. All FNIII domain sequences were obtained as described in the Methods section, 
except for the FNIII domains from CbhA which were extracted manually based on the published 
information [152]. Domain organization is based on combined dbCAN and CDD data.
proteins also contain one or more CBMs (Table 1). This last number is even higher 
(76.0%) when dbCAN is used instead of CAZy to annotate the CBM domains. This 
clearly points to a link between the presence of FNIII and CBM domains in proteins.
Phylogenetic analysis
A phylogenetic tree with all eukaryotic, archaeal and (a random selection of) 
bacterial FNIII containing carbohydrate acting enzymes (with phylogeny based 
on the FNIII sequences as annotated by CDD) listed in CAZy was made (Fig. 
2). Two FNIII-like domains from Clostridium thermocellum were also included 
(discussed in the next paragraph). The tree shows six clusters. Three clusters 
contain mainly bacterial FNIII domains, another cluster is of a mixed type with 
several examples of interkingdom gene transfer (indicated in gray in Figure 2) The 
two remaining clusters are clearly distant from the others. One contains most 
of the FNIII domains in eukaryotic CAZy proteins (indicated in green in Figure 
2), while the other contains most of the FNIII domains obtaind from archaeal 
CAZy proteins (indicated in blue in Figure 2). There is no clear FNIII clustering 
evident at the bacterial genus/species levels. For example, FNIII domains from 
similar enzymes obtained from different Streptomyces species are scattered 
throughout the tree. This again suggests that these FNIII domains have been 
obtained through horizontal gene transfer. The tree suggests that the FNIII 
domains in CAZy proteins originated from bacteria, since the eukaryotic cluster 
(indicated in green in Figure 2) and archaeal cluster (indicated in blue in Figure 
2) are further from the origin of the tree. This contrasts to literature were it has 
been stated that prokaryotic FNIII domains originate from Eukarya [227,228]. To 
analyze whether the subset of FNIII in CAZy enzymes is representative for all FNIII 
domains, two additional phylogenetic trees were produced including 100 (Fig. 
S1) or 1000 (data not shown) FNIII domains randomly picked from SMART [22], 
but containing an equal number of domains from each of the four kingdoms. 
Neither of these two additional phyologenetic trees produced showed clear 
clustering of FNIII domains according to kingdoms, or a clear origin of the tree 
(Fig. S1). Clearly, these trees also do not support the hypothesis that bacterial 
FNIII domains were originally obtained from eukaryotes. This conclusion was 
reached in 1992 based on phylogenetic analysis of the 13 bacterial FNIII domains 
known at that time, all from carbohydrate acting enzymes, when compared to 
26 eukaryotic FNIII domains [227]. This conclusion was restated in 2002 when 
the first bacterial FNIII domain 3D structure was solved, and based on the 
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phylogenetic analysis of 20 of the 135 bacterial FNIII domains which were at 
that time (July 2001) listed in SMART [228]. This appears to be the last time that 
the subject was studied using a bioinformatics analysis, but subsequently it has 
been referred to in many other FNIII domain studies and reviews (for example 
[229–233]). The phylogenetic trees presented in this study (Fig. 2, Fig. S1) do 
not support the conclusion that Eukarya are at the root for FNIII domains. Since 
about 33% of all FNIII domains currently listed in SMART is from prokaryotes, 
also the statement that there are many more eukaryotic FNIII domains than 
prokaryotic ones has become outdated [227,228]. We conclude that on basis of 
all available information there is no evidence that bacterial FNIII domains were 
originally obtained from eukaryotes. 
FNIII domains as cellulose surface modifiers
Two FNIII-like domains from Clostridium thermocellum cellobiohydrolase CbhA 
(GenBank CAA56918.1) were shown to act as cellulose surface modifiers [152], 
making the smooth and even surface of the cellulose substrate rough and 
uneven. These two domains were not among the 3,219 FNIII domains identified 
in this study, because they were not identified as such by CD-search [135]. 
Our additional PFAM analysis [21] also did not identify them as FNIII domains. 
Therefore these CbhA domains were extracted manually from the protein 
sequence, using the published information [152]. Their sequences were used 
for alignment together with all other bacterial FNIII sequences obtained from 
characterized carbohydrate acting proteins (Fig. 3). 
The two FNIII-like domains extracted from CbhA only show 7-14% identity and 
15-30% similarity to the 24 characterized FNIII domains from the bacterial 
carbohydrate acting enzymes included in the alignment (Fig. 3), while identity 
among the 24 true FNIII domains is 17-80% (30-84% similarity). In a phylogenetic 
analysis, the two CbhA domains do not cluster with other FNIII domains (Fig. 2). 
Four residues that are known to be conserved in FNIII domains [235] are also 
fully conserved in the FNIII domains included in the alignment (Fig. 3, highlighted 
in blue, pink, yellow and green). Only the leucine residue is conserved in the two 
domains from ChbA. We conclude that these two domains of ChbA in fact are 
not FNIII domains at all according to the current definitions. This also is reflected 
in their listing in CDD where they are currently indicated as “FNIII-like2 domains”. 
Since the suggestion that FNIII domains function as surface disruption domains 
was based only on the experimental results obtained with these two domains in 
ChbA, this hypothesis is now no longer supported by experimental data. 
Location of FNIII domain in the protein
Since domains acting as stable linkers between other protein domains are not 
expected to be found at the terminus of a protein, the position of FNIII domains 
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Figure 3: Alignment of all 24 bacterial FNIII domains explicitly reported in literature [71,73,75,151–
153,160,210,212–214,226,234], in carbohydrate acting enzymes. Sequences were extracted 
as described in methods except for the two “FNIII-like domains” from C. thermocellum CbhA 
(GenBank CAA56918.1) which were not recognized as such by the domain annotation tools, and 
were therefore extracted manually [152]. Predicted (Phyre2 [29]) conserved β-sheets are indicated 
in red. A conserved tryptophan in the 2nd β-sheet is indicated in blue, a conserved tyrosine in 
the 3rd β-sheet is indicated in pink, a conserved leucine is indicated in yellow, while a conserved 
aromatic residue in the 6th β-sheet is indicated in green (only the leucine residue is conserved in 
the two FNIII-like domains of CbhA). Other conserved residues are indicated in gray. Amino acid 
numbering is based on MaAmyA-833.
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within the 2,486 FNIII containing enzymes listed in CAZy was studied. For 
comparison, the position of CBMs in CAZy proteins (based on annotation of CBM 
domains with dbCAN) was included. We defined domains as terminal domains 
when there are less than 100 aa between the predicted domain sequence and 
the protein N- or C-terminus. Also, it was not allowed for the remaining amino 
acids to contain a protein domain as identified by either CD-search or dbCAN. 
In total there are only 332 proteins that have a FNIII domain either at the N- or 
at the C-terminus including five proteins with both an N- and C-terminal FNIII 
domain. This is 14% of all FNIII containing proteins. In comparison, 82% of all 
CBM containing proteins have a CBM located at the protein terminus (Fig. 4). 
Only in a small number of CBM families (13 out of 66 families), the majority 
of the CBM members is not located at one of the protein termini (Fig. 4). 
Interestingly, terminal FNIII domains are found at a similar ratio at either terminus 
of the protein. In contrast most of the individual CBM families seem to have a 
preference for either the N- or C-terminus (Fig. 4). Taken together, these results 
show that FNIII domains are mainly found in between other protein domains. 
This supports the hypothesis that FNIII domains may function as stable and/or 
flexible linkers. 
Figure 4: Percentage of FNIII or CBM containing proteins (excluding CBM68-CBM73) with at least 
one domain located at the terminal protein end (defined as < 100 aa from the protein terminus, 
not containing any other defined domains). CBM: percentage of all CBM containing proteins with 
a terminal CBM. For specific CBM families, the percentage of proteins with less than 50% terminal 
CBMs is also shown.
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Enzyme activities associated with FNIII domains
Of all enzymes listed in CAZy, 2,486 proteins contain one or more FNIII domains 
(Table 1). Of these 2,486 enzymes, 124 have been characterized and have at 
least one EC number in the CAZy. In Figure 5 an overview is shown of the number 
of different EC numbers associated with these enzymes. The enzyme classes to 
which the EC numbers belong are also indicated. The same analysis was also 
performed for the 50,301 CBM containing enzymes (Table 1), of which 2,273 
have one or more EC numbers listed in CAZy. CBM families associated with five 
or more different EC numbers are included in Figure 5. 
 
Figure 5: Number of unique EC numbers associated with characterized FNIII and CBM containing 
proteins. Only CBM containing proteins associated with at least five unique EC numbers are 
shown. The major EC activity groups are indicated: Oxidoreductases (EC 1.x), Transferases (EC 2.x), 
Hydrolases (EC 3.x), Lyases (EC 4.x). None of the proteins was associated with the Isomerase (EC 
5.x) or Ligase (EC 6.x) classes.
Enzymes that contain FNIII domains are associated with 24 unique EC numbers 
(Table S1). In addition, they are associated with all four main enzyme activities 
listed in CAZy, more than for any of the CBMs (Fig. 5). CBM1, 13 and 32 containing 
enzymes are associated with 20 different EC numbers, the highest number of 
unique EC numbers associated with a single CBM family (Fig. 5). For individual 
CBM families it is to be expected that they do not associate with a large number 
of activities, since their main function is to bind to specific substrates that also 
the associated catalytic domain can interact with. For example a CBM type able 
to specifically bind cellulose would be of little use in a starch degrading enzyme. 
This is indeed largely reflected in the results on CBM association with EC numbers 
(Fig. 5). Some CBMs are associated with a large number of EC numbers but in 
those cases the enzymes mainly have activities related to the substrate that is 
bound by the CBM or substrates a related substrate. We consider a substrate 
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related when in a natural environment it is common for the carbohydrate that 
is bound by the CBM to be in close proximity to the substrate of the catalytic 
domain. For example some xylanases have an cellulose binding domain but 
since both xylan and cellulose are known to be in close proximity to each other 
in plant cell walls [236] this is considered as an related CBM. FNIII domains on 
the other hand are associated with many different enzymatic activities, ranging 
from chitin-acting (chitinase) and cellulose-acting (cellulose) to starch-acting 
(α-amylase and pullulanase). Such a broad distribution does not point to a role 
for FNIII as a binding domain that supports interaction of the resident catalytic 
domain with a specific substrate. The appearance of FNIII domains in many 
different enzyme types instead suggests a less specific role, e.g. as a stable linker.
FNIII domains function mainly as stable linkers
Since 2002, three functions have been suggested for FNIII domains in 
carbohydrate active enzymes [60,151,152]. This paper shows that two previously 
characterized domains of C. thermocellum cellobiohydrolase CbhA in fact are 
not FNIII domains at all (Fig. 2, 3). Their proposed function in substrate surface 
disruption thus no longer holds for true FNIII domains. When FNIII and CBM 
domains are compared for their position in the protein and association with 
specific enzyme activities, a clear difference is observed. While CBM generally 
display a certain substrate binding specificity and usually are part of enzymes 
with specific catalytic activities for the same substrate, this is not the case for 
FNIII domains. The suggested role for FNIII domains in substrate binding thus 
appears unlikely. It is well known that CBMs use aromatic residues to interact 
and bind to carbohydrates. However, the 3D structure of the FNIII domain from 
chitinase A1 showed that the domain did not have any accessible aromatic 
residues [24] which makes it less likely that it can function as a CBM. As shown in 
Table 1, 71.7% of the FNIII containing proteins also contains a CBM (as annotated 
by CAZy) which increases up to 76.0% when dbCAN is used to annotate the CBM 
domains. Finally, FNIII domains are mainly located between other domains, 
unlike CBMs which are often present at the terminal end of proteins. On basis of 
these considerations we conclude that the available evidence suggests that FNIII 
domains function as stable linkers in multi-domain proteins. 
In truncation studies the full length enzyme is usually compared with constructs 
in which either the CBM or both the CBM and FNIII domain(s) were removed. 
In these studies, removal of only the CBM usually affects activity on insoluble 
substrates [73–75,151–153,209,213,214], while the additional removal of the 
FNIII domains showed no further effects. In a study of the chitinase A1 from 
Bacillus circulans WL-12a, the single CBM present was re-attached after removal 
of one or two intermediate FNIII domains, allowing a direct test for the FNIII 
function [60]. Removal of one FNIII domain showed a ~20% activity decrease on 
insoluble colloidal chitin, and removal of both FNIII domains resulted in a ~50% 
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activity decrease. Removal of only the CBM also caused a ~50% activity decrease. 
When the CBM was not re-attached, the removal of one or both FNIII domains did 
not further affect activity. In all cases the activity on a soluble substrate remained 
unaffected [60]. These experimental data thus support the suggested function 
of FNIII domains as stable protein linkers, acting in the optimal placement of 
different enzyme domains towards each other, and towards the substrate. 
In conclusion, the multiple FNIII domains in the M. aurum B8.A MaAmyA and 
MaAmyB proteins thus may act as a spacer between the catalytic domain, the 
two CBM25 domains, and the CBM74 domain (in case of MaAmyA) (Fig. 1), to 
provide optimal position and/or flexibility of these domains with respect to each 
other and towards the substrate. 
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Figure S1: Phylogenetic tree based on 100 FNIII domain sequences found in an equal number of 
proteins from 4 different kingdoms (Archaea, Bacteria, Viral and Eukarya). For each kingdom, 25 
FNIII containing proteins were selected at random from the SMART database thus representing a 
diversity of proteins. The light blue line indicates the highest branch of the tree from the origin. A 
larger tree with 10 times more FNIII containing proteins showed similar results (data not shown).
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Table S1: Overview of the number of EC numbers associated with the FNIII containing proteins
In the CAZy database, 124 of the FNIII containing proteins are associated with one or more EC numbers. 
Total number of FNIII containing proteins with an EC number: 124
Number of FNIII containing proteins associated with 1 EC number: 112
Number of FNIII containing proteins associated with 2 EC numbers: 10
Number of FNIII containing proteins associated with 3 EC numbers: 2
Since some FNIII domains are related to more than 1 EC number, there are in total 138 EC 
numbers linked to the 124 FNIII containing proteins (based on the CAZy database)
 Total EC numbers unique EC numbers
Oxidoreductases (EC 1.x) 2 1
Transferases (EC 2.x) 1 1
Hydrolases (EC 3.x) 133 21
Lyases (EC 4.x) 2 1
Total 138 24
























































The evolutionary origin and possible 
functional roles of FNIII domains in two 
Microbacterium aurum B8.A granular 







Amylases are well known as soluble starch hydrolyzing enzymes, classified 
mainly in Glycosyl Hydrolase (GH) family 13, but also in GH70 and GH77 [20]. 
Less is known about amylases that are able to degrade raw starch. In this thesis 
we present the characterization of two novel raw starch degrading enzymes 
(Fig. 1) which were isolated from the Gram-positive bacterium Microbacterium 
aurum B8.A that is able to grow on starch granules as carbon- and energy source 
[125,127]. The study of these two enzymes provides new insights on raw starch 
degradation. 
Figure 1: Domain organization of MaAmyA, MaAmyB and the general conserved domain 
organization of the novel GH13_42 subfamily which includes MaAmyB. The gray background 
indicates the 484 amino acids which are highly conserved (99% identity on DNA level) 
between MaAmyA and MaAmyB which includes three FNIII domains that are highly similar 
to each other (>95% identity on DNA level). Colors indicate conserved regions or domains: □: 
signal sequence; ■: GH13 catalytic domain AB region; ■: GH13 catalytic domain C region; 
■: FNIII domain; ■: CBM25 domain; ■: CBM74, a novel CBM domain (chapter 3); ■: aberrant 
C-region found in all GH13_42 members. The total number of amino acids in MaAmyA and 
MaAmyB is indicated. 
The first enzyme, a large multi-domain α-amylase (an endo-acting enzyme) 
designated MaAmyA (148 kDa), is described in chapters 2 and 3. The second enzyme 
was characterized as a large multi-domain α-glucan 1,4-α-maltohexaosidase (an 
exo-acting enzyme), designated as MaAmyB (135 kDa) which is described in 
chapter 4. Both MaAmyA and MaAmyB contain 2 Carbohydrate Binding Module 
25 (CBM25) domains and an exceptionally high number (4) of Fibronectin type 
III (FNIII) domains (Fig. 1). Therefore, a detailed phylogenetic analysis of CBM25 
and FNIII domains in both these enzymes, as well as in carbohydrate acting 
bacterial enzymes in general, is presented in chapters 4 and 5.
CBM25 domains of MaAmyA are essential for raw starch 
degradation and pore formation 
A total of 74 CBM families have been characterized for their carbohydrate 
binding ability. Members of CBM 20, 21, 25, 26, 34, 41, 45, 48, 53, 58, 69 and 
74 are known to bind to starch and are therefore also known as starch binding 
domain (SBD) [20]. The presence of an SBD in amylase enzymes is known to 
enhance the catalytic efficiency of raw starch degradation [64,65]. In literature 
it has been shown that raw starch degrading enzymes may contain one or more 
CBM domains, and therefore have a relatively large molar mass (Chapter 1, Table 




one or multiple CBM domains were removed have given contradicting results. 
In some cases the ability of the truncated enzyme to degrade raw starch was 
unaffected [76] while in other examples raw starch degradation activity was 
lower or completely lost upon removal of all CBMs [64]. It has been shown that 
various raw starch degrading enzymes are able to form pores in starch granules, 
but the relation between pore formation and presence of CBMs had not been 
studied. We studied the multi-domain α-amylase MaAmyA, which consists 
of a family GH13, subfamily 32 (GH13_32) α-amylase catalytic domain with 2 
CBM25 and 4 FNIII domains, and a C-terminal tail (Fig. 1). Various C-terminally 
truncated MaAmyA variants were constructed and characterized. Removal 
of the C-terminal tail had no significant effect on the raw starch degradation 
rate, but resulted in a significant reduction of the size of the pores formed by 
MaAmyA in starch granules (see Chapter 2, Fig. 7). The additional removal of the 
3 FNIII domains did not have a significant effect on pore formation or raw starch 
degradation. Further deletion of the 2 CBM25 domains did not affect the soluble 
starch degrading activity of MaAmyA (see Chapter 2, Table 1), but resulted in 
complete loss of raw starch degradation and pore formation (see Chapter 2, Fig. 
5, 6), revealing that in MaAmyA these domains have an essential role in the raw 
starch degrading activity of MaAmyA.
Two different systems appear to enable raw starch degradation 
This thesis shows a strong relation between the CBM25 domains of MaAmyA 
and its raw starch degrading activity. This relation has also been reported in 
literature for CBM25 and other SBDs on raw starch degradation (see Chapter 1, 
Table 1). However, this does not explain how other amylases lacking CBMs can 
degrade raw starch (see Chapter 1, Table 1). Our overview of fully sequenced 
raw starch degrading enzymes (see Chapter 1, Table 1) shows that amylases 
lacking CBMs usually belong to other GH13 subfamilies then amylases with 
CBMs, such as MaAmyA. For example, barley amylase degrades raw starch but 
lacks CBM domains; instead it uses binding regions located on the surface of the 
catalytic domain (AB- or C-region). These regions have been defined as surface 
binding sites (SBS) and their role in starch binding and degradation has been 
demonstrated [237]. Modification of essential amino acids in barley amylase 
SBS resulted in loss of starch binding and degradation [237]. In later studies 
SBS have also been identified in other amylases, including bacterial amylases 
[122]. Interestingly SBS are mainly found in GH13 subfamilies which contain raw 
starch degrading amylases that lack CBMs (see Chapter 1, Table 1) [122,238]. We 
therefore conclude that amylases have either SBS or CBMs to enable raw starch 




A possible role for CBM74 in human GIT starch fermentation
Chapter 3 reports the identification and characterization of a novel protein domain 
at the C-terminal end of MaAmyA which enhances its pore forming ability. Starch 
granules were treated similarly with MaAmyA, or with the MaAmyA construct 
without CBM74. After examination by Scanning Electron Microscopy (SEM), the 
pores formed by the construct containing CBM74 are, on average, 3 times larger. 
To study this novel domain in more detail, the C-terminal tail was expressed 
separately and characterized as a novel CBM (CBM74), able to bind to both 
soluble and raw starch. Bioinformatics analysis showed that CBM74 members 
occur more widespread in bacterial amylases and are commonly part of very 
large and complex amylases which usually also contain additional CBMs. A large 
proportion of these amylases originate from bacteria which were isolated from 
(human) gut (related) environments (Chapter 3). It is well known that in healthy 
adults, all naturally occurring starches are completely degraded [126,198]. 
The human digestive enzymes cannot degrade raw starch, and this so-called 
resistant starch ends up in the large intestine where it is completely fermented 
by the resident bacterial population. The enzymes responsible for this bacterial 
starch degradation remain to be identified. In two independent human studies 
it was shown that obese subjects who were unable to fully ferment resistant 
starch (RS2 or RS3) had only relatively low numbers of Ruminococcus bromii 
and Bifidobacterium adolescentis [126,239] related strains in their feces, while 
no significant relation with other bacterial strains could be found. One study 
showed that raw starch degradation improved significantly when B. adolescentis 
or R. bromii were added to a feces sample of such a test subject, while two 
other bacterial strains tested had no significant effect [126]. The genomes of B. 
adolescentis and R. bromii both encode a large and multi-domain amylase with 
a CBM74 domain, while none of the other strains mentioned in these 2 studies 
[126,239] has such a CBM74 homolog. It therefore appears likely that the large 
complex amylases with a CBM74 domain are specialized in the degradation of 
raw starch in the Gastro Intestinal Tract (GIT) of humans and other mammals. 
Functional collaboration of MaAmyA and MaAmyB 
The raw starch degradation capability of MaAmyA was compared to that of 
culture fluid from M. aurum B8.A grown on MMTV medium which had granular 
potato starch as major carbon source. The resulting culture fluid contained 
all enzymes secreted by the bacterium. The samples had an equal activity of 
300 U on the soluble substrate CNPG3 (2-chloro-4-nitrophenol (CNP) group 
coupled to maltotriose (G3)). Results showed that when raw starch is used as a 
substrate, MaAmyA alone was unable to achieve the fast and high degradation 
rates obtained by the culture fluid (Fig. 2). This resulted in a search for and the 
discovery of a second large multi-domain GH13 enzyme which was designated 
MaAmyB, again with 2 CBM25 domains and 4 FNIII domains (Fig. 1). The gene 




on the genome of M. aurum B8.A. The MaAmyB enzyme was characterized as 
an α-glucan 1,4-α-maltohexaosidase which is an exo-acting amylase (Chapter 4). 
The MaAmyB enzyme has an exceptionally large catalytic domain, with 3 peptide 
inserts. Based on a bioinformatics analysis we showed that MaAmyB is part of a 
new GH13 subfamily, GH13_42, which currently has 165 members, mostly from 
Streptomyces species; none of these putative enzymes had been characterized. 
Most members have the same general domain organization, with 2 CBM25 
domains but with only 1 FNIII domain located N-terminally of the catalytic 
domain (Fig. 1). The strong conservation of the CBM25 tandem in GH13_42 
members, in combination with the finding that the presence of the CBM25 
domains in MaAmyA had a strong effect on raw starch degradation, suggest that 
also GH13_42 members are likely involved in raw starch degradation. However, 
since these large enzymes are difficult to handle and express, we have been 
unable to characterize MaAmyB in detail biochemically. Bioinformatics analysis 
revealed that the C-region of GH13_42 members is aberrant and unlike most 
C-regions outside GH13_42 has usually no additional domains attached to it: 
The CBM25 tandem is located at the N-terminus in GH13_42 enzymes while in 
most other cases it is located C-terminally of the catalytic domain. Therefore we 
speculate that the C-region of GH13_42 members has a function, which would 
be hindered if additional domains were attached to it. Additional research is 
needed to gain insight in the functions of these aberrant C-regions.
Figure 2: Comparison of granular wheat starch degradation rates and SEM images of MaAmyA and 
M. aurum B8.A culture fluid. Both SEM images have a magnification of 5000x. Culture fluid was 
obtained from cells grown on MMTV medium supplemented with granular starch (see Chapter 
2). Starch degradation was determined by the Anthrone method (see Chapter 2). Dashed lines 
indicate the time point used for the SEM image. The bar graph shows the measured sizes of the 
pores for each of the 2 starch granules. Since the culture fluid (CF) treated granules also contained 
some extremely large pores (LP), these were included separately in the graph (CF LP). For the 
negative control, an empty vector construct was used and treated similar to MaAmyA. Granules 
treated with negative control did not contain any pores after 48 hours (Fig. 6C, Chapter 2). This 




The finding that MaAmyB functions as an exo-amylase leads to the speculation 
that MaAmyA and MaAmyB act together in the degradation of starch granules in 
a similar way as has been reported for α-amylases and glucoamylases [202–205]. 
This is further supported by the fact that in the genomes of various Streptomyces 
species, genes encoding MaAmyB homologs are often located in close proximity 
to genes encoding a potential raw starch degrading amylase which belongs 
to the same GH13_32 subfamily as MaAmyA and includes one or more SBDs 
(Chapter 4). We hypothesize that the α-amylase (MaAmyA) initiates the attack 
and forms pores in the granules. These pores allow the exo-amylase (MaAmyB) 
access to the inside of the granule after which the granules are rapidly further 
degraded from the inside. This hypothesis would explain the results obtained for 
MaAmyA and M. aurum B8.A culture fluid during the granular starch degradation 
experiments described in Chapter 2 and summarized in Figure 2. MaAmyA is 
present in both samples and initiates starch granule degradation by formation 
of pores. When the first pores are made, MaAmyB which is only present in 
the culture fluid sample, presumably is able to enter the granules and rapidly 
degrades the granular starch from the inside. This process causes the increase in 
the degradation rate after 6 hours (Fig. 2). The MaAmyA treated sample shows a 
decrease after 6h instead. We excluded that this was due to enzyme instability as 
the addition of fresh MaAmyA after 24 h or 48 h did not result in an increase of 
the degradation rate. The SEM images taken from the culture fluid samples after 
6 h of incubation show only a few big pores combined with numerous small pores 
which make the granules look porous. In contrast, even after 48 h the MaAmyA 
treated granules are still solid granules with many small pores (Fig. 2). This finding 
also corresponds to literature which describes that the outer layer of the granule 
is more difficult to hydrolyze [240,241], so it makes sense that a specialized 
enzyme (MaAmyA) has been recruited to act on it to form the initial pores. The 
finding that the initial degradation rates (first 6 h) are similar for granules treated 
with only amylases or with a mixture of amylase and an exo-amylase, has not 
been reported as such in current literature that describes synergy between 
α-amylase and glucoamylase enzymes for raw starch degradation. This could 
be due to the fact that often higher enzyme concentrations have been used. 
As explained in Chapter 2, we used low concentrations of MaAmyA since the 
expression yield of the enzyme was relatively low. It should also be noted that in 
many studies limited data was collected at the initial stage of the reaction. The 
similarity in degradation rates in the first stages of granular starch degradation 
may therefore have been overlooked [202–205]. Based on our experiments, it 
appears likely that MaAmyA and MaAmyB work in synergy: MaAmyA introduces 
pores in the granular surfaces, allowing MaAmyB to enter the starch granules and 
to degrade the starch using its exo-acting activity. The latter may be based on the 
mechanism of starch granule degradation as reported in earlier studies[242]. In 
future work it would be interesting to compare the rate of granule degradation 
only involving an exo-amylase, entering the granular core via surface cracks and 




FNIII domains act as flexible stable linkers in carbohydrate acting enzymes.
Both MaAmyA and MaAmyB contain 4 FNIII domains, which is an exceptionally 
high number. The role of FNIII domains in carbohydrate acting enzymes had not 
been determined with certainty yet as previous literature showed contradicting 
results. Three functions have been suggested: surface modification of an 
insoluble substrate [152], substrate binding domain and linker region. A 
bioinformatics analysis was performed to gain insight in the function of FNIII 
domains in carbohydrate acting enzymes (Chapter 5). All FNIII domains present 
in carbohydrate acting enzymes listed in the CAZy database were traced. 
Through phylogenetic analysis it was demonstrated that two domains previously 
identified as FNIII in fact were not FNIII domains, but instead indicated as FNIII-
like 2 domains by CDD. Since these two domains were the only FNIII domains 
which were reported to function as surface modifier [152], this potential function 
could be rejected for FNIII domains in general. Additional bioinformatics analysis 
was performed in which the positions of the FNIII domains and CBMs (families 
1 through 67) of all carbohydrate acting enzymes listed in the CAZy database 
were determined and compared. This analysis revealed that FNIII domains are 
mainly located in between other domains, while CBM domains are commonly 
found at the termini of the enzymes. In addition FNIII domains are found in 
enzymes that act on various substrates while the specific CBM domains are 
found in enzymes acting on the carbohydrate which the CBM is able to bind 
to. We therefore conclude that it is likely that FNIII domains mainly function as 
stable flexible linkers in carbohydrate acting enzymes. In Chapter 2, we observed 
that the additional deletion of the 3 C-terminal FNIII domains from MaAmyA 
(Fig. 1) had no effect on pore formation and raw starch degradation by the 
truncated mutant MaAmyA protein (made possible by the 2 CBM25 domains). 
This indicates that these FNIII domains function as stable flexible linkers, putting 
CBM74 at a suitable and functional distance from the CBM25 domains. To study 
this further, construction of MaAmyA derivatives with the 1-3 C-terminal FNIII 
domains deleted, but with CBM74 present, is recommended. CBM74 has been 
identified as functional in introducing relatively large pores in starch granules. 
Characterization of these MaAmyA derivatives may provide insights in the 
specific roles of CBM25 and CBM74 domains present, and the role as stable 
flexible linker of the 1-3 FNIII domains.
Bioinformatics tools 
For the work in this thesis, numerous bioinformatics tools and databases such 
as the Carbohydrate Acting enZYmes database (CAZy) [20], Conserved Domain 
Database (CDD) [135] and the database for Carbohydrate-active enzyme 
Annotation (dbCAN) [26], were commonly used. Especially to study the role 
of FNIII domains in carbohydrate acting enzymes a lot of protein domains 
were annotated in a large number of enzymes. Although all the enzymes used 




necessary to find the exact domain organization of the enzymes as well as to 
identify the FNIII domains . Since CDD does not contain information for all CBM 
domains, additional databases had to be employed, such as dbCAN. The use 
of different databases is not only inconvenient, but also leads to variations in 
results depending on the database used. For example for all proteins listed in 
the CAZy database approximately 5% more CBM domains were identified (of 
CBM families 1 through 67) when using dbCAN [26] (Chapter 5). CBM families 
68 through 74 are currently not part of any database and are therefore not 
recognized by domain annotation tools which use either dbCAN or CDD. Even 
when domains are recognized correctly, their exact size and position as indicated 
by the different search tools is often not corresponding. This is due to differences 
in the methods used by each database to generate consensus sequences and 
scoring matrix for each protein domain model. Amino acid sequences submitted 
to conserved domain database search tools (such as Conserved Domain search 
(CD-search), which is used to search CDD) are compared to these domain 
models (using their scoring matrixes) to identify conserved domains. CDD also 
uses 3D structural information in its domain models, while dbCAN only works 
with sequences. As a result the AB-region in amylases as identified by dbCAN 
lacks the first β-sheet and last α-helix of the TIM barrel, while CDD correctly 
identifies the full region. Another issue is that different databases use different 
classifications: for example, the GH13 subfamilies as defined by CAZy are not 
equivalent to the different GH13 models as identified by CDD. In literature these 
kind of differences have been mentioned before [20], and are the results of 
differences in strategies, thresholds, goals, methods, training sets and expert 
curation between the CAZy team and the other tools [20].
In our opinion, solving these issues would be greatly beneficial to the field of 
carbohydrate enzyme research. We propose coupling of CAZy with CDD such 
that CDD will be able to show all the domains with their CAZy names and also 
identify the domains currently missing. Coupling with CDD would be preferred 
over coupling with dbCAN, since CDD is already widely used and established, 
and uses structural data to show the placement of domains as accurately as 
possible. In addition, CDD is able to handle large datasets and already contains 
many more domains when compared to dbCAN. This might in turn help the 
carbohydrate field to identify other interesting domains to study such as we did 
with FNIII domains. 
MaAmyA and MaAmyB evolution in M. aurum B8.A
Throughout the work described in this thesis one observation was quite 
remarkable: MaAmyA and MaAmyB are both very distinctive from other known 
enzymes currently in databases. For example MaAmyA is the only GH13_32 
enzyme with FNIII domains and a CBM74 domain while MaAmyB has twice the 
number of FNIII domains as any of its GH13_42 homologs (Fig. 1,3). Currently M. 




they are not encoded in any of the 25 genome sequences of other Microbacterium 
strains currently in databases. In addition, the M. aurum DSMZ 8600 type strain 
has no amylolytic activity [127]. We therefore speculate that MaAmyA and 
MaAmyB have originated from intense domain shuffling and heterologous gene 
transfer from other bacteria. This view is supported by the detailed sequence 
analysis of the amyA and amyB genes, which show extremely high identity (99%) 
for a large part of both enzymes including the 2 CBM25 and the following 3 FNIII 
domains (FNIII1,2 and 3) (Fig. 3). In addition there is high identity (>95%) among 
FNIII1,FNIII2 and FNIII3 (Fig.3) (Chapter 4). Further analysis revealed a hairpin 
loop in the DNA following the FNIII3 domain, which is an indication for a recent 
recombination [243]. 
M. aurum B8.A has been isolated from the sludge of a potato waste water 
treatment plant [125], which was very rich in raw starch granules, which may 
well have been the driving force for the formation of enzymes like MaAmyA and 
MaAmyB. It is likely that other soil dwelling bacteria were also present in this 
environment and may have been the original donors of MaAmyA and MaAmyB 
precursors. One likely donor could be a Streptomyces species, as some species 
which have a homolog of MaAmyB, also have an α-amylase located nearby on 
the genome that belongs to the same GH13_32 subfamily as MaAmyA [82] 
(Fig. 3). The CBM74 typical for MaAmyA is also found as part of large multi-
domain GH13_28 or GH13_19 amylases in various soil dwelling bacteria such as 
Paenibacillus, which could have been the donor for this domain. The very high 
identity between FNIII1,FNIII2 and FNIII3 in MaAmyA and MaAmyB indicates 
that these domains have been recently duplicated. Since M. aurum B8.A uses 
MaAmyA and MaAmyB to efficiently degrade granular potato starch it is likely 
that the additional duplicated FNIII domains (FNIII1,2 and 3) are especially 
beneficial. The extra FNIII domains likely result in an optimal distance between 
the catalytic domain and the CBM(s). However, since we did not re-attach CBM74 
in MaAmyA after the removal of FNIII1, 2 and 3 domains or made any deletion 
constructs of MaAmyB, we can only speculate. It seems that M. aurum B8.A is a 
good example of a bacterium that has evolved successfully by strongly adapting 




Figure 3 A: Protein domain organization of MaAmyA and MaAmyB and 4 related proteins. All 
proteins are shown with the N-terminus on the left hand side. The dotted line box indicates a 
stretch of domains that is highly similar between MaAmyA and MaAmyB (>99% identity), 
suggesting a relatively recent duplication event. The FNIII domains that are identical in MaAmyA 
and MaAmyB are named FNIII1, FNIII2 and FNIII3. The first FNIII in MaAmyA is named FNIIIA and the 
fourth FNIII in MaAmyB is named FNIIIB. Equal fill patterns indicate domains with high similarity. 
Solid filled domains do not have similarity to any other domain shown. AmlB (CAB06622.1) 
and BAA22082.1 are included as representatives of GH13_32 with high similarity to MaAmyA. 
AmlC (CAB06816.1) is included as a representative of GH13_42 with high similarity to MaAmyB. 
BAB86376.1 is included as a representative of a group of chitinases containing FNIII domains 
with high similarity to FNIII1,FNIII2,FNIII3 and FNIIIB. CBM74 is a novel CBM domain (chapter 3). 
B: Schematic representation showing the orientations of the genes encoding theM. aurum B8.A 





In this work we describe a synergistic enzyme system from M. aurum B8.A which 
is highly adapted to its environment. We characterized two large multi-domain 
enzymes, MaAmyA and MaAmyB, which are unlike any enzyme currently in 
databases, and speculate about their origin. We defined the novel GH13_42 
subfamily to which MaAmyB belongs and show that all members share a general 
conserved domain organization which differs from other GH13 amylases, 
including N-terminal CBM25 and a FNIII domains as well as an enlarged AB-
region and aberrant C-region. More research is needed to fully understand the 
structure/ function relations of this enzyme and gain insight in the roles of its 
additional domains. 
The data shows that the CBM25 domains in MaAmyA have a clear role in raw 
starch degradation and demonstrate their requirement for pore formation. 
We also defined and characterized the C-terminal tail of MaAmyA as the novel 
CBM74 domain which seems to be involved in resistant starch degradation in 
the mammalian gut. Although it is known that all natural resistant starches 
(RS1, 2 and 3) cannot be degraded by human GIT enzymes but are instead fully 
fermented in the large intestine [244–246], it is currently unknown how the 
bacteria degrade resistant starches. We show that CBM74 is commonly found in 
large and complex amylase enzymes which are obtained from bacteria isolated 
from the human gut and related environments (Chapter 3, Fig. 5). However such 
enzymes have not yet been studied. More research is needed to fully understand 
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Samenvatting voor een breed publiek
Deze samenvatting is geschreven voor een breed publiek. Om deze 
reden worden enkele belangrijke begrippen hier wat uitgebreider 
geïntroduceerd en zijn sommige zaken wat vereenvoudigd opgeschreven. 
Ook zijn een aantal resultaten in vereenvoudigde vorm weergegeven. 
Voor de volledige wetenschappelijk tekst en verantwoordingen wordt u 
verwezen naar de Engelstalige samenvatting en overige hoofdstukken van 
dit proefschrift.
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De titel van dit proefschrift is, vrij vertaald naar het Nederlands,  “De biochemische 
karakterisatie en bio-informatica analyse van twee grote multidomein enzymen 
van Microbacterium aurum B8.A welke betrokken zijn bij de afbraak van 
zetmeelkorrels”. Dat is een hele mond vol en zal u mogelijk niet zo veel zeggen. 
Iedereen die mij wel eens heeft gevraagd waar ik onderzoek naar doe herkent 
waarschijnlijk wel twee woorden, namelijk “enzymen” en “zetmeel”. In de 
introductie hieronder wordt daarom een en ander kort uitgelegd met name 
ook de betekenis van amylase (een enzym) en zetmeelkorrels. Daarna volgt de 
samenvatting van het werk dat in dit proefschrift is beschreven.
Introductie
Zetmeel is een koolhydraat en komt veel voor in ons voedsel. Aardappelen, pasta 
en brood zijn voorbeelden van voedingsmiddelen die voor een belangrijk deel 
uit zetmeel bestaan. Zetmeel is opgebouwd uit twee verschillende ketens van 
glucosemoleculen: amylose en amylopectine. Het verschil tussen beide is dat 
amylose een lineaire keten is terwijl amylopectine vertakkingen heeft (zie Fig. 1). 
In planten wordt zetmeel opgeslagen als korrels. Deze zijn compact en resistent 
tegen afbraak door de meeste enzymen. De zetmeelsamenstelling en korrels 
verschillen per plantensoort die de korrels produceert. Aardappelzetmeelkorrels 
zijn bijvoorbeeld gemiddeld veel groter dan tarwezetmeelkorrels.
Figuur 1: Van zetmeelkorrel tot glucose, de opbouw van een zetmeelkorrel schematisch 
weergegeven. A: Elektronenmicroscoop foto van een halve tarwezetmeelkorrel waarop de semi-
kristallijne en amorfe lagen zichtbaar zijn. B: De lagen in een zetmeelkorrel, waarbij te zien is dat 
één kristallijne laag eigenlijk bestaat uit meerdere kristallijne lagen afgewisseld door een dunne 
amorfe laag. C: schematische weergave hoe amylose en amylopectine een kristallijne laag vormen. 
D: amylose (blauw) en amylopectine (zwart). E: Glucose.
Enzymen zijn eiwitten die een reactie kunnen versnellen (ook wel katalyseren 
genoemd) zonder dat ze daarbij zelf verloren gaan. Ze bestaan net als alle eiwitten 
uit aminozuren. Het aantal aminozuren verschilt per eiwit, zo bestaan enzymen 
die zetmeel af kunnen breken gemiddeld uit zo’n 500 tot 600 aminozuren. De 
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door mij bestudeerde enzymen bestaan echter uit meer dan twee keer zo veel 
aminozuren. Deze aminozuur keten is niet lineair en plat, maar gevouwen. Door 
deze vouwing ontstaan er 3D structuren, welke domeinen genoemd worden. 
Een eiwit kan bestaan uit meerdere domeinen. (Fig. 2)
Figuur 2: Schematische weergave van een eiwit met 2 domeinen. De zwarte lijn stelt de aminozuur 
keten voor. De domeinen staan aangegeven. Onderaan staat een schematische weergave van de 
domeinorganisatie van het eiwit. Het getal 511 geeft aan hoeveel aminozuren er in totaal in het 
eiwit zitten. 
Een domein kan een specifieke functie hebben binnen een eiwit. Daarom 
worden eiwitdomeinen in groepen (families) ingedeeld. In databases online 
wordt bijgehouden welke domeinen tot welke familie behoren en indien bekend 
welke functie ze hebben. Voor koolhydraatenzymen wordt dit bijgehouden in 
de CAZy ( Carbohydrate-Active enZymes) database, te vinden op www.cazy.org. 
Enzymen die zetmeel afbreken worden ook wel amylases genoemd. Ze 
katalyseren de afbraak van het glucosepolymeer zetmeel. Een voorbeeld 
hiervan is speekselamylase. Dit is een α-amylase enzym dat zetmeel omzet 
in kortere glucose polymeren en uiteindelijk tot maltose, wat uit 2 glucose 
eenheden bestaat (Fig. 3). Omdat α-amylase een glucose polymeer op bijna 
elke plaats kan splitsen behoort α-amylase tot de endo-amylases. Mensen 
produceren twee α-amylases in het spijsverteringsstelsel, speeksel amylase en 
alvleesklier amylase. Verdere afbraak van maltose naar glucose wordt gedaan 
door een ander enzym, genaamd α-glucosidase, dat in de dunne darm wordt 
geproduceerd. Dit katalyseert dezelfde hydrolysereactie als α-amylase, echter 
α-glucosidase kan maar één glucose per keer vrij maken van het uiteinde van 
een glucose polymeer. Daarom behoort α-glucosidase tot de exo-amylases (Fig. 
3). Amylases in ons spijsverteringsstelsel zorgen er dus voor dat zetmeel wordt 
afgebroken tot glucose, dat in de dunne darm in het bloed wordt opgenomen en 
dient als energiebron voor ons lichaam.
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Figuur 3: Schematische weergave van endo- en exo amylase activiteiten op zetmeel en maltose. 
Rode pijlen geven aan waar endo amylases kunnen knippen. Zwarte pijlen geven aan waar exo 
amylases kunnen knippen. 
De eerder genoemde amylases werken alleen goed als het zetmeel in opgeloste 
vorm beschikbaar is. Planten zetmeelkorrels zijn echter niet oplosbaar in 
water. Tijdens de bereiding van ons voedsel wordt zetmeel vaak bewerkt, 
waardoor de zetmeelkorrels toch kunnen worden afgebroken. Zetmeelkorrels 
kunnen bijvoorbeeld stuk gaan door het vermalen van voedsel, waardoor ze 
afbreekbaar worden. Ook wordt veel voedsel verhit. Dit zorgt ervoor dat de 
zetmeelkorrels opzwellen en water opnemen. Hierdoor worden zetmeelkorrels 
(beter) toegankelijk voor enzymen zoals amylases, waardoor ze kunnen worden 
afgebroken. 
In ons dieet zitten ook producten die niet behandeld of verhit zijn en waarin 
dus hele zetmeelkorrels zitten. Omdat onze eigen spijsverteringsenzymen deze 
niet volledig kunnen afbreken wordt dit ook wel resistent zetmeel genoemd. 
Alles wat we niet kunnen verteren verlaat het lichaam weer via de ontlasting. Uit 
onderzoek is gebleken dat de ontlasting van gezonde mensen met een gezond 
gewicht geen zetmeel(korrels) bevat. Dit komt omdat resistent zetmeel in de 
dikke darm wordt omgezet (gefermenteerd) door bacteriën. Bij de aanvang 
van mijn onderzoek was niet bekend hoe bacteriën precies in staat zijn om 
zetmeelkorrels af te breken. 
In microscopisch onderzoek naar de afbraak van zetmeelkorrels door bacteriële 
amylases is opgevallen dat sommige enzymen die wel zetmeelkorrels kunnen 
afbreken gaten maken in zetmeelkorrels. Uit ander onderzoek is gebleken dat 
amylases die langer zijn wel zetmeel kunnen afbreken en de kortere varianten 
niet, terwijl beide wel oplosbaar zetmeel kunnen afbreken. Hierbij bleek dat de 
langere amylases een of meer extra domeinen hadden die specifiek koolhydraten 
konden binden zonder dat deze werden afgebroken. Deze domeinen worden 
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koolhydraatbindings domeinen (afgekort CBMs, Carbohydrate Binding Module 
in het Engels) genoemd. 
Op basis van deze resultaten was de verwachting dat CBMs er voor zorgen dat 
enzymen zetmeelkorrels kunnen afbreken, waarbij gaten gevormd worden in de 
zetmeelkorrels. Dit is al eerder onderzocht, maar in dat onderzoek bleek dat het 
enzym ook zonder CBMs nog gaten kon maken in zetmeelkorrels [1,2]. Uit een 
overzicht (Introductie, tabel 1,2) van alle 37 tot nu toe onderzochte bacteriële 
amylases die zetmeelkorrels kunnen afbreken blijkt bovendien dat er negen 
andere amylases zijn die geen CBMs nodig hebben om zetmeelkorrels af te 
breken. Voor een aantal anderen is juist aangetoond dat de CBMs wel nodig zijn 
om zetmeelkorrels af te breken. Er was daarom extra onderzoek nodig om dit te 
verklaren. 
Inleiding
In dit proefschrift worden twee geheel 
nieuwe amylase enzymen beschreven 
die in staat zijn om zetmeelkorrels af te 
breken. Deze enzymen zijn afkomstig 
van de bacterie Microbacterium aurum 
B8.A, welke in staat is om te groeien op 
zetmeelkorrels. Het bestuderen van deze 
twee enzymen heeft geholpen om beter 
te begrijpen hoe zetmeelkorrels kunnen 
worden afgebroken. 
Het eerste enzym dat is bestudeerd 
noem(d)en we MaAmyA (Microbacterium 
aurum Amylase A). Het is net als menselijk 
speekselamylase een α-amylase. Het eerste wat opvalt is dat MaAmyA veel 
groter is dan andere α-amylases (Fig. 4). Hoewel het deel dat zetmeel afbreekt 
(het katalytische domein) vergelijkbaar is bevat MaAmyA nog zeven extra 
domeinen, waaronder twee CBM25 waarvan bekend is dat deze aan zetmeel 
kunnen binden. In hoofdstuk 2 hebben we de rollen van de extra domeinen van 
MaAmyA bestudeerd. Een nieuw zetmeel bindend domein (CBM74) is in detail 
bestudeerd in hoofdstuk 3. 
Figuur 4 : Schematische weergave van MaAmyA. HSA, speeksel amylase (Human Salivary Amylase 
in het Engels) is toegevoegd ter vergelijking om te laten zien wat MaAmyA zo bijzonder maakt. De 
getallen geven de lengtes aan (in aantal aminozuren) van de verschillende enzymen. ■: katalytisch 
domein, ■: FNIII domein, ■: CBM25 domein, ■: Onbekend domein. FNIII domein, CBM25 en 
Onbekend domein worden later in de deze samenvatting uitgelegd.
Microbacterium aurum B8.A 
De Microbacterium aurum B8.A bacterie 
is gevonden in slib uit de waterzuiver-
ingsinstallatie van een aardappelverwerkings-
fabriek. Bij het kweken van de bacterie 
viel op dat de kolonies een goudgele 
kleur hadden. Hieraan dankt de bacterie 
zijn naam (aurum is Latijn voor goud). In 
laboratoriumexperimenten werd de gevonden 
bacterie vergeleken met een bekende 
Microbacterium aurum bacteriestam DSMZ 
8600 uit een standaard bacteriecollectie. 
Hieruit bleek dat de nieuw gevonden bacterie 
in staat was om aardappelzetmeelkorrels af 
te breken, terwijl de bekende uit de collectie 
dat niet kon. De nieuw gevonden bacterie 
was dus duidelijk anders en kreeg daarom de 
toevoeging B8.A.
152
Nederlandse samenvatting voor een breed publiek
N 
L
CBM25 domeinen in MaAmyA zijn essentieel voor zetmeelkorrel 
degradatie en porievorming
MaAmyA is een α-amylase. Het katalytisch domein 
behoort net als de meeste α-amylase tot de 
GH13 familie. Naast het katalytisch domein bevat 
MaAmyA, 4 FNIII domeinen, 2 CBM25 domeinen 
en een onbekend domein. Hoewel FNIII domeinen 
vaak voorkomen in andere eiwitten, is hun rol in 
koolhydraatenzymen niet duidelijk. Dit is daarom 
nader onderzocht en wordt in een latere paragraaf 
besproken. CBMs kunnen aan koolhydraten 
binden zonder deze af te breken. Een aantal CBM-
families waaronder CBM25 kunnen aan zetmeel 
binden. MaAmyA bevat dus twee zetmeelbindende 
domeinen (CBM25). 
Om de effecten van de verschillende extra domeinen in MaAmyA te bestuderen 
heb ik verschillende versies van het enzym gemaakt waarbij één of meer 
domeinen waren verwijderd (Fig. 5). Analyse van deze enzymen toont aan 
dat de CBM25 domeinen noodzakelijk zijn voor de activiteit van MaAmyA op 
zetmeelkorrels.
 
Figuur 5: Verschillende versies van MaAmyA die zijn gemaakt en hun activiteit op zetmeelkorrels. 
Alle MaAmyA versies waren actief op oplosbaar zetmeel. ■: katalytisch domein, ■: FNIII domein, 
■: CBM25 domein, ■: Onbekend domein.
De zetmeelkorrels die behandeld zijn met de verschillende MaAmyA-versies 
zijn ook bekeken met een microscoop. Daarvoor is een Scannende Elektronen 
Microscoop (SEM) gebruikt. Deze kan hogere vergrotingen halen dan een 
‘gewone’ lichtmicroscoop, waardoor we de poriën die MaAmyA in zetmeelkorrels 
maakt kunnen zien (Fig. 6). Hierbij is gekeken welke van de gemaakte MaAmyA 
versies (Fig. 5) poriën kunnen maken en of de poriën verschillend zijn. De 
resultaten laten zien dat CBM25 nodig is voor porievorming. Zonder CBM25 zijn 
er alleen wat ondiepe beschadigingen zichtbaar ten opzichte van onbehandelde 
korrels (Fig. 6).
Hoewel de activiteiten (zowel op oplosbaar zetmeel als zetmeelkorrels) gelijk 
waren voor alle MaAmyA-varianten met CBM25 (Fig. 5), laten de SEM-resultaten 
zien dat er wel een verschil is tussen de gevormde poriën. De poriën die gevormd 
GH13 
De meeste amylases bevatten 
een katalytisch domein wat tot de 
13e Glucoside Hydrolase familie 
behoort. Tot nu toe zijn er 135 GH 
families bekend. Alle GH enzymen 
kunnen glycosidische bindingen 
in koolhydraten afbreken in een 
reactie waarbij water wordt 
gebruikt (hydrolyse reactie), van-
daar hun naam. De meeste GH13 
domeinen zijn actief op zetmeel. 
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worden door MaAmyA met het onbekende domein zijn groter dan de poriën die 
gevormd worden zonder het onbekende domein. Op basis van deze resultaten 
kan geconcludeerd worden dat de CBM25 domeinen in MaAmyA noodzakelijk 
zijn voor activiteit op zetmeelkorrels en porievorming. De aanwezigheid van 
het onbekende domein zorgt voor grotere poriën. Daarnaast lijken de FNIII 
domeinen geen effect te hebben op de activiteit of porievorming. 
 
Figuur 6: Overzicht van zetmeelkorrels, na 48 uur behandeling (incubatie) met verschillende 
MaAmyA varianten. ■: katalytisch domein, ■: FNIII domein, ■: CBM25 domein, ■: Onbekend 
domein.
CBM74 is mogelijk betrokken bij de fermentatie van resistent 
zetmeel in mensen
In hoofdstuk 3 wordt beschreven hoe het onbekende domein los is geproduceerd 
(alleen het roze domein uit Fig. 4) en geanalyseerd. Daarbij is aangetoond dat 
het onbekende domein wel aan zetmeel kan binden maar het zetmeel niet kan 
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Figuur 7: Fylogenetische boom van alle 77 gevonden CBM74 domeinen, inclusief MaAmyA, samen met 
een selectie van andere bekende CBM families. Tevens worden de domeinorganisaties van alle eiwitten 
weergegeven, alsmede informatie over de classificatie van het katalytische domein, de bacteriesoort 
welke het eiwit produceert en waar deze bacterie oorspronkelijk is gevonden (geïsoleerd). De lengte van 
de lijnen geeft aan hoeveel verschil er zit tussen de verschillende CBMs (schaalbalk geeft de lijn lengte aan 
die overeen komt met 0.1 aminozuur verandering per positie).
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afbreken. Tevens is aangetoond dat de aminozuurvolgorde van het onbekende 
domein anders is dan de 73 tot dan toe beschreven CBM-families (Fig. 4). Deze 
resultaten, samen met het effect op porievorming in zetmeelkorrels (Fig. 6 C en D) 
resulteren in de conclusie dat dit de eerste gekarakteriseerde vertegenwoordiger 
is van een nieuwe familie van koolhydraatbindende domeinen. Omdat dit de 74ste 
familie is die is beschreven in de literatuur heeft hij de naam CBM74 gekregen.
Om te onderzoeken hoeveel verschil er zit 
tussen verschillende CBM74-domeinen 
onderling en tussen CBM74 en bekende 
CBM-families is een fylogenetische analyse 
gedaan. Hiervoor werden de eiwitdatabases 
doorzocht en 76 eiwitten gevonden die 
een CBM74 domein bevatten. Van deze 76 
eiwitten is bekeken wat voor eiwitten het zijn, 
hoe hun domeinorganisatie eruit ziet (wat 
voor domeinen naast CBM74 zitten er in), 
door welke bacteriën ze gemaakt worden en 
waar die bacteriën oorspronkelijk gevonden 
(geïsoleerd) zijn. Deze resultaten (Fig. 7) laten zien dat CBM74 alleen in bacteriële 
eiwitten zit, en dan met name in grote α-amylases in combinatie met minimaal 
één CBM25 of CBM26 domein. Ongeveer de helft van deze bacteriën is geïsoleerd 
uit het menselijke spijsverteringsstelsel of een gerelateerde omgeving (zoals een 
riool). Als dit wordt bekeken voor alle zoogdieren is het zelfs ~75%. Dit wijst op 
een relatie tussen CBM74 en darmbacteriën. 
Bij gezonde mensen wordt al het resistente zetmeel uiteindelijk gefermenteerd 
door darmbacteriën, maar in twee onafhankelijke studies is gerapporteerd dat 
dit niet altijd het geval is voor mensen met obesitas [3,4]. Deze studies hebben 
vervolgens gekeken naar het voorkomen van verschillende darmbacteriën bij 
mensen met obesitas en gezonde mensen. Hieruit bleek dat mensen met obesitas 
veel minder tot geen Ruminococcus bromii en Bifidobacterium adolescentis 
bacteriën in hun ontlasting hadden. Wanneer deze bacteriën werden toegevoegd 
aan een ontlastingmonster van mensen met obesitas dan werd resistent zetmeel 
wel afgebroken. Juist Ruminococcus bromii en Bifidobacterium adolescentis 
bevatten een amylase met CBM74, terwijl de andere darmbacteriesoorten 
welke zijn getest in deze onderzoeken geen CBM74 domein bevatten. Het lijkt er 
dus op dat de grote complexe amylases met CBM74 een belangrijke rol hebben 
bij de fermentatie van resistent zetmeel in het spijsverteringsstelsel van mensen 
en zoogdieren.
GH13 subfamilies
De GH13 familie heeft heel veel leden 
(meer dan 35000). Omdat er toch wel 
duidelijk verschillende groepen zichtbaar 
waren zijn er subfamilies gemaakt op basis 
van de aminozuurvolgorde van het GH13 
domein. Het subfamilienummer volgt na 
een underscore achter GH13. Bijvoorbeeld 
GH13_42 voor subfamilie 42. Momenteel 
zijn er 42 subfamilies bekend. Daarnaast 
zijn er GH13 leden die niet tot een 
subfamilie behoren en daarom (nog) geen 
subfamilienummer hebben.
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Samenwerking tussen MaAmyA en MaAmyB
De zetmeelkorrelafbraak door MaAmyA is vergeleken met die door 
cultuurvloeistof van een M. aurum B8A cultuur die is gegroeid op medium met 
zetmeelkorrels.  Hierbij valt op dat de activiteit op zetmeelkorrels sterk verschilt, 
ondanks het feit dat de activiteit op oplosbaar zetmeel vergelijkbaar is. Waar 
MaAmyA alleen niet verder komt dan ~20% 
afbraak in 48 uur, zit de cultuurvloeistof 
al binnen 24 uur over de 50% afbraak (Fig. 
8). Wanneer de zetmeelkorrels met een 
vergelijkbaar afbraakpercentage met SEM 
worden bekeken is er ook een duidelijk 
verschil zichtbaar. Korrels behandeld met 
MaAmyA zien er uit als massieve korrels 
met één formaat poriën, terwijl de korrels 
die zijn behandeld met M. aurum B8.A 
cultuurvloeistof volledig poreus zijn en zowel 
grote als kleine gaten laten zien (Fig. 8). 
Figuur 8: Vergelijking van de zetmeelkorrelafbraak van MaAmyA en M. aurum B8.A 
cultuurvloeistof. De SEM foto’s van behandelde zetmeelkorrels zijn gemaakt na 6 uur (M. aurum 
B8.A cultuurvloeistof) of 48 uur (MaAmyA) incubatie. Het staafdiagram toont de verschillen in de 
groottes van de gevormde poriën. Omdat de M. aurum B8.A cultuurvloeistof (CV) naast veel kleine 
poriën ook een aantal grote poriën (GP) heeft zijn deze apart in het staafdiagram weergegeven.
Deze resultaten tonen aan dat M.aurum zeer waarschijnlijk naast MaAmyA 
gebruik maakt van één of meer extra enzymen om zetmeelkorrels efficiënt en 
volledig af te breken. Analyse van het DNA van M. aurum B8.A resulteerde in 
de identificatie van een gen coderend voor een tweede amylase, MaAmyB. In 
het DNA van M.aurum B8.A liggen de genen van MaAmyA en MaAmyB naast 
elkaar, wat er op kan wijzen dat ze functioneel met elkaar te maken hebben. 
Cultuurvloeistof
De cultuurvloeistof werd gemaakt door 
Microbacterium aurum B8.A stam gedu-
rende twee dagen te groeien in een 
vloeibaar medium waaraan zetmeelkorrels 
waren toegevoegd. Vervolgens werden de 
bacteriën en zetmeelkorrels verwijderd. De 
cultuurvloeistof bevatte alle enzymen die 
door Microbacterium aurum B8.A waren 
geproduceerd om de zetmeelkorrels af te 
breken. 
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In tegenstelling tot MaAmyA is MaAmyB een exo-amylase. Hierdoor kan 
MaAmyB alleen zetmeel vanaf de uiteinden afbreken. MaAmyB heeft naast het 
katalytische domein zes extra domeinen (Fig. 9). In hoofdstuk 4 wordt dit enzym 
meer uitgebreid beschreven.
Wat opvalt is dat het katalytische domein van MaAmyB ongeveer 20% groter is, ook 
al hoort het katalytische domein net als MaAmyA bij de GH13 familie (Fig. 9). Dit 
is een indicatie dat MaAmyB een vertegenwoordiger is van een nieuwe subgroep 
van de GH13 familie. Dit werd bevestigd na een fylogenetische analyse, waarvoor 
ook databases werden doorzocht met alle tot nu toe bekende eiwitsequenties. 
Hierbij werden 165 eiwitten gevonden met katalytische domeinen die in dezelfde 
groep als MaAmyB horen, voornamelijk in Streptomyceten. Samen vormen ze 
de nieuwe GH13 subfamilie 42 (GH13_42). Opvallend is dat alle leden van de 
GH13_42 subfamilie een vergelijkbare domeinorganisatie hebben, met telkens 
2 CBM25 domeinen en 1 FNIII domein welke voor het katalytische domein 
liggen (Fig. 7). Dit is bijzonder omdat geen van de tot nu toe beschreven GH13 
subfamilies dit heeft. Omdat we bij MaAmyA hebben aangetoond dat de CBM25 
domeinen noodzakelijk zijn voor zetmeelkorrelafbraak, en deze in de GH13_42 
subfamilie bijna altijd aanwezig zijn, lijkt het er op dat GH13_42 leden (zoals 
MaAmyB) ook betrokken zijn in de afbraak van zetmeelkorrels.
Figuur 9: Schematische weergave van MaAmyA, MaAmyB en de algemene domeinorganisatie van 
de GH13_42 subfamilie. Het katalytische domein van MaAmyA is direct boven het katalytische 
domein van MaAmyB geplaatst om het verschil in lengte tussen de 2 domeinen duidelijk weer te 
geven. De getallen geven de lengtes (in aantal aminozuren) van de verschillende enzymen aan. ■: 
katalytisch domein, ■: FNIII domein, ■: CBM25 domein, ■: CBM74.
Aangezien MaAmyB een exoactiviteit heeft en betrokken lijkt bij de afbraak 
van zetmeelkorrels, speculeren we dat in M. aurum B8.A MaAmyA en MaAmyB 
samenwerken in de zetmeelkorrelafbraak. Een soortgelijke samenwerking is al 
gerapporteerd tussen bacteriële α-amylases (endo-amylase) en glucoamylases 
(exo-amylase). Tevens komen in sommige Streptomyceten enzymen met 
GH13_42 domeinen voor, waarvan de genen op het DNA dichtbij genen liggen 
voor enzymen die lijken op MaAmyA. Onze hypothese is dat de endoamylase 
MaAmyA werkt als een boor en poriën maakt in de zetmeelkorrels. Vervolgens 
kan de exoamylase MaAmyB via deze poriën de zetmeelkorrel binnendringen 
en deze van binnenuit geheel afbreken. Deze hypothese past bij de data 
weergegeven in Figuur 8. Gedurende de eerste uren zal MaAmyA het meeste 
afbraakwerk doen (poriën maken in het oppervlak van de korrels), waardoor de 
afbraakpercentages in de twee geteste samples vergelijkbaar zijn (Fig. 8). Als de 
gaten eenmaal gemaakt zijn en MaAmyB hierdoor de korrels binnen kan dringen 
en deze van binnenuit begint af te breken, zal de afbraak versnellen. Dit is te zien 
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in Figuur 8: na 6 uur incubatie neemt de relatieve afbraak door de M.aurum B8.A 
cultuurvloeistof (wat zowel MaAmyA als MaAmyB bevat) toe, terwijl die door 
MaAmyA alleen afneemt.
FNIII domeinen fungeren als stabiele flexibele verbindingsstukken 
in koolhydraatenzymen
Zowel MaAmyA als MaAmyB bevatten vier FNIII-domeinen. Dit is voor 
koolhydraatenzymen een extreem hoog aantal aangezien minder dan 0.5% 
van alle koolhydraatenzymen die zijn opgenomen in de CAZy.org database 
een FNIII domein bevatten, en vaak niet meer dan twee FNIII domeinen per 
enzym. De rol van FNIII-domeinen in koolhydraatenzymen is onduidelijk. In de 
literatuur worden resultaten gevonden die elkaar tegenspreken. Een tweetal 
functies voor FNIII-domeinen worden in meerdere artikelen genoemd: een rol 
als oppervlaktebindingsdomein (vergelijkbaar met een CBM), of als flexibel 
verbindingsstuk tussen twee andere domeinen. We hebben een gedetailleerde
analyse gedaan om meer inzicht te krijgen in de mogelijke functie van FNIII-
domeinen in koolhydraatenzymen (hoofdstuk 5). Hiervoor hebben we eerst 
alle FNIII-domeinen in enzymen uit de CAZy database gehaald en vervolgens 
gekeken waar ze zich in het eiwit bevinden (tussen andere domeinen of aan een 
uiteinde). Ook keken we naar de activiteiten van enzymen met FNIII-domeinen 
om te zien of er een verband was tussen deze enzymen en een specifieke groep 
koolhydraten. Ter vergelijking werden deze analyses ook gedaan met bijna alle 
CBM-families (CBM1-67 en CBM74). De resultaten laten zien dat FNIII-domeinen 
vaak tussen twee andere domeinen liggen, terwijl CBM-domeinen juist vaak op 
een van de eiwit uiteindes liggen. Daarnaast werd er geen verband gevonden 
tussen eiwitten met een FNIII-domein en katalytische activiteit op een specifieke 
groep koolhydraten, terwijl zo’n verband wel gevonden werd voor enzymen 
met specifieke CBMs. Zo worden er bijvoorbeeld geen zetmeelbindende CBMs 
gevonden in enzymen die cellulose afbreken, terwijl FNIII-domeinen voorkomen 
in enzymen die of zetmeel of cellulose afbreken. Deze resultaten wijzen er 
op dat FNIII-domeinen fungeren als flexibele verbindingsstukken. Om dit 
goed te kunnen vaststellen zou bijvoorbeeld na het verwijderen van de FNIII-
domeinen van een enzym het andere type domein dat er achter zat moeten 
worden teruggeplaatst. Dit hebben we niet gedaan bij de MaAmyA-studie die 
beschreven is in hoofdstuk 2. Er is wel een publicatie over een ander enzym 
waarin dit experiment beschreven wordt en de resultaten van dit experiment 
passen bij onze hypothese dat FNIII-domeinen in koolhydraat enzymen fungeren 
als flexibele verbindingsstukken. 
De afbraak van zetmeelkorrels door bacteriële amylases
We hebben in hoofdstuk 2 laten zien dat MaAmyA CBM-domeinen nodig heeft 
voor het introduceren van poriën in zetmeelkorrels en de (gedeeltelijke) afbraak 
hiervan. Dit roept de vraag op hoe sommige bacteriële amylases zonder CBMs 
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dit ook kunnen (Introductie, Tabel 1). Hierbij valt op dat amylases die geen CBM 
nodig hebben in een andere GH13 subfamilie zitten dan amylases die wel een 
CBM nodig hebben (Introductie, Tabel 1). In de literatuur wordt gemeld dat een 
aantal van deze amylases op het katalytisch domein ook een soort van CBMs 
hebben. Dit worden oppervlaktebindingsplekken (SBS, Surface Binding Sites 
in het Engels) genoemd. Deze SBS zijn tot nu toe alleen gevonden in GH13 
subfamilies waar ook de amylases toe behoren die geen CBM nodig hebben 
om zetmeelkorrels af te breken. Onze conclusie is dat er twee mogelijkheden 
zijn waarop amylases zetmeelkorrels kunnen afbreken, namelijk met extra CBM 
domeinen of door de aanwezigheid van SBS in het katalytisch domein. 
Conclusies
Resistent zetmeel zoals zetmeelkorrels kan op twee manieren door bacteriële 
amylases worden afgebroken. Dit kan met behulp van extra CBM-domeinen in 
het enzym of door SBS in het katalytische domein. In het geval van MaAmyA 
van M. aurum B8.A gebeurt dit met behulp van CBM25. Daarnaast is er in 
MaAmyA een nieuw CBM-domein gevonden, CBM74, dat zeer waarschijnlijk 
een belangrijke rol speelt in de fermentatie van resistent zetmeel (bijvoorbeeld 
zetmeelkorrels) door darmbacteriën. De FNIII-domeinen in koolhydraatenzymen 
lijken te fungeren als flexibele verbindingsstukken om zo de samenwerking 
tussen het katalytisch domein en CBMs te optimaliseren. Tenslotte lijkt het er op 
dat in M. aurum B8.A MaAmyA en MaAmyB samenwerken om zetmeelkorrels 
efficiënt af te breken. 
Referenties
1 Lin L-L, Chyau C-C & Hsu W-H (1998) Production and properties of a raw-starch-degrading 
amylase from the thermophilic and alkaliphilic Bacillus sp. TS-23. Biotechnol. Appl. Biochem. 
28, 61–68.
2 Lo H-F, Lin L-L, Chiang W-Y, Chie M-C, Hsu W-H & Chang C-T (2002) Deletion analysis of the 
C-terminal region of the α-amylase of Bacillus sp. strain TS-23. Arch. Microbiol. 178, 115–
123.
3 Ze X, Duncan SH, Louis P & Flint HJ (2012) Ruminococcus bromii is a keystone species for the 
degradation of resistant starch in the human colon. ISME J. 6, 1535–1543.
4 Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat 
A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J & Flint HJ (2011) Dominant and 








Het is bijna zo ver, met het afronden van dit proefschrift komt er een eind aan 
mijn promotieonderzoek bij Microbiële Fysiologie, ook wel MicFys genoemd. 
De afronding van dit proefschrift is de laatste stap van een lang traject. Enige 
achtergrondinformatie om te illustreren wat dit traject voor mij heeft betekend 
is hierbij wel belangrijk. 
Ik wist al vrij snel dat mijn hart lag bij het laboratorium en dat ik graag de hoge 
laboratorium opleiding (HLO) wilde doen. Talen waren echter altijd een groot 
struikelblok en deze maakten het afronden van de HAVO en de bijbehorende 
talen onmogelijk. Toen uiteindelijk duidelijk werd dat dyslexie de oorzaak was 
van de problemen met talen heb ik hier gericht ondersteuning en bijles in 
gehad en was het uiteindelijk toch mogelijk om mijn MAVO diploma te halen 
en door te stromen naar het MLO. Mevrouw Schepers en Mevrouw Harmsen, 
ik ben jullie zeer dankbaar voor de geboden ondersteuning, zonder jullie was 
dit volledig in het Engels geschreven proefschrift er nooit geweest. Ik heb erg 
geprofiteerd van de praktijkgerichte ervaring van het MLO. Ook heeft het MLO 
ertoe geleid dat ik kon doorstromen naar het HLO. Met het afronden van het 
HLO heb ik mijn oorspronkelijke doel bereikt, maar zoals uit het bestaan van 
dit proefschrift blijkt, was dit niet mijn eindstation. Tijdens mijn afstudeerstage 
kwam ik in aanraking met de Rijksuniversiteit Groningen. Ik vond mijn project 
bij de groep moleculaire genetica zo leuk dat ik besloot masteropleiding 
“Moleculaire Biologie en Biotechnologie” te gaan volgen. Tijdens deze master 
ontmoette ik voor het eerst Prof. Dijkhuizen die zichzelf meteen voorstelde 
als Lubbert. Sindsdien heb ik Lubbert ook niet anders gekend (het ging zelfs 
zover dat medestudenten het eens hadden over “We hebben straks college 
van Professor Dijkhuizen” waarbij ik vervolgens dacht “Hmm ken ik die? Oh 
wacht, ze bedoelen Lubbert?”). Na mijn schakelprogramma heb ik Lubbert 
gevraagd om mijn studieleider te zijn en bleef ik regelmatig terug keren naar 
MicFys. Wat begon als een stage binnen MicFys onder leiding van Slavko Kralj 
en Wieger Eeuwema en een externe stage bij Basic Supply Group BV, waarbij 
ik bij MicFys kwam om experimenten te doen, is uiteindelijk uitgegroeid tot dit 
promotietraject.
Na mijn master kwam de mogelijkheid om een promotieonderzoek te doen als 
onderdeel van het TIFN B1003 “Slow starch” project. Hierbij was de keuze voor 
mijn promotor snel gemaakt. Ik voerde mijn onderzoek wederom uit bij MicFys 
en werd dus een vast lid van de groep. Hier werd ik, mede door mijn IT hobby, 
ook al snel gevraagd of ik de zorg voor alle IT gerelateerde zaken binnen de 
vakgroep op mij wou nemen. 
Mijn oorspronkelijke onderzoek was gericht op het bestuderen van zure 
hydrolyse producten van enzymatisch gemaakte glucose polymeren (o.a. 
reuteran), waarvan was aangetoond dat deze amylase enzymen konden 
remmen. Na ruim een jaar onderzoek waarin het niet lukte om dit te 
reproduceren, konden we de eerder gevonden resultaten verklaren en konden 
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we definitief concluderen dat er geen sprake was van inhibitie van amylases 
door dit soort zure hydrolyse producten. Op dat moment kwam de verhuizing 
van MicFys vanuit Haren naar het nieuwe gebouw op het Zernike terrein. 
Eenmaal daar konden we aan een nieuw project beginnen: het bestuderen van 
een bacterie (Microbacterium Aurum B8.A) welke enzymen maakte die in staat 
waren om zetmeelkorrels af te breken. Dit werk en de resultaten hiervan staan 
in dit proefschrift beschreven.
Met het afronden van dit werk wil ik graag een aantal mensen bedanken.
Ten eerste wil ik mijn promotor Lubbert Dijkhuizen bedanken voor de geboden 
kansen en het gestelde vertrouwen. Zowel op werk gebied als daarbuiten stond 
je mij altijd bij. De vele stimulerende discussies, feedback op manuscripten en 
presentaties hebben bij gedragen om mij een betere onderzoeker te maken. 
Mocht je in de toekomst nog eens problemen hebben met je laptop of toe 
zijn aan een nieuwe dan ben je altijd welkom. Daarnaast wil ik ook mijn co-
promotor Rachel van der Kaaij bedanken. Telkens als ik ergens mee vast zat 
kwamen jullie weer met nieuwe inzichten en ideeën waarmee ik weer verder 
kon. Rachel, jouw voortdurende steun met name in de laatste jaren was voor 
mij onmisbaar, niet alleen om goede wetenschappelijke artikelen te leren 
schrijven, maar ook om dit proefschrift tot een succesvol einde te brengen. Dat 
je dit zelfs hebt voortgezet nadat je een nieuwe werkplek kreeg waardeer ik 
enorm. 
Daarnaast wil ik ook de mensen van TIFN bedanken. In de eerste plaats Rob 
Hamer en Erik van der Linden voor het gestelde vertrouwen en de geboden 
kansen. Vervolgens natuurlijk mijn collega’s van het slow starch project, Met 
name Lizette Oudhuis, Peter Sanders en Alle van Wijk voor de discussies en 
hulp bij het project. Daarnaast ook Albert Woortman, Salomeh Ahmadiabhari, 
Marion Priebe en Coby Eelderink, met wie we minstens een keer per maand 
gezamenlijk overleg hadden en die mij daarbij juist inzicht gaven in het grotere 
geheel van het slow starch project. Hierbij keken Albert en Salomeh samen met 
Lizette vanuit een polymeer chemie achtergrond naar het project en Marion 
en Coby vanuit een meer medische achtergrond. Tevens verzorgden zij de 
(humane) studies waarin de verschillende ideeën in de praktijk getest konden 
worden. Pieter mag in dit dankwoord ook zeker niet ontbreken. In Haren waren 
we kantoorgenoten en stond je altijd voor mij klaar voor labgerelateerde zaken, 
maar ook daarbuiten. Daarnaast zorgde jouw inzet voor de vele neventaken 
ervoor dat het lab en de apparatuur soms letterlijk bleef draaien. Ook had je 
bijna altijd overal wel een back-up voor als er onverwacht op het lab eens iets 
op was, of wanneer ik door een spontane uitbereiding van een experiment een 
gebrek had aan LB-broth. Ik ben dan ook erg blij dat je mijn paranimf wilt zijn. 
I would also like to thank my other former office mate Munir Anwar for your 
encouragements during my study and good atmosphere in the office. I was 
honored to be your paranimf. Hans ik wil jou bedanken voor de tips, het mee 
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denken en ook zeker voor het CNPG3 substraat wat jij aan mij hebt gegeven, 
waarvan ik zoals je kan lezen dankbaar gebruik heb gemaakt. Jolanda, ik wil 
jou graag bedanken voor je support en gezelligheid die je hebt gegeven in 
het nieuwe kantoor. We hebben vele discussies gevoerd over onze projecten, 
toekomst en daarbuiten. Ook de lunchpauzes die we vaak samen met Evelien 
hielden waren zowel gezellig als ook leerzaam. Evelien, al jouw hulp en ideeën 
om het construct tot expressie te brengen in Rhodococcus waren onmisbaar 
en Gerda, hoe het jou toch altijd weer lukte om de meest rare constructen die 
ik had bedacht te realiseren bleef me verbazen. We hadden niet voor niets 
wel eens de uitspraak “Als het niet lukt om een construct te maken, geeft het 
dan voordat je opnieuw begint eerst nog aan Gerda”. Ik heb het erg getroffen 
dat jij zelfs nog na je pensioen als vrijwilliger bij de groep betrokken bleef om 
DNA constructen te maken. Evelien, ook na het vertrek van Jolanda hebben 
we de gezamenlijke lunches voortgezet. Mede dankzij jouw projectwissel 
waren ze nog altijd zowel gezellig als nuttig, met goede discussies over zowel 
mijn als jouw project. Ook in de minder werk-gerelateerde zaken, heb je mij 
altijd bijgestaan. Ik ben dan ook erg blij om ook jou als paranimf te hebben. 
Alicia, ik wil jou bedanken voor alle hulp en bijdragen aan het werk en support. 
Jou bijdrage aan het CBM74 werk was onmisbaar en ik heb van jou heel veel 
geleerd over CBMs en de methoden en technieken die beschikbaar zijn om ze 
te bestuderen. 
Dear Ceylan, I would certainly not forget about you. I enjoyed it a lot to 
supervise you during your internship and we both learned a lot. Even if things 
got tough you quickly continued, cheerful as ever. It was a lovely period of 
my promotion. Jacqueline, although I was not your full supervisor I was still 
glad to have kind of adopted you as my student. It is always nice to see that 
someone tries to make the most of their internships and since you had a lot 
of waiting time during your experiments you wanted to do something extra in 
those hours. I was happy that you joined me and Ceylan during those times 
and I gladly showed you the PCR and recombinant DNA techniques we used. 
Scheduling was a bit of a challenge but we managed to make it work. I have 
good memories of you both and I’m glad that I could help you both during your 
studies. We had a really good time and the photo that we took at the borrel 
still makes Pieter slightly jealous ;) I would like to thank the former and current 
MicFys members for their feedback, support and the good atmosphere during 
my promotion, Ahmed, Ana, Bai, Carmen, Cecile, Coenie, Dennis, Geralt, Hans-
Jörg, Hien, Huifang, Ilse, Jan, Jelle, Joana, Justyna, Kamila, Karina, Lara, Laura, 
Maarten, Marc, Markus, Mark, Marnix, Marta, Mirjan, Robert, Sebas, Sahar, 
Sander, Slavko, Theo, Tim, Wieger, Wouter, Xiangfeng, and everyone else I 
might have missed.
Elena, I would like to thank you for your help, tips and advice on how to 
proceed after I obtain my PhD and increase my chances to find a job. 
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We kunnen natuurlijk niet het secretariaat vergeten. Bea, Manon en later 
ook Anmara. Telkens als ik ook maar ergens tegen aan liep qua geregel of 
administratief kon ik altijd even bij jullie langs lopen en werd het geregeld. 
Jullie deur stond altijd open, en het was altijd gezellig. Bea ik wil je ook in het 
bijzonder bedanken voor het proofreaden van mijn Nederlandse samenvatting. 
Lieve Pa en Ma, jullie kunnen hier natuurlijk niet ontbreken. Jullie hebben me 
altijd gesteund en ervoor gezorgd dat ik sommige zaken direct goed aanpakte, 
ook als ik zelf op dat moment nog niet zo het nut van zag… (ik herinner mij 
een typecursus tijdens de middelbare school op het 8e en 9e lesuur waar ik 
helemaal geen zin in had). Ook ben ik heel blij met jullie support bij het maken 
van de keuze richtingen, soms tegen de adviezen van anderen in. Als ik er op 
terug kijk ben ik er zeker van dat deze route voor mij de beste optie is geweest, 
zowel op professioneel als ook op persoonlijk vlak. Ook dat ik telkens weer de 
auto mee kon nemen voor stage of later naar Haren omdat de verbindingen 
met het openbaar vervoer veel meer tijd kostten waardeer ik zeer. Mijn 
schoonouders, Jan en Ina, maar ook mijn schoonzus en haar vriend, Kim en 
Tim, mogen niet ontbreken. Jullie hebben me met open armen ontvangen en 
hebben mijn traject volledig ondersteund en met interesse gevolgd. Kim, ik 
wil jou in het bijzonder bedanken voor het proofreaden van mijn Nederlandse 
samenvatting.
Dan zijn we bijna aan het eind, maar er ontbreekt natuurlijk nog iemand. 
Mijn liefste Rivca, jij bent mijn steun en toeverlaat geweest gedurende dit 
hele traject. Je was en bent er altijd voor mij en ik kan altijd op jou bouwen. 
Sommigen zeggen dat een promotie de leukste of belangrijkste dag in je 
leven is, echter geen promotie kan onze trouwdag (in het eerste jaar van mijn 
promotietraject) overtreffen. Inmiddels ben jij ook aan een promotietraject 
begonnen, (waar een gesprekje op een MicFys kerstdiner allemaal toe kan 
leiden). Ik hoop dat ik jou daarbij net zo bij kan staan als dat jij voor mij gedaan 
hebt. Jij bent de liefde van mijn leven en ik ben heel blij en gelukkig dat ik je 
mede door mijn opleidingstraject op het HLO heb leren kennen. We zijn de 
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